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 The prevalence of type 2 diabetes mellitus (DM) has increased dramatically over the past two 
decades, particularly among adults living in rural communities.   Related health complications include 
structural brain changes and decreased cognitive function.  Cognitive decline associated with DM may 
influence one’s ability to perform self-care and affect glycemic control. In turn, poor glycemic control 
contributes to increased complications associated with DM. Although one’s ability to maintain glycemic 
control may be highly dependent on cognitive abilities, there is limited understanding about the 
relationship between cognitive function, self-care, and glycemic control in rural adults with DM. 
Specific aims of this study were to: 1) examine the relationships between cognitive function, 
glycemic control, and contributing factors (age, years with DM, education category, 
cardiovascular (CV) risk, level of depression) in rural adults with DM; 2) examine whether 
cognitive function predicts glycemic control in rural adults with DM; 3) examine the relationship 
between cognitive function, self-care, and contributing factors (age, years with DM, education 
category, everyday problem-solving, and level of depression) in rural adults with DM; and, 4) 
examine whether cognitive function predicts self-care in rural adults with DM. 
 This descriptive study included a convenience sample of (N=56) rural adults with DM. A 
face-to-face interview was conducted with each participant, where performance of the cognitive 




measured with neuropsychological tests. Frequencies of performing DM self-care activities of adherence 
to diet, exercise, blood glucose monitoring, foot care and medications were queried to determine levels of 
self-care, and a recent glycohemoglobin was obtained to determine glycemic control. 
 Main results were that cognitive function in domains of attention, executive function, 
mental processing speed, or verbal episodic memory, after controlling for modifiable and non-
modifiable covariates, did not independently explain glycemic control or the frequency of DM 
self-care activity performance by rural adults with DM. The covariates cardiovascular risk and 
depression independently explained cognitive function, and depression independently explained 

























 The prevalence of diabetes mellitus (DM) has increased dramatically in the United States 
(US) over the past two decades.  According to the Centers for Disease Control (CDC, 2014), the 
number of newly diagnosed cases of DM in adults between the ages of 18-79 more than tripled 
from 493,000 in 1980 to over 1.4 million in 2014. The CDC (2014) reported that 21 million 
people in the US have been diagnosed with type 1 or type 2 DM, with type 2 accounting for 90-
95% of the cases. Another 8.1 million are thought to have DM but are undiagnosed, bringing the 
total to 29.1 million, or 9.3% of the US population. The prevalence of DM increases as age 
increases (20-44 years =4.1%, 45-64 years = 16.2%, and over 65 years =25.9%) (CDC, 2014). 
Risk of death among adults with DM is almost twice that of adults without DM. Related 
comorbidities and health complications include structural brain changes and cognitive 
dysfunction, cardiovascular disease, blindness, kidney failure, nervous system damage, and 
lower limb amputations.  These sequelae are estimated to increase the overall direct costs to the 
healthcare system by $176 billion annually (CDC, 2014).  
 Maintaining glycemic control by maintaining one’s glycohemoglobin or HbA1c level at 
7% or below reduces microvascular and neuropathic complications (American Diabetes 




adequate glycemic control through the combined effects of diet, exercise, and medication, all of 
which require some degree of self-care practice.  The complexity of maintaining adequate 
glycemic control, however, requires the ability to perform ongoing self-care routines that require 
multiple cognitive processes. Hence, decreased cognitive function may influence one’s ability to 
perform self-care and affect glycemic control (Qiu et al., 2006). 
 The Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-
MIND) study (n=2,977), an Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial 
(N=10,251) sub-study, examined differences between rate of cognitive decline and structural 
brain changes in ACCORD participants (Cukierman-Yaffe et al. 2009a). Measurements of 
cognitive domains included mental processing speed, learning capacity, attention, working and 
verbal memory, executive function based inhibition, and global cognition. Results revealed an 
inverse age-adjusted relationship between cognitive test scores and degree of chronic 
hyperglycemia, as measured by HbA1c levels. Findings supported the hypothesis of a 
progressive relationship between decreased cognitive function and chronic hyperglycemia, and 
in turn decreasing cognitive function and poorer glycemic control.   The findings were 
concerning, as achieving glycemic control requires decision based self-care that centers on 
information collection and processing, which are cognitive processes that appear to be at risk for 
impairment in persons with DM (Cukierman-Yaffe et al., 2009). The profile of affected cognitive 
domains in DM is well documented, and includes attention, executive function, mental 
processing speed, and verbal episodic memory (Reijmer et al., 2010). This profile of cognitive 
deficits is associated with impaired self-care performance (Nguyen et al., 2010; Primozic, 
Tavcar, Avbelj, Dernovsek, & Oblak., 2012; Qiu et al., 2006), and may affect glycemic control 




cognitive dysfunction may include comorbidities and sociodemographic variables (Manschot et 
a., 2007; Nguyen et al, 2010; Saczynski et al., 2008). Adults (> 18 years of age) in rural 
communities are also at greater risk for poorer glycemic control than are adults in non-rural 
communities because they often have less access to DM resources, travel greater distances for 
health care, and have lower availability of specialty services (Hale, Bennett, & Probst, 2010). 
 There is a gap in our understanding about: 1) what factors influence cognitive function, 
self-care performance, and glycemic control in rural adults with DM, 2) the relationship between 
cognitive function and glycemic control in rural adults with DM, and 3) the relationship between 
cognitive function and DM self-care performance in rural adults with DM.  The overall purpose 
of this study was to examine the relationship between cognitive function (i.e. attention, executive 
function, mental processing speed, verbal episodic memory), self-care performance (diet, blood 
glucose testing, foot care, exercise, medications), and glycemic control among rural adults with 
DM over the age of 45.  
Specific Aims and Research Hypotheses 
Aim 1: Examine the relationships between cognitive function, glycemic control, and contributing 
factors (age, years with DM, education category, cardiovascular (CV) risk, level of depression) 
in rural adults with DM who are ages 45 and older. 
Hypothesis 1.1: Increased age, years with DM, CV risk, depression, and decreased years of 
education will correlate with declining function in cognitive domains of attention, executive 
function, mental processing speed, and verbal episodic memory.  
Hypothesis 1.2: Increased age, years with DM, CV risk, depression, and decreased years of 
education will correlate with poorer glycemic control. 




Hypothesis 2.1: Glycemic control, after controlling for contributing factors, would 
independently predict performance in cognitive function measures. 
Hypothesis 2.2:  Cognitive function, after controlling for contributing factors, would 
independently predict glycemic control.  
Aim 3:  Examine the relationship between cognitive function, self-care, and contributing factors 
(age, years with DM, education category, everyday problem-solving, and level of depression) in 
rural adults with DM. 
Hypothesis 3: Increased age, years with DM, depression, and decreased years of education, 
everyday problem-solving, glycemic control, and cognitive function would correlate with poorer 
levels of DM self–care.  
Aim 4: Examine whether cognitive function predicts self-care in rural adults with DM. 
Hypothesis 4: Cognitive function, after controlling for contributing factors, would independently 
predict self-care performance. 
Background 
Pathophysiology Associated with Cognitive Dysfunction in DM 
 Although the exact mechanisms are unknown, four major physiological factors 
commonly contribute to cognitive dysfunction in DM:  metabolic (hyper/hypoglycemia, 
impaired glucose metabolism); endocrine (hyperinsulinemia, insulin resistance, hypothalamic-
pituitary-adrenal axis dysregulation); vascular (micro and macrovascular disease, endothelial 
dysfunction, inflammation, blood-brain barrier permeability changes, dyslipidemia); and, central 
nervous system disorders (neuronal homeostasis changes, genetics, amyloidal deposits, 




 Proper brain function requires continuous glucose and oxygen supply. Associations 
between impaired glucose metabolism (Lamport, Lawson, Mansfield & Dye, 2009; McCrimmon 
et al., 2012; Zhong et al, 2012), chronic hyperglycemia (Convit, 2005; Lamport et al., 2009), and 
impaired cognition have been reported.  Mechanisms involving blood-brain barrier glucose 
transport have shown that cognitive effort increases glucose uptake leading to localized brain 
glucose level depletion (Convit, 2005; Lamport et al., 2009). Blood-brain barrier glucose 
transport is mediated by endothelial cell expressed transporter GLUT1. Increased contact 
between blood, endothelial cells, and GLUT1 require greater transport demands. Impaired 
endothelial vasodilation and insulin resistance (defined as reduced cellular response to intrinsic 
insulin) are associated, hence a dysfunctional compensatory mechanism for cognitive effort 
induced blood glucose reductions may result (Convit, 2005; Lamport et al., 2009). 
 Insulin resistance occurs in pre-DM and DM and appears to have several unclear effects 
on neuronal activity (Convit, 2005; Williamson, McNeilly, & Sutherland, 2012) and cognition 
(Baker et al. 2011; Yanagawa et al., 2011). Insulin resistance may potentiate detrimental brain 
effects of cortisol elevations. Increased cortisol exposure has been associated with reductions in 
hippocampal volume (Convit, 2005), which places the hippocampus, a brain structure essential 
for memory function, at risk for damage from hypoxia and hyperglycemia (Convit, Wolf, 
Tarshish, & de Leon, 2003; Convit, 2005; Wrighten, Piroli, Grillo & Reagan, 2009). Animal 
models support a physiological role of insulin as a cognitive modulator in the hippocampus with 
a critical role in hippocampal memory processing (McNay & Recknagel, 2011). Brain MRI has 
shown hippocampal atrophy in persons with DM (Convit et al., 2003; Convit, 2005; den Heijer et 
al., 2003; Gold et al., 2007). Reduced functional connectivity between hippocampus, temporal 




functions (Zhou et al., 2010).  Associations have been found between brain atrophy and poorer 
cognitive scores in DM patients, but findings are inconsistent (Brundel et al., 2012; Christman, 
Vannorsdall, Pearlson, Hill-Briggs, & Schretlen, 2010; by de Bresser et al., 2010; vanElderen et 
al., 2010). 
Cognitive Dysfunction in DM 
  The prevalence of cognitive dysfunction in DM was not evident in the literature, as little 
is known regarding stages of appearance and progression over time.  In a systematic review of 
the relationship between glycemic control and cognitive function in individuals with DM 
Cukierman, Gerstein, & Williamson (2005) found that studies differed in their use of cognitive 
tests but overall results indicated DM participants had greater rates of cognitive decline and risk 
of future dementia than persons without DM. Early stages of DM are often undiagnosed; hence, 
early cognitive decline often goes unnoticed as well (Fischer, deFrias, Yeung, & Dixon, 2009; 
Nooyens, Baan, Spijkerman, & Vershuren, 2010; Okereke et al., 2008; Ruis et al., 2009; 
Saczynski et al., 2008; Yeung, Fischer, & Dixon, 2009). Impaired glucose metabolism and 
insulin sensitivity found in a pre-DM stage are linked to cognitive dysfunction. Metabolic 
syndrome (also a pre-DM stage) and DM have similar cognitive deficit profiles (Reijmer et al., 
2010). The impact of associated risk factors for cognitive dysfunction, such as insulin resistance, 
chronic hyperglycemia, hypertension and hyperlipidemia is unclear (Cukierman-Yaffe et al., 
2009a; Cukierman-Yaffe et al., 2009b; Umegaki et al, 2012a; Umegaki et al., 2012b; van den 
Berg et.al, 2008).  
   Cognitive domains most often affected in DM include attention, executive function, 
mental processing speed, and verbal episodic memory.  Less affected domains include 




be affected more than long term memory (Reijmer et al., 2010). Different processes for cognitive 
decline in DM may occur.  There is evidence for: 1) mild slowly progressing decline beginning 
in pre-DM stages, and 2) severe faster decline with high prevalence of vascular and Alzheimer’s 
dementia (Reijmer et al., 2010). 
Self-care in DM 
 For persons with DM, maintaining health necessitates performance of daily self–care 
activities essential for achieving and maintaining good glycemic control, which, in turn, reduces 
complication rates. The cognitive deficit profile in DM, especially executive function, has been 
linked to impairment in performance of self-care, activities of daily living (ADLs) and 
instrumental activities of daily living (IADLs) (Nguyen et al., 2010; Primozic et al., 2012; Qiu et 
al., 2006; Thabit et al., 2009; Thabit et al., 2012). Findings by Primozic et al. (2012) showed DM 
patients with poorer cognitive abilities, specifically related to planning and problem solving, 
were more likely to have difficulty understanding and recalling self-care instruction. Results by 
Nguyen et al., (2010) were unable to confirm links between executive function, DM knowledge 
and adoption of self-care practices, but did support an association between poorer executive 
function and poorer glycemic control. Findings suggested that complex relationships linking 
cognition, knowledge and self-care remain largely unknown. Future studies are needed to clarify 
these relationships. 
Glycemic Control 
 Glycemic control, defined as the optimal level of average blood glucose levels associated 
with reduction of complications of DM (ADA, 2014). It is best measured by glycosylated 
hemoglobin, or HbA1c, which is a measure of the attachment, or glycation, of glucose to 




reported as a percent of glycated hemoglobin in the blood, where the higher the level of glucose 
in the blood is, the higher the percent of HgA1will be. HbA1c reflects the average blood glucose 
over 3-4 months (the average life span of a red blood cell) and therefore has a strong predictive 
value for DM complications (ADA, 2014).  Maintaining HbA1c at 7% or below has been shown 
to reduce microvascular and neuropathic complications, however individual recommendations 
may vary. More stringent goals (HbA1c <6.5%) may be appropriate with persons with a short 
DM duration and no significant cardiovascular disease.  Less stringent goals (HbA1c <8%) may 
be more appropriate for those with a history of severe hypoglycemia, advanced microvascular or 
macrovascular complications, or extensive comorbid conditions (ADA, 2014). 
Contributing Factors to Cognitive Function in DM 
 Age and DM. 
The presence of DM in midlife (age 57-60 years) has been consistently associated with 
increased risk of accelerated cognitive decline in later years (Nooyens et al., 2010; Rawlings et 
al., 2014; Tuligenga et al., 2014), but study results have varied in the affected cognitive domains 
and the magnitude of the cognitive decline (Reijmer et al., 2010). In a systematic review by 
Reijmer and colleagues (2010), cognitive deficits were found to be more evident in persons with 
DM over the age of 65 years old when compared with control groups (Reijmer et al., 2010).  
Longitudinal studies showed cognitive decline in persons with DM over an average of five years 
that exceeded normal aging effects between 1.5 and 2 times. While these results demonstrated an 
increased risk of cognitive decline among older adults with DM, it must also be noted that 
cognitive testing differed between studies. Other longitudinal studies showed no accelerated 
cognitive decline (Reijmer et al., 2010). Reijmer and colleagues concluded that the decreases 




suggesting the effects of age and DM on cognition share a common etiology, and DM is a risk 
factor for cognitive decline. 
Number of years with DM.  
 Cognitive dysfunction in persons with DM has been associated with the length of 
time one has DM. Some studies have shown that increased duration is associated with a mild 
decline, and other studies have shown a faster rate of decline (Reijmer et al., 2010). Cognitive 
dysfunction in DM may have a specific time of onset with no further decline, and different 
cognitive domains may be affected at different times (McCrimmon et al., 2012). The duration of 
time with DM and associated cognitive decline may also reflect chronic exposure to other risk 
factors and comorbidities such as lifestyle, demographic, hypertension, obesity, and depression 
(Reijmer et al., 2010).  
 Cardiovascular risk factors in DM. 
 The brain can be considered a target end-organ in DM and pre-DM, but the causative 
factors for cognitive deficits are difficult to define due to the comorbidities associated with DM. 
Cardiovascular, or heart and blood vessel disease, includes numerous problems on a 
macrovascular (myocardial infarction, stroke, carotid, coronary or peripheral arterial disease) and 
microvascular (neuropathy, retinopathy, nephropathy) level, many of which are related to 
atherosclerosis. Macrovascular disease appears to have a strong association with DM and is 
estimated to cause around 80% of mortality in DM (McCrimmon et al., 2012). Macrovascular 
disease correlates with brain atrophy and cognitive deficits in DM, but association with cerebral 
perfusion is unclear (Manschot et al., 2006; Manschot et al., 2007; McCrimmon et al., 2012; 
Tiehus et al., 2008b). Microvascular disease has a primary role in cerebrovascular pathology, but 




et al., 2012; Nelson et al., 2009). Cerebrovascular or cardiovascular risk factors associated with 
DM may mediate or moderate cognition at various times for various durations (Cukierman, 
Gerstein, & Williamson, 2005). An aim of the proposed study is to examine the influence of 
cardiovascular disease on cognitive dysfunction in DM. 
 Depression in DM. 
  Although the relationship is unclear, depression is more prevalent in persons with DM 
than those without the disease. Some speculate that it may be a consequence of coping with a 
chronic disease or the result of damaging metabolic consequences affecting cerebral 
neurotransmitter levels or vascular integrity (Reijmer et al., 2010).  Sullivan et al. (2013) found 
that depression in ACCORD-MIND participants was associated with greater cognitive decline in 
domains of mental processing speed (p=.003), verbal memory (p=.001), and executive function 
(p=.02). Also, depression may be a predictor for poor self-care (Primozic et al., 2012; Qiu et al., 
2006). Depression can impair one's ability to adhere to self-care regimens, potentially worsening 
the course of a chronic illness and causing a downward spiral. Because depression and disability 
are associated, recognition and treatment of depression in chronically ill persons is thus an 
important part of clinical management (Lamers et al., 2008). 
 Health disparities and rurality. 
   A rural community is defined as an area with a population of fewer than 50,000 people, 
and has a core population density of fewer than 1000 persons per square mile (Hart, Larson, & 
Lishner, 2005).  According to United States Census 2000 population statistics, nearly 21% of the 
population lives in rural areas (Bureau of the Census, 2010).  Adults (> 18 years of age) in rural 
communities are at greater risk for poorer glycemic control than adults in non-rural communities 




DM resources when compared to non-rural populations and thus travel greater distances for 
health care (Hale, Bennett, & Probst, 2010; Quandt et al., 2005; Utz, 2008). A data analysis from 
the 2006 Behavioral Risk Factor Surveillance System (n=29,501) explored differences in DM 
care and DM outcomes associated with rural residence (Hale et al., 2010). Rural residents with 
DM were disadvantaged compared with non-rural residents with DM in education level (p<.001), 
income level (p<.001), and health insurance coverage (p<.009).  Rural residents were also less 
likely to report having had DM screening exams (foot exam p=.006, eye exam p=.006), and more 
likely to report occurrence of retinopathy (p=.007) and foot ulcers (p=.036) (Hale et al., 2010). 
Because rural residents have a higher incidence of DM, longer distances to care, and lower 
availability of specialty services than do non-rural residents, they are an important public health 
target group.  
 Brown et al. (2009) and Kilbourne and colleagues (2006) proposed socioeconomic status 
as a major factor in health outcomes in health disparities research in vulnerable populations, as 
race/ethnicity alone is not fully explanatory. Community characteristics such as education and 
income levels are considered as risk factors of poorer health outcome (Brown et al., 2009; 
Kilbourne et al, 2006). The framework presented by Kilbourne et al, (2006) includes individual, 
household, and community factors as part of socioeconomic status, as the progression of a 
chronic disease such as DM is likely influenced by these factors over time. Gender, age, and 
racial/ethnic factors are considered as covariates in the framework. Socioeconomic status may 
influence health outcomes through mediating/moderating factors such as health behaviors, 







 As previously noted, DM is a complex disorder with four major physiological factors that 
commonly contribute to cognitive dysfunction in DM (McCrimmon, Ryan, & Frier, 2012). The 
profile of affected cognitive domains in DM is also well documented, and includes attention, 
executive function, mental processing speed, and verbal episodic memory (Reijmer et al., 2010). 
This profile of cognitive deficits is associated with impaired self-care performance (Nguyen et 
al., 2010; Primozic, Tavcar, Avbelj, Dernovsek, & Oblak., 2012; Qiu et al., 2006), and may 
affect glycemic control (Munshi et al., 2012, Thabit et al., 2012). In addition to the structural 
brain changes associated with DM, other contributing factors for decreased cognitive function 
include sociodemographic variables, comorbidities, and duration of having DM (Saczynski et al., 
2008). Based on the literature, a conceptual framework (Figure 1) was developed to describe the 
relationships among these factors. The framework incorporates biological, environmental and 
behavioral influences on cognitive function, self-care, and glycemic control in persons with DM. 
 Embedded in the framework is a model for DM self-care based on the self-care model by 
Song (2010). A situation-specific theory for self-care in heart failure patients (Riegel and 
Dickson, 2008) was adapted by Song (2010) for DM self-care. Situation-specific theories focus 
on specific phenomena seen in clinical practice, and are limited to a specific population or field 
of practice. They are theories that incorporate the complexity of nursing and which provide 
important frameworks for use in both nursing practice and research (Im & Meleis, 1999). The 
DM self-care model by Song (2010), self-care consists of two components:  Self-care 
maintenance and Self-care management. Self-care maintenance includes behaviors one may 
utilize to maintain physiologic stability- symptom monitoring and treatment adherence.  Song’s 




blood glucose testing, exercise, and foot examination). Self-care management incorporates active 
decision making in response to awareness of sign and symptom changes, and includes five 
stages: 1) recognition, 2) evaluation, 3) decision to take action, 4) treatment implementation, and 
5) treatment evaluation. Self-care maintenance activities are routine and differ from decision 
making and problem solving required in Self-care management.  In this dissertation research, 









































Figure 1.1. Conceptual Framework
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Figure 1.2 DM Self-Care Framework for Guiding Analysis  
Adapted from:  Song (2010). Journal of Cardiovascular Nursing; 25(2): 93-98.  
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 A secondary analysis was conducted using data from the Cognitive Deficits in Chronic 
Heart Failure Study (PI: Pressler; NR008147).  In the analysis, 414 participants (mean age 61.5 
years; 51% women) were included.  Cognitive deficits were measured and compared among four 
groups-persons with both heart failure (HF) and DM (n=94), persons with HF and not DM 
(n=157), persons with DM and not HF (n=30), and persons without HF or DM (n=133).  
Compared with persons with no HF and no DM, persons with HF and DM had significantly 
worse scores in cognitive processes of verbal memory (p<.001), visuospatial ability (p=.03), 
attention (p=.01, p=.03), executive function (p=.001), and mental processing speed (p<.001). 
Post hoc results with Tukey’s Honestly Significant Differences also showed that patients with 
HF and DM had worse scores compared with patients without HF or DM in executive function, 
verbal memory, mental processing speed, working memory, and visuospatial ability recall.  After 
controlling for age and years of education, group differences remained for tests in domains of 
verbal memory, mental processing speed and executive function.  These important findings 
illustrate that the presence of comorbid DM in HF patients has a great impact on cognition and 
that little is still known about the combined effects of these two chronic diseases.  These findings 
prompted further study into the cognitive processes of persons with DM and the impact on 
functional status and glycemic control. 
Structure of the Dissertation 
 This dissertation follows a three-manuscript format consisting of five chapters: an 
introduction, three manuscript-style papers, and conclusion. In the first chapter, background 
knowledge, aims and hypotheses, theoretical framework, and preliminary study are presented. 





to what is known about the relationship between cognitive function in DM and DM self-care ane 
where knowledge gaps exist. The second manuscript (Chapter 3) investigated the relationships 
between cognitive function, contributing factors, and glycemic control. Chapter 4, the third 
manuscript, investigated the relationships between cognitive function, self-care, contributing 
factors, and glycemic control. The final chapter provides a summary of the results, overall 
conclusions, clinical implications of the findings, strengths and weaknesses of the research, and 
directions for future study. 
Summary 
  Glycemic control may be highly dependent on cognitive and self-care abilities. There is 
a lack of knowledge about the relationship between cognitive function, self-care, and glycemic 
control in rural adults with DM.  While decreased ability to perform cognitively complex daily 
self-care tasks has been shown to be an early indicator of cognitive decline, however, the 
relationship of specific cognitive domains to self-care performance is unclear. The role of other 
contributing factors to cognitive and self-care performance is also uncertain. For persons with 
DM, activities involved with self-care routines are unique, yet have some similarities in 
cognitive requirements such as processing information, decision making and problem solving. 
There is a knowledge gap concerning the differences in level of cognitive function and 
performance of DM self-care routines. It is important to identify what factors put persons with 
DM at risk for cognitive decline, poor self-care performance and glycemic control, so 
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Cognitive Function and Self-Care in Adults with Type 2 Diabetes- 
  State of the Science 
Introduction 
 The prevalence of diabetes mellitus (DM) has increased dramatically in the United States 
(US) over the past two decades.  According to the Centers for Disease Control (CDC, 2014) 21 
million people in the US have been diagnosed with type 1 or type 2 DM, with type 2 accounting 
for 90-95% of the cases. Another 8.1 million are thought to have DM but are undiagnosed (CDC, 
2014), bringing the total to 29.1 million, or 9.3% of the US population. The prevalence of DM 
increases as age increases (20-44 years =4.1%, 45-64 years = 16.2%, and over 65 years =25.9%) 
(CDC, 2014).   Risk of death among adults with DM is almost twice that of adults without DM. 
Related comorbidities and health complications include structural brain changes and cognitive 
dysfunction, cardiovascular disease, blindness, kidney failure, nervous system damage, and 
lower limb amputations.  These sequelae are estimated to increase the overall costs to the 
healthcare system; direct costs alone are estimated to add $176 billion annually (CDC, 2014). 
Glycemic control significantly reduces the occurrence of complications, and is fundamental to 
managing DM (American Diabetes Association, 2013). The American Diabetes Association 





through the combined effects of diet, exercise, and medication, all of which require some degree 
of self-care practices.   
   The ACCORD-Memory in Diabetes (ACCORD-MIND) study (n=2,977), a sub-study of 
the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial (N=10,251), examined 
differences between the rate of cognitive decline and structural brain changes in ACCORD 
participants (Cukierman-Yaffe et al. 2009). The results revealed an age-adjusted association 
between higher HbA1c levels and poorer cognitive test scores in the domains of global cognition 
(p<.0001), executive function (p=.0094), mental processing speed (p<.0001), and verbal memory 
(p=.0142), and supported the hypothesis of a progressive and positive relationship between 
chronic hyperglycemia and cognitive dysfunction. Also, the results with estimating the 
independent relationship between HbA1c and cognitive measures when adjusting for risk factors 
of duration with DM, history of cardiovascular disease and stroke, race, and language, revealed 
small but significant differences in R2 values when HbA1c was included and excluded in the 
models. The researchers concluded that while the relationship between HbA1c and cognitive 
dysfunction may be explained by risk factors other than chronic hyperglycemia, HbA1c levels 
are modifiable with therapeutic decisions, and glycemic control is important for preserving 
cognitive function. The findings were concerning, as achieving glycemic control requires 
decision based self-care that centers on information collection and processing, which are 
cognitive processes that appear to be at risk for impairment in persons with DM (Cukierman-
Yaffe et al., 2009). 
 DM is associated with structural brain changes and dysfunction in the cognitive processes 
essential for learning and performing ongoing self-care activities to maintain glycemic control 





(Biessels, Strachan, Visseren, Kappelle, and Whitmer, 2014; Cukierman-Yaffe et al., 2009). In 
order to understand the link between brain changes in DM and glycemic control, it is necessary 
to examine the relationships between cognitive dysfunction in DM, self-care abilities, and 
glycemic control, and to identify contributing risk factors that may be modifiable.  
Methods 
 The aim of this scoping literature review was to identify and summarize the existing state 
of knowledge about cognitive dysfunction in DM and DM self-care. The analysis was guided by 
the following questions:  What factors are related to cognitive dysfunction in persons with DM? 
What is known about the association between cognitive dysfunction and performance of self-care 
activities among persons with DM? 
Search Methods 
 
 A literature search was conducted from January 2005 through December 2014 to reflect 
contemporary research on the topic. Databases included were:  MEDLINE, PubMed, CINAHL, 
and PsycINFO. Key search terms (MeSH) were: type 2 diabetes mellitus, cognition, cognition 
disorder, self-care, and self-management.  Electronic searches were supplemented by hand 
searches from reference lists from publications that met the search criteria.  
Inclusion and Exclusion Criteria 
 The searches were limited to English language, journal articles, meta-analyses, 
observational studies, randomized control trials, reviews, and systematic reviews. Data-based 
studies that included adult persons with type 2 DM, and pertained to cognitive dysfunction and 
/or self-care in type 2 DM were included.  Commentaries, letters to the editor, summaries, and 







  The search yielded 373 publications, 11 of which were duplicates. Of the 362 unique 
publications, 288 were not directly related to cognitive dysfunction in DM or DM self-care, and 
did not meet eligibility criteria (see Figure 2.1).  
 






          The 74 publications were critiqued and categorized into four groups: 1) pathophysiology 
related to cognitive dysfunction in DM (n=39); 2) reviews of empirical studies related to 
cognitive dysfunction in DM (n=6); 3) data-based studies related to cognitive dysfunction in DM 
(n=18); and, 4) publications related to self-care in DM (n=11). 
Pathophysiology Related to Cognitive Dysfunction in DM 
 The 39 publications in this category covered four major physiological factors that 
commonly contribute to cognitive dysfunction in DM:  metabolic (hyper/hypoglycemia, 
impaired glucose metabolism); endocrine (hyperinsulinemia, insulin resistance, hypothalamic-
pituitary-adrenal axis dysregulation); vascular (micro- and macrovascular disease, endothelial 
dysfunction, inflammation, blood-brain barrier permeability changes, dyslipidemia); and, central 
nervous system disorders (neuronal homeostasis changes, genetics, amyloidal deposits, 
depression) (McCrimmon, Ryan, & Frier, 2012).  
  Four publications specifically addressed the metabolic, endocrine, and vascular factors 
related to brain metabolism and cognitive dysfunction, finding that cognitive dysfunction was 
associated with impaired glucose metabolism (Lamport, Lawson, Mansfield & Dye, 2009; 
McCrimmon et al., 2012; Zhong et al, 2012), chronic hyperglycemia (Lamport et al., 2009), 
insulin resistance (Convit, 2005; Williamson, McNeilly, & Sutherland, 2012), and histories of 
severe hypoglycemia (Feinkohl et al., 2014). Affected cognitive domains included global 
cognition (Feinkohl et al., 2014; Zhong et al, 2012), executive function, mental processing speed, 
and nonverbal memory (Feinkohl et al., 2014). Studies of mechanisms involving blood-brain 
barrier glucose transport demonstrate that cognitive effort increases glucose uptake, thereby 





glucose transport is mediated by endothelial cell expressed transporter GLUT1, increased contact 
between blood, endothelial cells, and GLUT1 requires greater transport demands. Impaired 
endothelial cellular function and insulin resistance (defined as reduced cellular response to 
intrinsic insulin) are associated, hence a dysfunctional compensatory mechanism for cognitive 
effort induced blood glucose reductions may result (Lamport et al., 2009).  
 Seven other publications in this category addressed the relationship between insulin 
resistance and its anatomical and functional effects on the brain. Insulin resistance, which occurs 
in both pre-DM and DM, has been associated with hippocampal volume reductions (Convit, 
2005), and appears to have several unclear effects on neuronal activity (Convit, 2005; 
Williamson et al., 2012), and cognition (Baker et al. 2011; Yanagawa et al., 2011).  The 
hippocampus, essential for memory function, is susceptible to damage from hypoxia and 
hyperglycemia (Convit, 2005; Wrighten, Piroli, Grillo & Reagan, 2009), and potentially from 
hypothalamic pituitary adrenocortical axis dysregulation (Bruehl et al., 2009). Insulin resistance 
may potentiate the detrimental brain effects of cortisol elevations, which has been associated 
with hippocampal volume reductions and memory performance (Convit, 2005). Animal models 
have demonstrated the physiological role of insulin as a cognitive modulator in the hippocampus 
that is critical in hippocampal memory processing (McNay & Recknagel, 2011). 
   Twenty-two publications focused on vascular disease, anatomical brain changes, and 
cognitive dysfunction. In individuals with DM, macrovascular and microvascular disease, 
chronic hyperglycemia, hypertension, and hyperinsulinemia have been associated with cortical 
and subcortical brain atrophy and cognitive dysfunction (Manschot et al. 2006; Manschot et al., 
2007; Tiehus et al., 2008; Tiehuis et al.,2009). Decreases in brain volume in DM vary from no 





(de Bresser et al., 2010; Espeland et al., 2013; van Elderen et al., 2010). Although hippocampal 
atrophy is evident among persons with DM (Convit, 2005; den Heijer et al., 2009; Gold et al., 
2007), it is not clear whether the hippocampus is more severely affected than other brain areas 
(Biessels & Reijmer, 2014). In a study over a two-year period Samaras et al. (2014) 
demonstrated that baseline DM was associated with greater increases in cerebrospinal fluid 
volumes (p=.02), and with declines in hippocampal, parahippocampal, precuneus and total brain 
volumes compared to no DM at baseline. The relationships between  brain volumes and 
cognitive performance in persons with DM varied between studies (Biessels & Reijmer, 2014; 
Brundel et al., 2012; Christman, Vannorsdall, Pearlson, Hill-Briggs, & Schretlen, 2010; Moran et 
al., 2013; Roberts et al., 2014; Verdelho et al., 2010; Zhang et al., 2014), however, two studies 
reported poorer performance in the cognitive domains of attention, executive function, memory, 
and mental processing speed in individuals with DM (Manschot et al., 2006; Manschot et al., 
2007). 
 Small vessel disease changes in the brain (i.e., silent brain infarcts and white matter 
lesions) may be predictive of cognitive decline in DM (Imamine et al., 2011). Manschot et al. 
(2006) found more cerebral infarcts and deep white matter lesions in persons with DM than in 
controls, as well as dysfunction in the cognitive domains of attention, executive function, and 
mental processing speed (Manschot et al., 2006). Frontal and prefrontal system executive 
dysfunction may be associated with hyperglycemia-related neuronal degeneration or small vessel 
disease- induced regional cerebral blood flow changes (Thabit et al., 2009). Chronic 
hyperglycemia has been linked with formation of advanced glycation end-products, which are 
believed to be linked to microvascular disease in DM, impaired neuronal function, glucose 





Guerrero-Berroa, Schmeidler, & Beeri, 2014). Although cerebrovascular pathology appears to be 
severe in DM, histopathologic studies examining the neuropathology of small vessel disease in 
DM are lacking (Nelson et al., 2009).   
 Lastly, six publications presented the results of MRI studies pertaining to structural and 
functional brain network connectivity. Compared with controls, persons with DM showed 
microstructural abnormalities in white matter tracts connecting frontal, parietal and temporal 
brain regions, which are associated with cognitive functions including attention, executive 
function, mental processing speed, and verbal memory. Reductions in mental processing speed 
and memory were significant (p<.05) (Reijmer et al., 2013). Medial prefrontal and temporal 
parietal brain regions that are most active at rest and deactivated during cognitive tasks are called 
the default mode network (DMN). The DMN has high metabolic activity, making it susceptible 
to the effects of hypo and hyperglycemia found in DM (Hoogenboom et al., 2014; Marder et al., 
2014). Recent studies have documented reduced functional connectivity between the 
hippocampus and several regions associated with the DMN (Hoogenboom et al., 2014; Musen et 
al., 2012; Zhou et al., 2010). Insulin resistance has been associated with decreased resting-state 
functional connectivity of the posterior cingulate cortex, a highly metabolically active area of the 
brain with high connectivity to other brain areas (Chen et al., 2014), and in other areas in the 
DMN where decreased functional connectivity occurs prior to the appearance of identifiable 
structural deficits (Musen et al., 2012).  Marder et al. (2014) found reduced activation and 
deactivation in the DMN during cognitive task performance in persons with DM compared with 
controls. Zhou et al. (2010) demonstrated dysfunction in episodic memory and executive 





reduced neuronal connectivity disturbances may be widespread in persons with DM and may 
impact learning and memory.   
Reviews of Empirical Studies Related to Cognitive Dysfunction in DM    
 The six comprehensive reviews of empirical studies related to cognitive decline in DM 
focused on the risk of cognitive dysfunction and dementia, the effects of aging, and risk factors 
associated with cognitive decline. In their review of 25 studies, Cukierman and colleagues 
(2005) reported well documented evidence of a greater rate and risk of cognitive decline and 
dementia in persons with DM. Although various cognitive tests were used in the studies, overall 
results indicated that having DM was associated with a 1.5-fold greater risk for cognitive decline 
(Cukierman et al., 2005); as such, the authors concluded that cognitive dysfunction should be 
considered a complication of DM. A meta-analysis including 19 longitudinal studies by Cheng 
and colleagues (2012) documented relative risks for persons with DM compared with persons 
without DM: 1.2 for mild cognitive impairment, nearly 2.5 for vascular dementia, 1.5 for 
Alzheimer’s disease, and 1.5 for any dementia. These findings suggest that DM is a risk factor 
for mild cognitive impairment as well as dementia. In addition, Biessels et al. (2014) found that 
having DM was associated with a 1.5-3 times greater conversion rate to dementia in persons with 
mild cognitive impairment, an intermediate stage between normal cognition and dementia.  
 Findings from cross-sectional case-control and population-based studies reviewed by 
Reijmer et al. (2010) showed worse performance for persons with DM compared to age-, sex-, 
and education- matched controls in the cognitive domains of attention, executive function, 
mental processing speed, and verbal memory. Effect sizes were small to medium (range 0.2-0.6), 
and were consistent across age groups (range 50-80 years) (Reijmer et al., 2010).  Decreased 





et al., 2014; Reijmer et al., 2010).  Longitudinal studies showed that cognitive decline exceeded 
normal aging effects by almost twice over an average of five years, and demonstrated slowly 
declining cognition across all age groups (Reijmer et al., 2010). However, observed differences 
were small and differed from the distinct decline typical for Alzheimer’s disease (Reijmer et al, 
2010).  The accelerated decline typically seen with dementia is believed to be a result of 
processes different from that of normal aging, and the additive effect of DM may translate into a 
dementia onset 2.5 years earlier than that experienced by those without DM (Biessels et al., 
2014). Often occurring years before DM diagnosis, impaired glucose tolerance (Lamport, 
Lawton, Mansfield, & Dye, 2009), hyperinsulinemia, and reduced insulin sensitivity (Reijmer et 
al., 2010) have been linked to cognitive decline similar to those with a diagnosis of DM.  
Metabolic syndrome (defined as the presence of three or more of these criteria: obesity, 
dyslipidemia, hypertension, elevated fasting blood glucose level, insulin resistance) has a 
cognitive deficit profile similar to that of DM (Reijmer et al., 2010). 
 The risk factors associated with DM (microvascular complications, hypertension, obesity, 
hyperlipidemia) are interrelated and may affect cognition at various times for various durations 
(Biessels et al., 2014; Cukierman, et al., 2005; Reijmer et al., 2010; van den Berg, Kloppenborg, 
Kessels, Kappelle & Biessels, 2009).  A systematic review by van den Berg et al. (2009) 
compared the profile and magnitude of cognitive deficits associated with each of four vascular 
risk factors: DM, hypertension, dyslipidemia, and obesity. Cognitive test results from the 
included studies were converted to effect sizes using Cohen’s d computations, and categorized 
into the pre-determined cognitive domains of attention, cognitive flexibility, general intelligence, 
language, perception/visuoconstruction, memory, and mental processing speed.  Results 





hypertension (HTN) showing the most associations. Median effect sizes (ranges: DM = 0 -1.9, 
HTN = 0.2 - 2.2) in the most commonly affected domains were memory (DM = 0.3, HTN = 0.4), 
attention (DM = 0.5, HTN = 0.4), and mental processing speed (DM =0.4, HTN = 0.2).  This 
review suggests that early subtle changes in cognition maybe similar with DM, dyslipidemia, 
HTN, and obesity, and may provide opportunities for early intervention to improve control of the 
identified risk factors and reduce cognitive decline.  
 Depression in persons with DM has also been shown to increase the risk of cognitive 
dysfunction and dementia (Reijmer et al., 2010). The relationship between depression in DM and 
cognitive decline is unclear, but may result from coping with a chronic disease or from 
metabolically-induced damage that affects cerebral neurotransmitter levels or vascular integrity 
(Reijmer et al., 2010).   
Data-Based Studies Related to Cognitive Dysfunction in DM 
 Eighteen studies focused on the relationship between cognitive dysfunction and DM, two 
studies on pre-DM, three on early DM, seven on duration of DM, and six on risk factors (see 
Table 1 for summaries).   
 Cognitive dysfunction in pre- and early DM. 
 Findings in studies pertaining to pre-DM (impaired fasting glucose or metabolic 
syndrome) showed that diagnosed and undiagnosed DM groups had slower mental processing 
speed than normoglycemic groups (Saczynski et al., 2008; van den Berg et.al, 2008). 
Undiagnosed DM groups had poorer verbal memory performance than either diagnosed DM or 
normoglycemic groups (Saczynski et al., 2008). In domains of attention and executive function, 
persons with metabolic syndrome had poorer performance than did controls (van den Berg et.al, 





performance by persons with DM in memory functions, mental processing speed (Nooyens, 
Baan, Spijkerman & Verschuren, 2010; Ruis et al., 2009), attention and executive functions, 
language comprehension, immediate memory and learning rate, and incidental memory (Ruis et 
al., 2009). Lower performance in executive functions was found in young adults with DM 
compared with controls, with the mean difference between groups largest at ages 35-44 years 
(p<.001) (van Eersel et al., 2013).  
 Cognitive dysfunction and duration of DM. 
 In studies examining the association between increased duration of DM and cognitive 
decline, similar results were found for several cognitive domains, and, in some domains, having 
DM was the cognitive equivalent of aging three years (Okereke et al., 2008). The presence of 
DM in midlife (age 57-60 years) has been consistently associated with an increased risk of 
accelerated cognitive decline in later years (Nooyens et al., 2010; Rawlings et al., 2014; 
Tuligenga et al., 2014). In studies comparing persons with DM to controls, decreases in global 
cognition over time tended to be worse with poor glycemic control (Ravona-Springer et al., 
2014; Rawlings et al., 2014; Tuligenga et al., 2014), showing a19-24% faster decline (Rawlings 
et al., 2014; Tuligenga et al., 2014), while persons with low and stable glycohemoglobin levels 
had the best cognitive performance over time (Ravona-Springer et al., 2014). Associations 
between DM and decline in verbal memory became stronger with increased DM duration 
(Okereke et al., 2008; Spauwen Kohler, Verhey, Stehouwer, & van Boxtel, 2013). Over a period 
of 6 to 20 years, persons with DM showed decreased mental processing speed and executive 
function when compared with controls (Fischer, de Frias, Yeung, & Dixon, 2009; Rawlings et 





 In incident DM (DM diagnosed after baseline), significant decline in mental processing 
speed over 6 years was the only deficit noted compared with controls; this deficit increased with 
DM duration (Spauwen et al., 2013).  Findings by Fischer et al. (2009), Rawlings et al. (2014), 
and Yeung, Fischer, and Dixon (2009) suggested that mental processing speed and speed-
intensive executive function tasks may be early markers for decline.  The cognitive domains of 
episodic and semantic memory and verbal fluency were measured less often and results varied 
(Fischer et al., 2009). No evidence of interaction between DM and gender on cognitive decline 
was found in studies by Nooyens et al., (2009), Okereke et al. (2008), Ruis et al., (2009), 
Tuligenga et al., (2014), van den Berg et al., (2008), or van Ersel et al., (2013). 
 Risk factors for cognitive dysfunction in DM. 
 Co-occurring comorbidities may be risk factors for cognitive dysfunction in DM, and 
cardiovascular disease may mediate the relationship between cognitive decline and DM 
(Cukierman-Yaffe et al., 2009). In a study of elderly persons with DM (mean age [SD] = 70.6 [+ 
42.5] years), Umegaki et al. (2012) found that the comorbidities of diabetic nephropathy, high 
systolic blood pressure, and high triglyceride levels at baseline were predictors of global 
cognitive decline over 6 years. Changes in clinical indices during the 6 year follow-up period 
associated with cognitive decline were higher HbA1c, lower high-density lipoprotein and higher 
diastolic blood pressure.  
 Higher prevalence and persistence of depression has been found in persons with DM 
compared to control groups (Degmecic et al., 2014; Koekkoek et al., 2012; Trento et al., 2013). 
Prevalence of depression has been reported to be from 8-31% (mean 18%) with DM and from 5-
24% (mean 10%) without DM (Koekkoek et al., 2012). Compared with controls, those with DM 





moderate, severe and very severe depression at 36.1% (Degmecic et al., 2014). The relationship 
between DM and depression may be bidirectional and influenced by biologic and behavioral 
factors (Degmecic et al., 2014; Sullivan et al., 2013; Trento et al., 2013). Studies examining 
cognitive function and depression in DM have had differing results, likely due to differences in 
sample size and assessment methods (Trento et al., 2013).  
 In a meta-analysis of three studies using identical depression scales and 
neuropsychological tests for memory, Koekkoek et al. (2012) examined the role of depressive 
symptoms (mild depression) on cognitive function and cognitive decline in persons with DM 
versus controls. In overall cognition, performance was worse in those with DM compared with 
the control group (p < .001). No difference was found in performance in all cognitive domains in 
persons with DM both with and without mild depression, and no association was noted between 
DM, mild depression, and accelerated cognitive decline (Koekkoek et al., 2012). Findings by 
Trento et al. (2013) over four years from baseline showed stable mean scores for depression, 
anxiety, and cognitive function in persons with DM who switched from non-insulin to insulin 
treatment. Improvement in cognition was seen in two treatment groups (non-insulin and insulin) 
four years after baseline (both p < .001). Depression and anxiety increased (both p <.001) in 
those on insulin in the same time period, while depression decreased (p=04) and anxiety level 
were unchanged in the non-insulin group. Women had higher levels of depression than men 
(p<.001), and increased duration of DM was associated with increased anxiety scores (p = .01) 
(Trento et al., 2013). A prospective study of participants in the ACCORD-MIND study, 
conducted over 40 months, demonstrated the association of depression with greater cognitive 
decline (but not necessarily cognitive impairment) in executive function (p = .02), mental 





depression and cognitive decline were not associated with cardiovascular disease, baseline 
cognition, age, or type of DM or hypertension treatment. These findings implicate depression as 







Summary of Data-Based Studies Related to Cognitive Dysfunction in DM 











Examine differences in 
cognition by glycemic 
status. Measured 
domains:  memory, 
mental processing 
speed (MPS) & 
executive function (EF)  
 
Normal glycemic 















 (n=955, mean age=76 
years, 64.4% female) 
IFG (n=744, mean age= 
75.3 years, 54.4% 
female) 
Undiagnosed DM (n=55, 
mean age=75.9 year, 
45.5% female)  
Diagnosed DM (n=163; 
mean age= 75.6 years; 
44.2% female)  
 
C   Cross- 
      sectional 
 
Compared with normal 
glycemic group: slower 
MPS in undiagnosed & 
diagnosed DM (both 
p<.01); poorer memory 
performance in 
undiagnosed DM (p<.05).   
 
DM duration > 15 years--
slower MPS (p<.001) & 
poorer EF (p<.05). 
 
Role of DM duration, 
vascular and 
neurodegenerative 
comorbidities not well 
defined 
van den Berg 












function between DM 
patients, metabolic 
syndrome patients & 
controls.   
Measured domains:  
abstract reasoning, 














DM (n=64, mean age=74.1 
years 50% female);  
MS (n=83, mean age=73 
years, 53% female);  
Control (n=100, mean 
age=73.6 years, 50% 
female) 
C Cross- 
     sectional 
Compared with controls 
DM & MS patients had 
poorer scores in MPS, 
attention & EF (p<.05). 
 
 DM & MS patient score 
differences were not 
significant. 
 
 DM risk factors did not 
differ between DM & MS 
patients suggesting they 








potentially in pre-DM 
  
 
Cognitive Dysfunction in Early DM 
 
    Nooyens et al. 
(2010)                                       
Examine association of 
DM status and 
cognitive decline. 
Measured domains: 





(DM at baseline) 








examine the impact 
of life style and 
biologic risk 
factors on health; 
Netherlands 
Eva Prevalent DM 
         (n=61, mean  
         age= 60.6 years, 49.2%  
         female);  
    I   Incident DM  
         (n=78, mean  
         age=57.4 years, 46.2%  
         female); 
No DM  
(n=2460, mean age=55 






     Longitudinal Baseline scores for with 
DM poorer compared to 
without DM. 
 
Prevalent DM compared 
with no DM had greater 
decline in: memory 
(p<.05), & cognitive 
flexibility (p<.01). 
 
Incident DM compared 
with no DM had greater 
decline in: memory, MPS, 
& cognitive flexibility (all 
p<.05) only for > 60 years 
age.  
 
Results supported that 
chronic hyperglycemia may 
affect different domains at 





Ruis et al.,                                                                       
(2009) 
Examine type and
severity of cognitive 
deficits in early DM 
(recent diagnosis).  
Measured domains:  
abstract reasoning, 
attention, & EF, 
language, memory 
(working, incidental, 
immediate / learning 







study, a national 
randomized 




usual DM care 
(Netherlands, 
2002-2004)  
Pr     DM  
         (n=183, mean  
    g   age=61.2 years,   
   %   38.8% female);  
     I   No DM  
         (n=69, mean 
          age=62.7 years, 




C   Cross- 
      sectional 
Compared with no DM 
group, with DM group had 
poorer performance in: 
memory (composite p<.05, 
immediate & incidental 
both p<.01), attention & 
EF, MPS, & language (all p 
<.05). 
 
Adjusted for IQ: DM group 
had poorer performance in: 
memory (composite & 
immediate both p<.05, 
incidental p<.01).  
 
Supports cognitive 
dysfunction already present 
in early DM. 
Van Eersel et 
al. (2013) 
Examine association of 
DM & cognitive 
function in persons 
aged 35-82 years. 
Measured domains: EF 














         (n=264, mean  
    g   age=64 years,   
   %   37% female);  
    I   No DM 
         (n=3871, mean  
         age= 54 years,  
         49% female)  
 
 
C   Cross- 
      sectional 
With DM had poorer scores 
compared with no DM in 
EF & memory (both 
p<.001) 
 
Difference between groups 
in EF scores was largest at 
age 35-44 years (p<.001) & 




groups in memory scores 
were similar in all age 
groups. 
 
Findings support presence 
of cognitive dysfunction in 








Duration of DM and Cognitive Dysfunction 
Fischer et al.                 
(2009)   
Examine temporal 
stability and decline 
patterns of cognitive 
domains of DM patients 
and healthy control 
persons. Measured 
domains: declarative 
memory (episodic & 
semantic), verbal 
fluency, MPS (semantic 
speed, reaction time), 
EF (inhibition, task 





Study, an ongoing 
multicohort study, 
sample three, wave 
1 & 2(initial 
N=570); initiated in 
late1980’s 
(Canada) 
     Wave 1: 
     DM (n=28, mean 
     age=68.5 years,  
     64.3% female); 
    No DM (n=272,  
     mean age=66.7  
    years, 69.1%  
     female);  
 
     Wave 2:  
     DM (n=28, mean  
     age=72.8 years, 
     64.3% female);  
     no DM (n=272,    
     mean age=71.1  
     years, 69.1% 
     female) 
     Longitudinal  
     (3 years) 
Repeated measures 
MANCOVAs group effects: 
DM poorer performance in 
EF (task shifting) & MPS 
(semantic speed) (p<.01);  
EF inhibition (p<.001, p<.05), 
MPS reaction time (p<.05).  
 
Findings supported deficits in 
MPS & speed intensive EF 
tasks may be early markers for 
cognitive decline in DM 
Okereke et al. 
(2008) 
Examine DM duration 
and cognitive decline in 
men and women.  
Measured domains: 
global cognition, verbal 












     PHS: 
     DM (n=553; mean  
     age=71.9 years;  
     100% male); 
    no DM (n=5354; 
     mean age=71.5  
     years; 100% male) 
 
     WHS:      
     DM (n=405;  
     mean age=65.9  
     years; 100%  
     female);  
     no DM (n=5921; 
     mean age=66.3 years;  
     100% female) 
 
C   Cross-                                                  
al   sectional 
 Compared with no DM, males 
& females with DM had lower 
baseline cognition scores. 
   
 Association between DM & 
cognitive decline stronger with 
increased DM duration (trends 
p <.001). 
 
No interaction between DM & 











term trajectories of 
glycemic control with 
cognitive performance 
in cognitively normal 









Based on level  
at entry  
(higher/lower), 
















selected from the 
Diabetes Registry 




.    Lower/Stable  
     (n= 227, mean 
     age=72.99 years,   
     mean entry 
     HbA1c=5.96)  
 
      Higher/Stable  
     (n= 365 mean 
     age=72.91 years,   
     mean entry 
     HbA1c=6.84)  
 
.    Lower/Increasing  
     (n= 123, mean 
     age=72.52 years,   
     mean entry 
     HbA1c=7.26)  
           
     Higher/Increasing 
      (n= 46, mean 
     age=70.78 years,   
     mean entry 
     HbA1c=7.76)  
 
     Lower/ Decreasing  
     (n= 59, mean 
     age=73.63years,   
     mean entry 
     HbA1c=9.19)  
 
Higher/Decreasing 
(n= 15, mean 
     age=69.73 years,   
     mean entry 
     HbA1c=10.73)  
 
C   Cross- 
      sectional 
Higher/Decreasing group had 
lower scores in overall 
cognition (p range= .02-.002) 
& EF (p range= .03-.005) than 
all groups except the 
Higher/Increasing group 
 
Higher/Decreasing group had 
lower scores in semantic (p 
range =.01-.005) than all 
groups except the 
Lower/Decreasing group 
 
Lower/Stable group performed 









between DM in midlife 
and 20-year cognitive 
decline. Characterize 
long-term decline 
across levels of glucose 
control. Measured 
domains:  EF, language, 
mental processing 
speed (MPS), verbal 
memory. Global z-score 
used to summarize all 
test performance. 
No DM  
(HbA1c <5.7),  
Pre-DM  
(HbA1c 5.7 – 6.4),  
 DM  







(ARIC) study, a 
prospective cohort 
study 
    No DM  
(n=11,572, 
mean age = 56.8 years, 
55.3% female)                                                                         
 
With DM (n=1779, 
 mean age =58.2 years, 





Average differences in 20-year 
decline comparing with DM & 
no DM (all p <.05):  global, EF 
& MPS (19%), language 
(71%).  
 
Global decline over 20 years 
compared with no DM was 
greater with DM (all levels of 
control p=.037) & preDM (p= 
.005).  
 
 DM with HbA1c > 7.0 
associated with greater decline 
than DM HbA1c <7.0(p=.071)  
 
Longer DM duration 
associated with greater decline 
for global & all domains (p for 
all trends < .003) 
S   Spauwen et  
     al. (2013)                                                 
Investigate the effects 
of baseline & incident 
DM on decline in 
cognition over 12 years. 
Measured cognitive 
domains (at 6 & 12 year 
follow-ups): EF, global 
function, MPS, verbal 
memory  
 
No DM,  
DM (at baseline), 
 incident DM  
(found at follow 
up) 
1290 participants at 




     NoDM 
      (n-1,222; mean age= 
      59.4 years; 50%  
      female) 
       Baseline DM                                                                                                                                    
(      n=68; mean age = 
       68.8 years; 50%  
       female) 
       Incident DM-6years 
       (n=54; mean age= 
       62.9 years; 33.3% 
       female)  
      Incident DM-12 years 
       (n=57; mean age= 
       57.4 years; 47.4%    
       female) 
         
        
Longitudinal Baseline DM decline over 12 
years compared with noDM:  
MPS & EF (p<.01); verbal 
memory (p<.05) 
Incident DM compared with 
no DM: subtle early decline in 
MPS 
 
12-year duration of DM had c 








Examine whether DM 
and pre-DM are 
associated with faster 
cognitive decline from 
late midlife (age 55 
years) to early old age 
(age 65 years). 
Examine association of 
DM duration & 





verbal fluency & verbal 




 Pre-DM,  
New DM,  








from the Whitehall 
II cohort study 
(London); 
Cognitive tests 
done 3 times over 
10 years (1997-99, 
2002-4, 2007-9); 
HbA1c done twice 
during follow up 
(2002-4, 2007-9) 
      Normoglycemic 
     (n=4703, baseline  
     mean age =        
     55.1 years, 27%  
     female, mean   
     HbA1c=5.4%)  
 
      Pre-DM 
     (n=648, baseline  
     mean age =        
     57.5 years, 27% 
     female, mean       
     HbA1c=5.71%)  
 
 New DM 
     (n=115, baseline  
     mean age =        
     59 years, 30%  
     female mean   
     HbA1c=6.27%)  
 
P    Known DM 
     (n=187 baseline  
     mean age =        
     57.4 years, 30%  
     Female, mean   
     HbA1c=6.84%)  
 
L   Longitudinal  
 
Known DM compared with 
Normoglycemic had faster 
decline in memory (45%; 
p=.046), reasoning (29%; 
p=.026, & global cognitive 
score (24%; p=.014). 
 
Pre-DM & New DM rates of 
decline similar to 
Normoglycemic. 
 
Poorer glycemic control in 
Known DM associated with 






Yaffe et al. 
(2012) 
Determine if prevalent 
& incident DM increase 
risk of cognitive 
decline;  
 
Determine if high 







attention, EF, MPS 
(DSST) 
DM, no DM at 
baseline 
 
 Incident DM 
identified over 10 
years with HbA1c 
done at years 4, 6, 
&10 
3069 participants in 






    DM at baseline 
      (n = 717,  
       mean age =74.2 years,  
      45.5% female) 
 
      NoDM at baseline  
     (n = 2193, mean age =  
     74.1 years, 53.8%  
     female) 
 
      Incident DM 
      (n = 159, mean age =   
      73.7 years, 49.1%  
      female) 
 
 
L   Longitudinal  
 
DM at baseline compared with 
noDM:  lower MMSE & DSST 
scores (both p=.001). Incident 
DM at baseline compared with 
noDM MMSE & DSST 
similar, but lower than DM 
 
DM at baseline compared with 
noDM decline over 9 years: 
lower MMSE (p=.008) & 
DSST 
(p = .001). Incident DM 
compared with noDM decline 
not significant, but lower than 
DM at baseline. 
 
DM at baseline: at 3.5 years 
higher HbA1c associated with 
poorer scores in MMSE 
(p=.003) & DSST (p =.04) 
Yeung et al., 
(2009)  
Examine group 
differences in cognitive 
performance by DM 
status and age (young-









reaction time), & verbal 
fluency 
DM, no DM P    Participants in the  
      Victoria  
      Longitudinal  
      Study,  
      sample three,  
      wave 1(initial  
      N=570);  
     Canada (2002- 
      2003) 
 
DM: young-old (n=24,  
mean age=63.6 years, 
66.7% female); old-old 
(n=17, mean age=75.6 
years,41.2% female)   
  
No DM: young-old 
(n=273, mean age=62.45 
years, 72.5% female); 
old-old (n=151, mean 
age=77.6 years, 63.6% 
female) 
 Cross- 
     sectional 
     DM group had poorer    
      scores than non DM in EF  
(inhibition p=.003; task                                        
switching p=.013), MPS             
(semantic speed tests p=.015 &   
p =.008). 
 Old-old group had poorer 
scores than young-old in all 
measures except semantic 
memory & verbal fluency 
(p range <.001-.047). 
 There were no interaction 
effects with age group & DM 
status indicating DM related 






       Risk Factors and Cognitive Dysfunction in DM 
    Cukierman-
Yaffe et al.
 (2009) 
     To examine the 
      relationship 
      between the  
      degree of 
      hyperglycemia in  
      DM & cognitive           
a    status. 
      Measures    
      included: 
:     HbA1c, FBG,  
      global cognition         
      (MMSE), visual  
m   motor speed,  
      learning   
      capacity,  
      attention &  
      working memory  
      (DSST), verbal  
      memory, EF- 
      inhibition  
 













age=62.5 years, mean 
DM duration=10.4 years, 
47% female) 
C   Cross- 
      sectional  
      data 
     Association between  
     1% higher HbA1c & poorer    
     scores in global cognition,      
     DSST (both p<.0001), 
     verbal memory (p=.014),  
     EF (p=.009). 
     No associations found for  
     FBG. 
     Findings supported a  
     relationship between poorer  
     HbA1c & progressive  




Determine rate of 
depression & anxiety & 
cognitive function in 
DM patients compared 





DM, no DM N = 108, (mean age 
= 61 years) 
epidemiological 
study, Croatia 
DM (n=66, 42% female); no 
DM (n=33% female) 
    
Cross-
sectional 
DM group have more 
depression & anxiety than no 
DM group (p=.035, p = .002) 
 
Prevalence of depression 
(moderate  
to very severe) in DM group = 
36%. 
 
 More cognitive dysfunction in 





influence of depressive 
symptoms (mild 
depression) on the 





(n=183, mean age = 63 
years, 39% female), no 
Meta-
analysis 
DM had worse performance 
than noDM in composite 
(p<.001), & no difference in 






DM & cognitive 
function with meta-








sectional (all 3 





DM (n=39, mean age = 
62 years, 72% female) 
UDES: DM (n =99, 
mean age =66years, 49% 
female), no DM (n=33, 
mean age= 64 years, 
58% female) 
Hoorn: DM (n=84, mean 
age = 75 years, 49% 
female), noDM (n=132, 
mean age = 74 years, 
58% female) 
 
Differences between DM with 
or without depression worse 
with depression but not 
significant in any cognitive 
domain. 
 
DM no greater cognitive 
decline over 3 years than 
noDM (p = .21) 
  
Difference between cognition 
in DM & no DM not mediated 
by mild depression 
Sullivan et al., 
2013 
Determine whether 






depression (PHQ-9) --at 
baseline, EF (Stroop 
Test), MPS (DSST), 
verbal memory 
(RAVLT)-- at baseline, 
20 & 40 months 
DM Participants from 
the ACCORD-
MIND sub-study 
N= 2977 (mean age = 
62.5 years, 46.6 % 
female) 
 
PHQ-9 score <10 
None to mild depression 
(n=2446, mean age = 
62.7 years, 44.7% 
female) 
 
PHQ-9 score > 10 
Moderate to severe 
depression 
(n=531, mean age =61.3 
years, 55.6% female) 
Longitudinal Participants with PHQ-9 scores 
> 10 compared with <10 
showed greater decline over 40 
months in:  EF (p = .02), MPS 
(p=.003), & verbal memory 
(p=.001) 
 
Effect of depression on risk of 
cognitive decline did not differ 
with baseline age or cognition, 
prior cardiovascular disease, or 
type of DM treatment. 
Trento et al., 
2014 
Investigate associations 
between clinical & 
sociodemographic 
variables in persons 
with DM, and 
depression, anxiety & 
global cognitive 
dysfunction (MMSE), 
over a 4-year time span. 
DM insulin (IT) &  
non-insulin (NIT) 
 treated at baseline  
(t0) & at 4 years 
(t4) 




IT t0 & t4 (n=214) 
NIT t0 & t4 (n=171) 
NIT t0 & IT t4 (n=41) 
Longitudinal IT t0 & t4: increased anxiety & 
depression (both p<.001), 
improved MMSE (p<.001) 
 
 NIT t0 & t4:  decreased 
depression (p=.04) improved 
MMSE (p<.001), anxiety 
unchanged 
 
NIT t0 & IT t4: no change in 







Females had higher levels of 
depression than males (p<.001) 
 
Anxiety increased with DM 
duration (p=.011) 
Umegaki et al. 
(2012) 
To examine the 
association of 
comorbidities in DM 
and cognitive decline 




Scale, HbA1c, fasting 
blood glucose and other 
clinical variables. 
DM Japanese Elderly 
Interventional Trial 
     All participants (n = 61,  
     mean baseline age= 
     70.6 years, 57.5%  
      female) 
       
      With MMSE 5 point  
      decline (n=23, mean  
       baseline age=72.8  
      years, 56.5% female) 
 
Without MMSE 5-point 
decline (n=238, mean 
baseline age=70.4 years, 
57.6% female) 
Longitudinal Baseline clinical variables 
differed in those with 5 point 
MMSE decline: higher systolic 
BP, & triglycerides, lower 
HDL, more 
Nephro/retino/neuropathy/ (p 
ranges <. 001- <.05); Adjusted 
logistic regression: higher 
systolic BP (p=.047) & 
triglycerides ( p=.029) 





The Relationship between Self-care and DM 
 Of the eleven publications that focused on the relationship between self-care and DM, six 
focused on cognitive dysfunction and DM self-care performance, three on cognitive dysfunction 
and self-care knowledge, and one on decision-making in DM self-care. (see Table 2 for 
summaries). Managing DM requires active participation in self-care, including both management 
strategies and daily performance of multiple tasks to maintain optimum health and quality of life, 
and to avoid complications (Song, 2010). Effective self-care positively correlates with better 
glycemic control, health outcomes, and perceived health (Song, 2010).  
Cognitive Dysfunction and DM Self-care 
 Studies that examined the relationship between cognitive dysfunction and DM self-care 
revealed a cyclic association between DM self-care, increased comorbidities and cognitive 
dysfunction, and decreased functional abilities (Feil, Zhu, & Sultzer, 2012), and increased health 
care utilization (Tran, Baxter, Hamman, & Grigsby, 2014). Performance of self-care 
maintenance (diet, blood glucose monitoring, and medication use) and self-care management 
(sign/symptom recognition, treatment implementation and evaluation) activities likely influence 
hospitalizations in different ways (Song, Ratcliff, Tkacs, & Riegel, 2012). Among those with 
DM who were hospitalized, the majority reported taking all doses of DM medications (88.3%) 
and checking blood glucose readings (58.7%) daily; more were able to recognize hyperglycemic 
symptoms than hypoglycemic symptoms (58.3% and 16.8%, respectively). Diet adherence (fruits 
and vegetables) was associated with decreased likelihood of hospitalization (p<.001). The 
incidence rate of hospitalization decreased with having a target glycohemoglobin (IRR =.86. 
p=.001), and with eating two or more snacks or dessert foods per day (IRR = .914, p=.043), but 





.037). Fewer hospitalization days were associated with having a target glycohemoglobin (IRR 
=.728, p<.001), and confirming hypoglycemia by checking blood glucose (IRR = .832, p =.033). 
In contrast, hospitalization days increased with recommended blood glucose testing frequency 
(IRR=1.170. p =.016) (Song et al., 2012).  
 With increased DM comorbidities and cognitive impairment, the ability to manage and 
adhere to self-care domains of exercise, blood glucose monitoring, diet, and foot inspection 
decreased (all p< .05) (Feil et al., 2012). The ability to exercise and follow diet recommendations 
were the most affected, but medication management was unaffected.  Compared with 
participants with the least cognitive impairment, those with moderate or severe impairment were 
less likely to exercise (moderate and severe both p=.05) or follow the recommended diet 
(moderate and severe both p=.01) (Feil et al., 2012). 
  Decreased executive function in persons with DM has been linked to poorer performance 
in activities of daily living (ADL) and instrumental activities of daily living (IADL)(Qiu et al., 
2006; Tran et al., 2014). Decreased medication management ability was predictive for increased 
nursing home admission, clinic, and emergency visits (Tran et al, 2014). Executive dysfunction 
may affect self-care abilities through impairments in insight, abstraction, judgment, planning, 
and problem solving (Primozic, Tavcar, Avbelj, Dernovsek, & Oblak, 2012; Thabit et al., 2009). 
Although intact executive function is essential for adherence, establishing new behaviors, 
suppressing old behaviors, and self-regulation (Tran et al, 2014), one study of older adults (mean 
age [SD] = 73 [+ 6.5] years) with mild impairment in executive function and verbal memory 
found no change in HbA1c over a two year time span (Palta et al., 2014). Some cognitive 





consequently impaired executive function may be present yet undetected in persons with normal 
global cognition, (Thabit et al., 2009). 
 Cognitive dysfunction and DM self-care knowledge. 
 Important antecedents to self-care are knowledge about DM and self-monitoring skill 
acquisition (Song & Lipman, 2008). Relationships between the multiple mechanisms linking 
cognition, knowledge and self–care are complex and not clearly delineated (Nguyen et al. 2010). 
Hewitt, Smeeth, Chaturvedi, Bulpitt, and Fletcher (2011) reported that older persons (mean age 
80.9 years) who took insulin and had global cognitive impairment had poorer knowledge about 
managing hypoglycemia (p=.013, p = .008) and medications during an acute illness (p=.017) 
than did those without impairment. Another study, which examined the relationship of self-care 
to the conceptualization and understanding of self-care in DM patients (mean age [SD] = 53.9 [+ 
17.3] years), found that participants with poor glycemic control lacked understanding of basic 
self-care (mechanisms of medications, concepts of glucose monitoring, symptom detection, role 
of exercise, dietary instructions, and behavior-lifestyle adjustment), and had difficulty detecting 
and solving problems (Lippa and Klein, 2008). Individuals with moderate glycemic control 
demonstrated a vague understanding of medications, monitored their blood glucose regularly, 
and inconsistently applied results to events. For example, while many of the participants could 
detect symptoms of hyper- or hypoglycemia, they often lacked the ability to correct for these 
states. Dietary rules tended to be broadly followed, but were overwhelming due to their number 
and complexity.  Also, the role of exercise was poorly understood and exercise beyond ADLs 
was uncommon.  Individuals with good glycemic control either had a fixed routine or utilized in-
depth medication knowledge to modify routines.  They tended to monitor blood glucose several 





exercise frequency was no greater than in the other two groups). Individuals in this group also 
used monitoring to develop diets and judge behavior success, and could effectively identify and 
manage episodes of hypo- and hyperglycemia (Lippa & Klein, 2008). 
 Decision-making in DM self-care. 
 The patient’s role in chronic disease has evolved to include not only treatment adherence 
but active decision making (Song, 2010).  Lippa, Klein, and Shalin (2008) examined 
relationships between levels of decision making and DM control, and the use of declarative 
(factual) and applied (procedural) knowledge in DM self-care.  Levels of decision-making range 
from novice to expert, and differ in the cognitive processes of problem detection and cue 
utilization, functional relationship comprehension and organization, and problem solving 
strategies. Novice level decision-making utilizes more superficial organizational patterns when 
applying knowledge to functional relationships, and exhibits less efficient problem-solving 
strategies than expert level decision making.  Greater use of problem detection cues was 
associated with better treatment adherence and lower blood glucose levels, and the more expert 
participants combined multiples cues to increase problem detection.  Participants who identified 
more functional relationships and had better problem-solving abilities also exhibited better 
adherence, but not necessarily better glycemic control. The probability of having accurate 
declarative knowledge was greater than the probability of being able to apply that knowledge in 
critical situations of hyper and hypoglycemia. The study revealed that having DM knowledge 
alone does not necessarily coincide with the application of that knowledge to self-care actions 







Summaries of Data-Based Publications Related to the Relationship Between Self-Care and DM 





Feil et al. (2012) To examine 
relationships between 
cognitive impairment 





Telephone Interview for 
Cognitive Status; Total 
Illness Burden (TIB) 
(with DM 
comorbidities 
categorized into 4 
quartiles) 
DM Participants from 




(mean age = 70 
years; 52.8% 
female) 
Cross-sectional For each level of 
cognitive 
impairment (3 levels 
best to worst): 
ability to manage 
each self-care 






reported being able 
to manage 
medications at all 
levels. 
 
Those with the most 
cognitive 
impairment 
compared with those 
with the least 
impairment were 
less likely to: 
exercise (moderate 
OR =.725, most 
OR=.712, both 
p<.05); & follow 
diet (moderate OR = 
.906, most OR = 
.618, both p <.01). 
 
Results for checking 





feet were not 
significant. 
Hewitt et al. (2011) To examine DM 
knowledge & 
management of older 
persons 
 
Assess the impact of 
cognitive impairment 
(CI)  






DM Participants from 










MMSE < 23  




total (n=144,14%),  
with CI (n =37,4%)  
 










comparing with & 
and without CI: with 
CI group gave more 
incorrect responses 
to DM management 
questions (p values 
= .013, .008, .017) 
 
  
Lippa & Klein 
(2008) 
To describe relationship 










N = 18 
(mean age =53.9 
years; 33% females) 
 
Glycemic control 
(HbA1c): poor  
(>7%, n=8), 
moderate (6.0-7.0 
%, n=5), good 
(<6%, n=5) 
Descriptive    Poor control: poor   
   understanding of  
   self-care, functional  
    dynamics of DM,  
    medications,     
    relationship of  
    glucose monitoring  
    & role of exercise;  
    poor problem  
    detection &  
    resolution;  
    moderate adherence 
     to medications;  
     no exercise. 
     Moderate control:  
     vague under- 
     standing of  
     medications & role  





     moderate  
     understanding of  
     diet; able to detect  
     problems, unable to  
     correct hyper- 
     glycemia. 
 
    Good control: either  
    had fixed routine, or  
    in depth under- 
    standing & adjusted  
    routine; minimal  
    exercise but  
    understood link 
  
Lippa et al. (2008) 
 





problem solving, types 
of knowledge—
declarative & applied) 
and DM self-care 
(adherence-SSCA & 
glycemic control-












(mean age =53.9 
years; 33% females) 
Descriptive Problem detection: 
better use of cues 
associated with 
better adherence & 
glycemic control 








(p<.05), but not 

















then probability of 
applying knowledge 
for high & low 
glucose (both p<.05) 
Nguyen et al. (2010)  To examine role of 
EF in acquiring 
knowledge& 
adopting 




attention, & working 
memory aspects of EF, 
and a derived 
composite measure  
DM DM patients 
recruited from three 
rural counties in 
North Carolina 
N = 90; 












  Final model 
including above, 
DM knowledge, 
DM meds &  
  self-care: DM 
knowledge (.01) 













changes in DM 
control (HbA1c), 
systolic blood 
pressure and lipids 
(LDL). 
 









year ancillary study 
in second phase 
(2004-2008)  
n = 613 

























Primozic et                                         
al. (2012) 
To identify                   
independent     
association of cognitive 
functions & 
psychological factors 
with DM self-care  
 
  To evaluate 
predictors of DM 
self-care  
 






planning & problem 
solving, working 
memory (Tower of 
London); MPS & 
cognitive flexibility 
(Stroop  
  Test); depression 
(HDI; distress 
(PAID) 






(mean age= 63.74 
years; 51% females) 
 
Descriptive Significant association 
between self-care & 
cognitive functions: 
Tower of London 
planning & problem 
solving, (p=.002); 












  Strongest 
predictors: better 





Qiu et al. (2006) 
 
To examine patterns of 
cognitive deficits in 




cognition (MMSE); EF 
& visuospatial  
(Block design); MPS 
(Trails A); EF(Trails B) 
DM 
No DM 
      Nutrition and   
      Memory in Elders 
      Study; Boston, MA 
      N = 291 
 
     DM  
     (n=115, mean  
      age= 74.5 years,  
      74% female) 
 
no DM  
(n=176,  
mean age = 77.4  
years, 78% female) 
Cross-sectional      DM group compared  
      with no DM, poorer 
      scores for:  
      MMSE (p=.02);  
      ADLs (p=.04);  
      EF/visuospatial  
      (p =.003);  
      EF (p=.03); 
      Attention/WM/EF  






memory, EF (Digit 
Span); verbal memory 
(Word List Learning); 
EF language (COWA); 
depression scale, ADLs 
      verbal memory 
       (p=.01&.04); & 
      more depression  
     (p=.03) 
 
Song et al. (2012) 
 
To evaluate the 
influence of DM self-
care on health outcomes 
of health care resource 
utilization (number of 
hospitalization and 
number of days) 






HRS-DM study  
(N=1509) 
Subsample n=726 









 mean stay:  
 3.83+ 10.7days);  
88.3% took all doses 
of DM meds daily; 
58.7% checked 
daily blood glucose; 
 
Hyperglycemia was 





Thabit et al. (2009) To assess for 
association between 
executive function (EF) 
test scores (EXIT25, 
FAB), DM self-care 
(SDSCA, IADLs) and 
metabolic parameters. 
MMSE for global 
cognition. 
DM DM patients 
recruited from a DM 
clinic in Dublin, 
Ireland 
N=50 
 (mean age= 67.0 
years; 32% females) 
Descriptive T-tests: EXIT25 
mean score 
indicated 14% had 
impaired EF, FAB 
mean score 
indicated 48% had 




& SDSCA not 
significant, but 
those with below 
normal FAB scores 
had lower SDSCA 















Tran et al. (2014) To examine whether 
older persons with DM 
had: 1) more cognitive 
dysfunction than older 
persons without DM, 2) 
executive dysfunction 
associated with 
impaired self-care, and 
3) executive 
dysfunction associated 












San Luis Valley 
Health and Aging 
Study; Colorado 
N=1,358 
No DM & with DM 
n=1,063 











Cross-sectional With DM group 
compared with no 
DM group scored 
worse in EF, global 
cognition, working 
memory (all p<.05), 
constructional 




In the with DM 
group: impaired EF 
was associated with 
decreased IADL 
ability, medication 
& meal management 
(p values < .013- < 
.001) ; decreased 






In the with DM 
group impaired EF 
was associated with 
increased nursing 
home admission (p 














 In this systematic state of the science review of 74 publications, the most important 
findings were: 1) recent research documenting the interplay of pathophysiological brain changes 
with cognitive dysfunction in DM, and the contribution of specific risk factors, 2) clarification of 
the presence of cognitive dysfunction in pre- and early DM, and 3) evidence relating cognitive 
dysfunction to DM self-care.  Further research is urgently needed to link these recent advances in 
knowledge together to explore relationships to glycemic control.  
 Publications included in this review and categorized as pathophysiology, reviews of 
empirical studies, and data-based studies related to cognitive dysfunction in DM addressed  
guiding question one: What factors influence cognitive dysfunction in persons with DM?  
Although studies differed in the use of cognitive tests, overall results of two systematic reviews 
(25 and 19 studies) indicated that persons with DM had a 1.5 times greater risk than persons 
without DM for cognitive decline (Cukierman et al., 2005), Alzheimer’s and any type of 
dementia, and 2.5 times greater risk for vascular dementia (Cheng et al., 2012). Longer duration 
of DM and poorer glycemic control were associated with a greater decline in several cognitive 
domains (Nooyens et al., 2010; Okereke et al., 2008; Ravona-Springer et al., 2014; Rawlings et 
al., 2014; Tuligenga et al., 2014). The cognitive domains most often affected in DM include 
attention, executive function, mental processing speed, and verbal memory (Reijmer et al., 
2010).  
 Because early stages of DM are often undiagnosed, early cognitive decline often goes 
unnoticed as well (Fischer et.al, 2009; Nooyens et al., 2010; Okereke et al., 2008; Ruis et al., 
2009; Saczynski et al., 2008; Yeung et al., 2009). Risk factors associated with DM-





affect cognition at various times for various durations (Biessels et al., 2013; Cukierman, et al., 
2005; Reijmer et al., 2010; van den Berg et al., 2009).  Along with these interrelated risk factors, 
age-related changes are influential in cognitive decline (Biessels et al., 2010; Reijmer et al., 
2010). A high prevalence of depression has been found in persons with DM (Degmecic et al., 
2014; Koekkoek et al., 2012; Sullivan et al., 2013; Trento et al., 2013), and may be another risk 
factor for cognitive decline (Sullivan et al., 2013). Evidence suggests that cognitive decline may 
follow two different processes in DM: 1) mild slowly progressing decline beginning in pre-DM 
stages, and 2) severe faster decline with high prevalence of vascular and Alzheimer’s dementia 
(Reijmer et al., 2010).  Critical points of cognitive decline in specific cognitive domains in 
persons with DM have yet to be defined  
 Causative mechanisms of structural brain changes in DM are also yet to be clarified. 
Primary etiologies of structural brain changes are associated with commonly occurring 
metabolic, endocrine, vascular, and central nervous system factors (McCrimmon et al., 2012).  
Mechanisms of impaired neurogenesis, blood brain barrier and vascular dysfunction, 
inflammatory processes, insulin resistance, and hyperglycemia have all been documented to play 
a role in the development of DM-related cognitive dysfunction (Biessels et al., 2014; Umegaki, 
2012). Several publications addressed the effects of insulin resistance on the anatomy and 
function of the brain. Insulin resistance, which occurs in both pre-DM and DM, appears to have 
several unclear effects on brain metabolism (Lamport et al., 2009; McKay & Recknagel, 2011), 
neuronal activity (Convit, 2005; Williamson et al., 2012), and vascular function (Lamport et al., 
2009; McKay & Recknagel, 2011).  Insulin resistance has been shown to be associated with both 





2007) and impaired DMN functional connectivity (Chen et al., 2014; Marder et al., 2014; Musen 
et al., 2012). 
 Decreases in brain volumes in DM compared with that in the normal aging process have 
been found to vary from no difference to a rate of up to three times greater (de Bresser et al., 
2010; Espeland et al., 2013; vanElderen et al., 2010). Hippocampal atrophy has repeatedly been 
shown in persons with DM (Convit, 2005; den Heijer et al., 2009; Gold et al., 2007); atrophy in 
other brain regions essential for memory and other higher cognitive functions has also been 
found (Samaras et al., 2014). Brain atrophy and poorer cognitive scores in DM patients are 
associated, but findings are inconsistent (Brundel et al., 2012; Christman et al., 2010; de Bresser 
et al., 2010; van Elderen et al., 2010). 
  Decreases in cognitive function associated with white matter tracts connecting frontal, 
parietal and temporal brain regions included attention, executive function, mental processing 
speed, and verbal memory (Reijmer et al., 2013). Recent studies have documented reduced 
functional connectivity between the hippocampus and the DMN (medial prefrontal and temporal 
parietal brain regions) (Chen et a., 2014; Hoogenboom et al., 2014; Musen et al., 2012; Zhou et 
al., 2010). Zhou et al. (2010) demonstrated dysfunction in episodic memory and executive 
function in persons with DM and postulated that reduced neuronal connectivity disturbances may 
be widespread in persons with DM, affecting learning and memory (Zhou, 2010).     
 Further research is needed to specifically target mechanisms of increased cognitive 
decline and prevalence of dementia in DM. Emerging technologies in imaging and biomarkers 
may assist in needed research to discover methods of preventing DM-related cognitive decline, 
potentially at pre-symptomatic and early stages of the disease. Contributing modifiable risk 





Limitations identified in this review include inconsistent cognitive testing, secondary analyses of 
data not collected solely in DM participants, and the lack of prospective studies. 
 In addressing the second guiding question regarding the association between cognitive 
dysfunction and DM self-care activities, publications were categorized as follows: 1) cognitive 
dysfunction and DM self-care performance, 2) cognitive dysfunction and DM self-care 
knowledge, and 3) decision making in DM self-care. 
 Having DM requires active participation in self-care to maintain physiologic stability, 
and requires behaviors including treatment adherence, sign and symptom monitoring, 
recognition, evaluation, and treatment implementation (Song, 2010). The daily routine an 
individual adopts differs from the decision making and problem solving required for coping with 
condition changes. Knowledge gaps exist concerning differences in self-care maintenance and 
self-care management activities (Song, 2010). 
 A complex relationship exists among all elements of DM self-care performance, 
increased comorbidities, increased cognitive dysfunction, decreased functional abilities and 
increased health care utilization (Feil et al., 2012; Tran et al., 2014). Increased presence of DM 
comorbidities and cognitive dysfunction has been shown to be associated with decreased 
adherence to self-maintenance (Feil et al., 2012). Self-care maintenance and self-care 
management activities can influence health outcomes in different ways (Song et al., 2012).  For 
example, achieving a target glycohemoglobin was associated with decreased rate and length of 
hospitalization, whereas adhering to recommended blood glucose testing frequency was 
associated with an increased length of hospitalization (Song, 2012).  
  Intact cognitive ability is necessary for the complex tasks necessary for daily DM self-





normal global cognition performance (Thabit et al., 2009). Executive dysfunction is linked to 
impairment in insight, abstraction, judgment, (Thabit et al., 2009), planning and problem solving 
(Primozic et al., 2012), and subsequently self-care, ADL and IADL performance (Nguyen et al., 
2010; Primozic et al., 2012; Qiu et al., 2006; Thabit et al., 2009).  Executive function is essential 
for adherence, establishing new behaviors, suppressing old behaviors, and self-regulation (Tran 
et al, 2014). Factors such as age, comorbidities, education, medications and sociodemographic 
variables may also contribute to cognitive dysfunction (Manschot et al., 2007; Nguyen et al., 
2010; Saczynski et al., 2008). 
 Important antecedents to self-care are knowledge about DM and self-monitoring skill 
acquisition (Song & Lipman, 2008). The links between cognition, DM knowledge and DM self–
care performance are complex and not clearly delineated (Nguyen et al. 2010).  
Lippa and Klein (2008) demonstrated a relationship between poor glycemic control, poor 
understanding of basic self-care, and difficulty with problem solving. Better glycemic control 
was associated with regular blood glucose testing and use of the test results to modify self-care 
routines (Lippa & Klein, 2008). Lippa et al. (2009) highlighted the difference between the two 
cognitive processes of having knowledge (declarative) and using knowledge (applied). The 
probability of having accurate declarative knowledge was greater than the probability of 
applying that knowledge in critical situations of hyper- and hypoglycemia. This suggests that 
having DM knowledge does not necessarily determine self-care actions (Lippa et al., 2009).  
Decision-making expertise requires problem detection, cue utilization, functional relationship 
comprehension and organization, and problem solving strategies (Lippa et al., 2009). Increased 
use of cues was associated with increased treatment adherence and lower blood glucose levels. 





with better treatment adherence, but not with lower blood glucose levels. Further research is 
needed to examine how cognitive processes are associated with self-care expertise, skill learning, 
and skill performance (Lippa et al., 2008).  
 Although declining cognitive function interferes with social and environmental 
interaction and affects quality of life and independence (Vance et al., 2011), it is often 
overlooked in chronic disease management until a neurologically based condition warrants 
attention. Cognitive dysfunction is also not typically considered when planning interventions for 
self-care and maintaining independence (Biessels et al., 2007; Rucker et al., 2012; Vance et al., 
2011).  Awareness of cognitive dysfunction is relevant not only for debilitated persons, but also 
for working adults whose job performance may suffer (Waclawski, 2012).  Addressing cognitive 
dysfunction has many implications for nursing and other health care disciplines, since strategies 
for preventing or reducing complications can be tailored relative to cognitive abilities (Munshi, 
2008; Rucker et al., 2012; Vance et al., 2011).  The findings of this review supported the 
dynamic nature of DM self-care and the need for targeted teaching strategies that assess and 
recognize the cognitive skills necessary for learning, problem solving, decision making (Lippa & 
Klein, 2008; Song et al., 2012), and goal setting (Song et al., 2010). A limitation of this review 
was the lack of systematic reviews and meta-analyses pertaining to DM-related cognitive 
dysfunction and DM self-care performance. 
 In summary, the daily routine an individual adopts differs from the decision-making and 
problem-solving required in response to condition changes. Knowledge gaps exist concerning the 
differences in self-care maintenance and self-care management activities and the cognitive 
processes underlying the different self-care behaviors.  Sign and symptom recognition in DM 





important for providing guidance to persons with DM. Cognitive dysfunction and other factors 
may interfere with understanding, recalling, and applying instructions, and may contribute to 
poor daily routine performance and impaired sign and symptom recognition. Further studies 
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Glycemic Control and Cognitive Function in Rural Adults with Type 2 Diabetes  
Introduction 
 The prevalence of type 2 diabetes mellitus (DM) is growing at epidemic proportions, 
especially among adults ages 45 and older (CDC, 2014). Persons with DM are at high risk for 
serious complications associated with chronic hyperglycemia, including structural brain changes 
and decreased cognitive function. Glycemic control, defined as maintaining a glycohemoglobin 
(HbA1c) at 7% or below, reduces microvascular and neuropathic complications associated with 
DM (ADA, 2016).   The complexity of maintaining adequate glycemic control demands 
performance of ongoing self-care routines that require multiple cognitive processes (Nguyen et 
al, 2010; Saczynski et al., 2008). Other factors contributing to decreased cognitive function 
include sociodemographic variables, age, gender, comorbidities, education, medications, and 
duration of having DM (Saczynski et al., 2008).   Rural adults (> 18 years of age) often have less 
access to DM resources and specialty care, and are at greater risk for poorer glycemic control 
than are adults in non-rural communities (Hale, Bennett, & Probst, 2010). While one’s ability to 
maintain glycemic control may be highly dependent on cognitive abilities, there is limited 
understanding about the relationship between cognitive function and glycemic control (Nguyen 
et al, 2010). The overall purpose of this study was to examine the relationship between glycemic 






Cognitive dysfunction in DM 
  Research findings regarding the appearance and progression of cognitive decline in DM 
is equivocal (Moheet, Mangia, & Seaquist, 2015).  Although it is well documented that persons 
with DM are at 1.5 times greater risk for cognitive decline (Cukierman et al., 2005), and all types 
of dementias (Cheng et al., 2012), early stages of DM and early cognitive decline are often 
undiagnosed (Fischer, deFrias, Yeung, & Dixon, 2009; Nooyens, Baan, Spijkerman, & 
Vershuren, 2010; Okereke et al., 2008; Ruis et al., 2009; Saczynski et al., 2008; Yeung, Fischer, 
& Dixon, 2009). There is evidence for both a mild slowly progressing decline beginning in pre-
DM stages, and a severe faster decline with high prevalence of vascular and Alzheimer’s 
dementia, with critical points of cognitive decline in specific cognitive domains have yet to be 
defined (Reijmer et al., 2010). 
  The Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-
MIND) trial, a sub-study of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) 
trial, examined differences between the rate of cognitive decline and structural brain changes in 
ACCORD participants (Cukierman-Yaffe et al. 2009). The results revealed an age-adjusted 
association between higher HbA1c levels and poorer cognitive test scores in the domains of 
global cognition, executive function, mental processing speed, and verbal memory, and 
supported the hypothesis of a progressive and positive relationship between chronic 
hyperglycemia and cognitive dysfunction. Also, the relationship between HbA1c and cognition 
became non-significant after controlling for age, sex, education, race, language, duration of DM, 
CV disease, and depression, in models with attention, executive function and global cognition, 





(2009) concluded that HbA1c levels may not be a major determinant in cognitive test 
performance; rather, sociodemographic and clinical factors are more influential.  
 Results by Manschot and colleagues (2006, 2007) indicated that cognitive domains of 
perception, visuoconstruction and language were less affected in persons with DM compared to 
age-, sex-, education- matched controls, and short-term memory appeared to be affected more 
than long-term memory (Reijmer et al., 2010). Cognitive processes of attention, executive 
function, mental processing speed and verbal episodic memory are essential for processing and 
learning new information, encoding and storing it in memory, and retrieving previously learned 
information, which is critical for performing good self-care (Cukierman-Yaffe et al. 2009). The 
hippocampus is highly vulnerable to the effects of hyperglycemia, with damage shown early in 
the course of DM. Hippocampal based cognitive functions such as verbal episodic memory may 
be initially affected, and as damage from DM progresses other associated cognitive processes 
show decline as well (Bruehl et al., 2009). Recent studies have documented reduced functional 
connectivity between the hippocampus and several associated regions (Hoogenboom et al., 2014; 
Musen et al., 2012; Zhou et al., 2010) where decreased functional connectivity occurs prior to the 
appearance of identifiable structural deficits (Musen et al., 2012).   
Age, level of education, gender, and cognitive dysfunction in DM 
Although DM in midlife (age 57-60 years) has been consistently associated with 
increased risk of accelerated cognitive decline in later years (Nooyens et al., 2010; Rawlings et 
al., 2014; Tuligenga et al., 2014), study results vary in the affected cognitive domains and the 
magnitude of the cognitive decline (Reijmer et al., 2010). In their systematic review of studies 
examining cognitive changes in persons with DM, Reijmer and colleagues (2010), noted that 





of the same age.  Findings from cross-sectional case-control and population-based studies 
reviewed by Reijmer et al. (2010) showed worse performance for persons with DM compared to 
age-, sex-, and education-matched controls in the cognitive domains of attention, executive 
function, mental processing speed, and verbal memory. Effect sizes were small to medium (range 
0.2-0.6), and consistent across age groups (range 50-80 years). In contrast, some longitudinal 
studies in the review showed cognitive decline in persons with DM over a five-year time span 
that exceeded normal aging effects by almost twice, where others showed no accelerated 
cognitive decline (Reijmer et al., 2010). The authors concluded that there is a dissociation 
between mild progressive cognitive decline and severe cognitive decline with regard to age 
groups, suggesting different processes (Reijmer et al., 2010).   
 Yeung, Fischer and Dixon (2009) examined performance differences in similar cognitive 
domains comparing groups with DM and without DM, and between age groups (young-old age 
53-70 years; old-old age 71-90 years). Age group comparisons revealed poorer performance by 
the old-old group compared with young-old in all measures except for semantic memory and 
verbal fluency. Importantly, there was no interaction between age group and DM status, 
indicating that DM-related cognitive deficits may be constant across age. VanEersel et al. (2013) 
examined the association of DM and cognitive function in persons with and without DM age 35-
82 years old. The participants with DM compared with those without DM had lower 
performance in executive function, with the mean difference between groups largest at ages 35-
44 years. In persons without DM, the percentage with low memory performance gradually 
increased from 45% in age group 35-44 years to 81% in age group > 75 years, while in persons 
with DM the percentage of those with low memory performance was higher and similar in all 





 In systematic reviews by Moheet et al. (2015) and Reijmer et al. (2010), the level of 
education was noted to be included as confounders in the analyses of several studies and did not 
account for variances in the results. Level of education was included in this analysis because 
some of the cognitive function measures are affected by education (Lezak, Howieson, & Loring, 
2004). There was no evidence of interaction between DM and gender on cognitive decline in 
studies by Nooyens et al., (2009), Okereke et al. (2008), Ruis et al., (2009), Tuligenga et al., 
(2014), van den Berg et al., (2008), and van Ersel et al., (2013). 
Cognitive dysfunction and duration of DM.  
 The degree of cognitive dysfunction in persons with DM has been associated with the 
length of time one has DM. Some studies demonstrate that increased DM duration is associated 
with a mild decline, while others have shown a faster rate of decline (Reijmer et al., 2010). It 
also has been argued that cognitive dysfunction in DM may have a specific time of onset without 
further decline and that different cognitive domains may be affected at different times 
(McCrimmon et al., 2012). The duration of time with DM and associated cognitive decline may 
also reflect chronic exposure to other risk factors, comorbidities, and co-existing conditions (e.g. 
such as lifestyle, hypertension, obesity, and depression) (Reijmer et al., 2010).  
 Okereke et al. (2008) examined the duration of DM and cognitive decline in male and 
female participants from two longitudinal studies, and found that associations between DM and 
cognitive decline increased along with the length of time one lived with the disease (Okereke et 
al., 2008).  In both gender groups with DM, baseline scores were poorer than those of men and 
women without DM in global cognition and verbal memory, and declined significantly over 4 
years; each additional year of age was associated with a decline of 0.03 units on the global score, 





evidence of interaction between DM and gender and cognitive decline. Spauwen, Kohler, 
Verhey, Stehouwer, and van Boxtel (2013) also found stronger decline in verbal memory in 
persons with DM compared with controls over a time span of 12 years. With three-year 
longitudinal data, Fischer, de Frias, Yeung, and Dixon (2009) examined temporal stability and 
cognitive decline patterns in persons with and without DM.  Compared with the group without 
DM, the group with DM demonstrated poorer performance in episodic and semantic memory, 
executive function, mental processing speed, and verbal fluency at baseline and three-year time 
points. Group effects for significant deficits were found for speed-based cognitive tasks in 
executive function (inhibition and task shifting) and mental processing speed (semantic speed 
and reaction time), which may indicate that these tasks are potential early markers for decline.  In 
incident DM (DM diagnosed after baseline), a significant decline in mental processing speed 
over 6 years was the only deficit noted compared with controls; this deficit increased with DM 
duration (Spauwen et al., 2013).  Findings by Rawlings et al. (2014), and Yeung, Fischer, and 
Dixon (2009) also suggested that mental processing speed and speed-intensive executive 
function tasks might be early markers for cognitive decline in individuals with DM. 
 Comorbidities in DM that may affect cognitive function 
 The brain is a target end organ in DM and pre-DM, but the causative factors for cognitive 
deficits are difficult to define due to the varied comorbidities associated with DM (McCrimmon 
et al., 2012). Although the cause and effect mechanisms remain unclear, for example, the 
cerebrovascular and cardiovascular (CV) risk factors associated with DM, affect cognition at 
various times for various durations (Cukierman, Gerstein, & Williamson, 2005; Umegaki et al., 
2012a; Umegaki et al., 2012b). CV disease is associated with numerous problems on a 





microvascular (neuropathy, retinopathy, nephropathy) level, many of which are related to 
atherosclerosis. Extent of macrovascular disease appears to have a strong association with DM 
and causes approximately 80% of mortality in persons with DM (McCrimmon et al., 2012). 
Macrovascular disease also correlates with brain atrophy and cognitive deficits in DM, but 
association with cerebral perfusion is unclear (Manschot et al., 2006; Manschot et al., 2007; 
McCrimmon et al., 2012; Tiehus et al., 2008). Microvascular disease has a primary role in 
cerebrovascular pathology and cognitive decline, but mechanisms are also not clearly defined 
(Manschot et al., 2006; Manschot et al., 2007; McCrimmon et al., 2012; Nelson et al., 2009). 
There is, however, evidence that reduced brain functional connectivity is associated with 
microvascular complications in DM as well as cognitive decline (Moheet et al., 2015). 
  The presence of depression has been associated with cognitive dysfunction in persons 
with DM (Sullivan et al., 2013), and there is a higher prevalence of depression in persons with 
DM (8-31%, mean 18%) than in persons without DM (5-24%, mean 10%) (Koekkoek et al., 
2012). Depression may be a consequence of stress from coping with a chronic disease, or of 
damage from metabolic derangements that affect cerebral neurotransmitter levels or vascular 
integrity (Reijmer et al., 2010). Depression and DM may have common etiologies and share a 
similar pathway between dysregulation and over activation of the hypothalamus-pituitary-
adrenal axis (HPA-axis) and sympathetic nervous system (SNS) (Champaneri, Wand, Malhotra, 
Casagranda, & Golden, 2010; Badescu et al., 2016). Both depression and chronic stress activate 
the HPA-axis and SNS which in turn causes prolonged increased levels of cortisol, adrenalin and 
noradrenaline, and promotes insulin resistance, obesity, and metabolic syndrome. 
Hypercortisolemia disrupts hippocampal neurogenesis (Badescu et al., 2016). Also, depression 





through SNS activation, which also promotes insulin resistance, and leads to development of 
DM, (Champaneri et al., 2010; Badescu et al., 2016).  
 In a meta-analysis of three studies using identical depression scales and 
neuropsychological tests for memory, Koekkoek et al. (2012) examined the role of mild 
depressive symptoms on cognitive function and cognitive decline in persons with DM versus 
controls. In overall cognition (composite z-score of domains attention, executive function, 
memory, and mental processing speed) performance was worse in those with DM compared with 
the control group. There were no performance differences in any cognitive domains in persons 
with DM, both with and without mild depression, and no association between DM, mild 
depression, and accelerated cognitive decline (Koekkoek et al., 2012). 
 Findings by Trento et al. (2013) over four years from baseline showed stable mean 
scores for depression, anxiety, and cognitive function in persons with DM who switched from 
non-insulin to insulin treatment. Cognition improved in the two treatment groups (non-insulin 
and insulin) four years after baseline. Depression and anxiety increased in those on insulin in the 
same period, while depression decreased and anxiety levels were unchanged in the non-insulin 
group. Women had higher levels of depression than men did, and increased duration of DM was 
associated with increased anxiety scores (Trento et al., 2013). 
 A prospective study of participants in the ACCORD-MIND study, conducted over 40 
months, demonstrated the association of depression with greater cognitive decline (but not 
necessarily cognitive impairment) in executive function, mental processing speed, and verbal 
memory (Sullivan et al., 2013). Depression and cognitive decline were not associated with CV 





implicate depression as a risk factor for the rapid development of cognitive decline in persons 
with DM (Sullivan et al., 2013). 
Glycemic control in DM 
 Glycemic control is the optimal level of average blood glucose levels associated with 
reduction of complications of DM (ADA, 2016). Glycosylated hemoglobin, or HbA1c, is a form 
of hemoglobin that measures the 3-month average plasma glucose concentration, and which has 
a strong predictive value for DM complications (ADA, 2016). The average, presented as a 
percentage, indicates how much glucose is adhering to red blood cells over their average life 
span (3-4 months).  For people without DM, a normal range of 4-6% equates to blood glucose 
level of between 70-126 mg/dl. A HbA1c of 7%, or a blood glucose level of 154 mg/dl, indicates 
consistently elevated blood glucose levels, and maintaining HbA1c levels at 7% or below is 
thought to reduce microvascular and neuropathic complications. More stringent goals (HbA1c 
<6.5%) may be appropriate with persons with a short DM duration and no significant 
cardiovascular disease.  Less stringent goals (HbA1c <8%) may be more appropriate for those 
with a history of severe hypoglycemia, advanced microvascular or macrovascular complications, 
or extensive comorbid conditions (ADA, 2016). 
Ravona-Springer and colleagues (2014) examined the relationships between long-term 
trajectories (mean duration =8.7 (2.64) years) of glycemic control and cognitive performance in 
cognitively normal adults with DM (mean age at study entry= 72.75 (4.63) years). Six 
trajectories were based on trends of HbA1c levels, that is whether the level was high or low at 
entry, and was stable, increasing or decreasing over time. The group with the lowest HbA1c 
levels at entry (mean = 5.96%) and were stable over time had the best performance in cognitive 





group with the highest HbA1c levels at entry (mean =10.7%) and decreased over time had the 
worst overall cognitive performance, followed by the group with moderately high HbA1c levels 
(mean = 7.76%) that increased over time. There were no significant trajectory group differences 
in domains of attention or verbal memory after adjusting for sociodemographic and 
cardiovascular factors, duration of DM or DM medication therapy. Although the cognitive scores 
were within normal range, the researchers suggested that considering a pattern or trajectory of 
glycemic control rather than a single HbA1c level might be predictive of cognitive performance 
in persons with DM (Ravona-Springer et al., 2014).          
Aims and Hypotheses 
 The specific aims of this study were to examine the relationships between covariates 
(age, years with DM, education category, cardiovascular risk, level of depression, and cognitive 
function), cognitive function, and glycemic control in rural adults with type 2 DM. The 
hypotheses were: 1) increased age, years with DM, levels of CV risk, depression, and decreased 
years of education would correlate with declining function in cognitive domains of attention, 
executive function, mental processing speed, and verbal episodic memory, 2) increased age, 
years with DM, levels of CV risk, depression, and decreased years of education would correlate 
with higher Hba1c levels, 3) HbA1c level, after controlling for the covariates, would 
independently predict cognitive function, and 4) cognitive function, after controlling for the 
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Participants and settings 
  Using a descriptive design and with approval from the University of Michigan 
Institutional Review Board (Study HUM00085816), 56 rural-dwelling men and women were 
recruited from primary care providers and diabetes education centers in two rural counties in 
northern Wisconsin and three in the Upper Peninsula of Michigan.  The prevalence of DM across 
the counties in each state is 8.9-10.6% and 10-12.2% respectively, which exceeds the overall 
national prevalence rate of 9.3% (CDC, 2014).  Available healthcare in each county includes 
public hospitals, community and rural health clinics, primary and specialty care (e.g. internal 
medicine, cardiology, neurology, nephrology, diabetes education). After an initial telephone 
screening, interviews were scheduled and informed consent obtained. The interviews were 
conducted between 12/22/2014 and 10/15/2015 at a clinic-based conference room or during 
home visits. 
Inclusion and exclusion criteria 
  As seen in Table 3.1, inclusion criteria were that participants had an established medical 
diagnosis of DM, were age 45 and over, had a HbA1c level within the past two months, and a 
total cholesterol and HDL within the past twelve months, completed at least the ninth grade, 
were able to read the English language, were available by telephone or mail for scheduling, and 
consented to participate in the study.  
 To limit confounding factors that could affect the relationship between study variables or 
affect cognitive function, exclusion criteria were: likelihood of dementia (Montreal Cognitive 
Assessment (MoCA) score <22) (Nasreddine et al., 2005), history of stroke with noted residual, 





amyotrophic lateral sclerosis), current or recently treated (within the past 5 years) major 
psychiatric disorders (e.g. schizophrenia, bipolar disorder, major depression), inadequate visual 
acuity to read printed study materials, history of or current major alcohol or substance abuse, 
hepatic encephalopathy, terminal illness, or dialysis dependence.    
Measures and Instruments 
Sociodemographic and clinical data 
 Data was collected during a 60- 90 minute face to face interview and from review of 
recent medical records. Sociodemographic data included age, gender, education category, work 
and marital status, race and ethnicity, and distance to health care. Clinical data included years 
with DM, presence of neuropathy (a complication of DM), and all medications. For participants 
45- 79 years of age, CV risk was estimated using the American College of Cardiology/American 
Heart Association (ACC/AHA) Task Force Cardiovascular Risk Calculator (Goff et al., 2013).  
The ACC/AHA Cardiovascular Risk Calculation is an estimate of 10-year risk for persons 40-79 
years of age (calculated as a percent) for atherosclerotic cardiovascular disease (ASCVD), 
defined as coronary death or nonfatal myocardial infarction, or fatal or nonfatal stroke. 
Additional information needed for the risk calculator was systolic blood pressure, smoking 
status, and total and HDL cholesterol levels. Other clinical data included height, weight, and 
body mass index. Age, years with DM, education category, CV risk, and level of depression 
were covariates. 
Dementia Screen for Exclusion Criteria  
The Montreal Cognitive Assessment (MoCA) was administered to screen potential study 
participants for the likelihood of dementia, and thus exclusion from the study. The MoCA has 30 





memory, visuospatial abilities, executive functions, verbal memory, attention and working 
memory, language, and orientation. The test takes approximately 10 minutes to administer and 
participants earn points for successful completion of various tasks. A perfect score is 30 with a 
score of 26 or greater considered normal. Scores between 22 and 26 indicate mild cognitive 
impairment, and scores below 22 indicates a likelihood of dementia, and provided the cutoff 
score for participant enrollment in the study (Freitas et al., 2013; Nasreddine et al., 2005).  
Glycemic Control 
  Glycemic control is the optimal level of average blood glucose levels associated with 
reduction of complications of DM (ADA, 2016). This was measured with glycosylated 
hemoglobin, or HbA1c, as previously discussed. As per the inclusion criteria, all participants had 
a documented HbA1c level from a certified laboratory done within two to three months prior to 
the interview.  
 Cognitive Function 
 The dependent variables representing aspects of cognitive function were the following: 
attention, executive function, mental processing speed, and verbal episodic memory. A brief 
description of the variables and measures follow, and are further described in Table 3.2. 
Attention.  Attention is the cognitive process of selectively concentrating on incoming 
stimuli and shifting focus to other stimuli, while suppressing competing distractions. Attention 
utilizes specialized brain networks that have limited information processing capacity (Posner & 
Rothbart, 2007; Strauss, Sherman, & Spreen, 2006).  Attentional processes are associated with 
multiple sensory brain areas (Bear, Connors & Paradiso, 2007). 
 Digit Span. Digit Span measures attention capacity by exposing individuals to 





recalling or further processing that information. It is comprised of two tests, Digits Forward and 
Digits Backward, which involve different cognitive activities of sustaining focus and short-term 
storage capacity (Choi et al., 2014; Strauss, Sherman, & Spreen, 2006).  Participants repeat 
number sequences that the examiner reads aloud, with increasingly longer sequences being tested 
in each trial.  In the forwards series, the sequences are repeated forwards, and in the backwards 
series, the sequences are repeated backwards.  Raw scores for Digits Forward indicate length of 
digit span (possible score range is 0 to 8) and Digits Backward (possible score range is 0-7) were 
analyzed as a total sum (possible score 0 to 15). Choi and colleagues (2014) found that older age, 
lower education level and female gender were associated with poorer performance on both Digit 
Span forward and backward, although results in prior studies differed with gender.   
Trailmaking Test Part A. Trailmaking Test Part A (Trails A) measures attentional 
processes of scanning and visuomotor tracking of a sequence and speed of performance (Reitan, 
1992). The test requires the participant to draw lines to connect randomly placed numbered 
circles into a consecutive numerical order. It is a timed test with scores based on the time 
required to complete the task, including time to correct any errors. The average completion time 
is 29 seconds for cognitively intact individuals, with greater than 78 seconds indicating cognitive 
impairment. To account for participants that could not complete the test, the scores were 
converted to a ratio of number correct per second, where a higher ratio indicated better 
performance. Problems with visual scanning and tracking on Trails A can indicate difficulties 
with conceptual tracking. Higher age and depression levels, and lower education levels and 
female gender are associated with poorer performance (Lezak et al., 2004; Reitan, 1992).  
Executive function.  Executive function comprises cognitive processes dependent upon 





switching between tasks, conflict resolution, and encoding information for short-term storage 
(Baddeley, 1998; Smith & Jonides, 1999). It is a supervisory system with two subsystems: one 
that processes visual and spatial input and the other that processes hearing and speech (Baddeley, 
1998; Diamond, 2013).    
    Controlled Oral Word Association Test (COWA). COWA is a test of verbal fluency 
associated with frontal and pre-frontal cortex function. It requires the participant to generate as 
many words as possible (excluding proper nouns and numbers) beginning with a letter given by 
the tester. Raw scores reflect the total number of acceptable words generated with three different 
letters (C, F, L) during three separate 60-second trials. Scores are adjusted for age and education 
and converted to a percentile. Lower scores indicate greater impairment (Lezak et al., 2004). 
Older age is associated with poorer performance, higher education level is associated with better 
performance, and gender has no association (Lezak et al., 2004; Strauss et al., 2006). 
 Trailmaking Test Part B. Trailmaking Test Part B (Trails B) is similar to Trails A, but 
measures processes of scanning and visuomotor tracking of a sequence, speed of performance as 
well as divided attention and cognitive flexibility (Reitan, 1992). The test requires the participant 
to draw lines to connect randomly placed numbered and lettered circles into an alternating 
sequence (i.e. 1, A, 2, B, 3 C, etc.). Like Trails A, the test is scored based on the time required to 
complete the task and make corrections.  The average completion time is 75 seconds for 
cognitively intact individuals, with greater than 273 seconds indicating cognitive impairment. To 
account for participants that could not complete the test, the scores were converted to a ratio of 
number correct per second, where a higher ratio indicated better performance. Elderly persons 





(Lezak et al., 2004). Higher age and depression levels, and lower education levels and female 
gender are associated with poorer performance (Lezak et al., 2004).  
Mental processing speed. Mental processing speed is the rate of processing information 
and includes variables of time to response (decision speed) and speed of response (perceptual 
speed) (Salthouse, 2000). 
 Digit Symbol-Coding.  Digit Symbol-Coding is a timed paper-and-pencil test that asks 
participants to match numbers with paired symbols and then copy the symbols into rows 
containing blank squares under its corresponding number. The score is determined by counting 
the number of correctly drawn symbols in the allotted 120 seconds. The maximum score is 133 
points (Lezak et al., 2004).  Age and depression have been shown to negatively affect test 
performance, while level of intellect, memory or learning capability does not. It is particularly 
sensitive to dementia with demonstration of rapidly declining performance rates associated with 
dementia progression (Lezak et al., 2004). 
 Letter and Pattern Comparison.  Letter Comparison task is a timed test where 
participants are asked to rapidly determine whether two side-by-side strings of letters are the 
same or different, then write ‘S’ (for same) or ‘D’ (for different) on a line between the pairs.  
Pattern Comparison task is similar, except the pages contain pairs of line segment patterns that 
require rapid classification as “same” or “different”.  Two separately timed (20 seconds each) 
trials of 21 pairs of letters and 30 pairs of patterns are administered, with the score derived by 
number of correct choices in the allotted time. The data reported are the average of the two 
attempts for each task (Salthouse & Babcock, 1991). Older age decreases performance (Salthouse, 





processing speed used extensively in a number of previous studies (Fisk & Warr, 1996; 
Salthouse and Babcock, 1991; Salthouse 1994). 
Verbal episodic memory. Verbal episodic memory is the ability to learn, encode, store 
and retrieve information about everyday personal experiences.  Dysfunction in episodic memory 
causes disruption in the ability to learn and recall new information (Budson, 2009; Cansino, 
2008). Core brain areas associated with episodic memory are the medial temporal lobe and 
hippocampus, which may be damaged in DM (denHeijer et al., 2003; Manschot et al., 2007).  
Hopkins Verbal Learning Test-Revised (HVLT-R).  The HVLT-R Total and Percent of 
Retention scores measures verbal memory functions of word list learning and recall. In this test, 
the participant is asked to learn and remember a list of 12 words that are verbally presented in 
three learning trials and a delayed recall (after 20-25 minutes) trial. Immediately after each of the 
three learning trials, the participants are asked to repeat the words they remembered. Scores are 
calculated for a total list learning score (the sum of the 3 trials), and percentage of words 
remembered after the 20-25-minute delay. The score range for the total list learning score is 0 to 
36, and for the percent of retention delayed recall 0 - 100 percent (Benedict et al., 1998; Strauss 
et al., 2006). The HVLT-R discriminates between patients with mild cognitive impairment and 
cognitively healthy persons. Older age and lower education levels decrease performance (Strauss 
et al., 2006; Woods et al., 2005).  
 Depression 
 As noted earlier, the presence of depression has been associated with cognitive 
dysfunction in persons with DM. Level of depression was a covariate in this study.  
 PHQ-8. The Patient Health Questionaire-8 (PHQ-8) measured level of depression. The 





occurrence of depression symptoms over the last 2 weeks. Response options are “Not at all,” 
“Several days,” “More than half the days,” and “Nearly every day,” with 0 – 4 points associated 
for each option, respectively. The score is the sum of responses, with score ranges from 0-24. 
The levels of depression symptom severity levels are: none (0-4), mild (5-9), moderate (10-14), 
moderately severe (15-19), and severe (20-24). The PHQ-8 is valid for diagnosing depression 
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Table of Measures and Instruments 
Factor Measure/Instrument Description  Remarks 
Glycemic control Glycosylated hemoglobin 
(HbA1c) 
A blood test that reflects 
average blood glucose over 
three months. Obtained from 
medical record. 
 
HbA1c at7% or below has been 
shown to reduce microvascular 
& neuropathic complications 
Processed by a CLIA certified 
laboratory.  
Attention Digit Span Measures attention capacity by 
exposure to increasingly larger 
amounts of information & 
immediate response to 
processed information. 
Participants repeat pairs of 
progressively longer number 
sequences that the examiner 
reads aloud, both forwards and 
backwards; score is total 
correct.  
 
Test –retest reliability 
coefficients range = .66 -.89. 
 
Raw scores of Digits Forward 
(range 0 -16), Digits Backward 
(range 0-14) analyzed as a total 
sum; Effects of age, education, 
and gender have varied between 
studies; 
 Trails A:   Timed test to connect randomly 
placed numbered circles into 
consecutive order; measures 




range from .60 - >.90. 
Scores correlated with caudate 
atrophy (r=.72) 
Score is time to complete tasks 
& correction or errors. Average 
time=29 seconds. Score was 
converted to ratio of number 







Executive Function Controlled Oral Word 
Association (COWA 
Tests verbal fluency (associated 
with frontal & pre-frontal 
cortex function). It tests rapid 
word generation in three timed 
word-naming trials using letters 
C, F, & then L; score is number 




coefficients in elderly persons 
after one year, (FAS letter set): 
range=.70-.71 (for F & S): total 
score, with A, <.70. 
Correlations comparing 
performance of COWA & 
Weschler Intelligence Scales 
Digit Span = (.45); Vocabulary 
= (.41); memory= (.17-.22); 
figure fluency = (.24). 
 
 Raw score: total number of 
words generated with three 
letters during three separate 60 
second trials. Adjusted score: 
sum of acceptable words from 
the trials adjusted for age, sex 
& education, converted to a 
percentile. Lower scores 
indicate greater impairment.  
 
 Trails B 
 
Timed test to connect randomly 
placed numbered & lettered 
circles into alternating sequence 
(1, A, 2, B, 3, C, etc.); measures 
visual scanning, tracking, 
divided attention & cognitive 
flexibility. 
 
Reliability coefficients range 
from .60 - >.90. 
Score is time to complete tasks 
& correction of errors. Average 
time=75 seconds. Score was 
converted to ratio of number 
correct per second; age, 
education, gender, & 





Scores correlated with caudate 
atrophy (r=.80).  
 
Mental Processing Speed Digit Symbol-Coding Timed test requiring copying 
symbols paired with numbers 
from a key into blank squares 
underneath a corresponding 
number; time allotted is 120 
seconds, score is number 
correctly copied. 
 
Test-retest reliability correlation 
coefficients range=.82-.88. In mild 
traumatic brain injury reliability 
=.74. Sensitive to dementia, 
with performance rapidly 
declining with dementia 
progression 
 
Maximum score =133 points. 
Sensitive to dementia, with 
performance rapidly declining 
with dementia progression 
 Letter & Pattern Comparison Two timed (20 seconds each) 
trials for each task: comparison 
of side-by-side strings of letters 
or line segment patterns, and 
written response of S (same) or 
D (different); score is number 
of correct choices. 
 
Reliability coefficients: Letter = 
.35-.80; Pattern = .29-.73. 
 
Score is average of two trials 
for each task. Age has a large 
effect on performance 
Verbal Episodic Memory HVLT-R Word list learning task to learn 
and recall 12 spoken words in 3 
learning trials; also delayed 
recall after 20-25 minutes; 
Scores calculated for sum of 3 
trails, delayed recall, percent 
retention. HVLT-R able to 





score is based on number of 
words recalled. 
 
Test-retest stability coefficient 
(r=.74). 
Discriminated btw mild cog 
impairment & cog healthy in 
two separate studies 
(sensitivities=.79 & .96; 
specificities =.95 & .80) 
 
cognitive impairment & normal 
cognition. Age & education 
affect performance 
 
Level of Depression Patient Health Questionnaire-8 
(PHQ-8) 
An 8-item self-administered 
questionnaire that queried 
presence depression symptoms 
over 2 weeks; score was the 
sum of responses, with score 







Score range from 0-24; levels 
symptom severity levels were: 
none (1-4), mild (5-9), 
moderate (10-14), moderately 
severe (15-19), and severe (20-
24); all items parallel symptoms 
of depression as described in 
the DSM-IV; valid for 
diagnosing & determining 
depression severity in primary 








 Data was analyzed using IBM SPSS statistics (version 22). Descriptive statistics (means, 
medians, standard deviations, ranges and frequencies) were generated to summarize the 
sociodemographic, clinical, and neuropsychological test data.  To test hypotheses one and two 
Pearson’s r and Spearman’s rank-order correlations were used to examine the relationship 
between age, years with DM, education category, cardiovascular risk, level of depression, and 
each cognitive function measure and HbA1c level. Spearman’s rank-order correlation, a 
nonparametric statistic with no requirement of normality, was used to account for outliers (Polit, 
2010). 
To test hypothesis three, hierarchical multiple regression was conducted to estimate the 
independent relationship between HbA1c and each of the cognitive function measures after 
controlling for non-modifiable (age, years with DM, education category) and modifiable 
covariates (cardiovascular risk, level of depression). The dependent variable, cognitive measures 
(attention, executive function, mental processing speed, verbal episodic memory), were entered 
in individual equations after first controlling for 1) age, years with DM, education category 
(model 1); 2) model 1 variables plus cardiovascular risk (model 2); 3) model 2 variables plus 
level of depression; and 4) model 3 variables plus HbA1c.  To test hypothesis four, hierarchical 
multiple regression was conducted to estimate the independent relationship between each 
cognitive function measure and HbA1c after controlling for non-modifiable (age, years with DM, 
education category) and modifiable covariates (cardiovascular risk, level of depression). The 
dependent variable, HbA1c was entered in individual equations with each cognitive function 
measure after first controlling for 1) age, years with DM, education category (model 1); 2) model 





4) model 3 variables plus each cognitive measure individually; and 5) model 3 variables plus all 
cognitive measures concurrently. 
Results 
Sample Characteristics 
 A convenience sample of 56 rural adults with DM was enrolled into this study. The 
sample size was determined by a medium-large effect size (determined from previous research), 
80% power, and alpha .05. Table 3.3 displays the sample characteristics and a summary of the 
clinical data. Among this sample, 53.6% were female, 96.4% were White, and 67.9% had 
between 12-15 years of education. Twenty-seven percent were employed; and 57.1% were 
retired. Almost fifty-two percent consumed no alcohol and 86% were non-smokers. Mean 
distance to access primary care was 11 miles, 51 miles to specialty care, and 10 miles to access 
emergency care. The majority had health insurance coverage (98.2%) and had no problems 
obtaining their medications (89.3%). For the 10.7% who reported difficulty obtaining their 
medications, reasons included high co-pays and insurance non-coverage for non-generic 
medications. 
 Participants mean number of years with DM was 12.7 ((SD 9.9), median = 12.0), and 
their mean HbA1c was 7.7% ((SD 1.6), median = 7.2). Just over one-third of the study 
population (34%) had participated in some DM education, while 39% and 27% had completed a 
program or never participated respectively. The majority of participants reported neuropathy 
(61%). The mean score of 5.5 ((SD 4.8), median =4.5) on the depression screening instrument, 
PHQ-8, indicated the presence of mild depression.  The mean percent of 10-year risk for 
atherosclerotic cardiovascular disease (defined as coronary death or nonfatal myocardial 





calculated for persons 40-79 years of age.  Mean systolic and diastolic blood pressure was 135.9 
((SD 20.0), median = 135.5) and 76.3 ((SD 9.8), median = 78.5), respectively.  The mean scores 
for all cognitive function measures were below the established norms, as displayed in Table 3.4.. 
The MoCA test, which was used to screen participants for the presence of dementia, indicated 
that 48% of the study sample had mild cognitive impairment.  Figure 3.2. displays MoCA mean 
scores by age category. Table 3.5. displays MoCA mean scores by level of depression. 
Table 3.3 
Sample Characteristics and Clinical Data (N=56) 
Characteristic/Clinical Data Result 
 
Range 
Age, years, mean (SD), median,  62.9 + 9.2, 64.0 45-89 
Gender, n (%) 
       Male 





Race, n (%) 
       African American 
       Native American 






Ethnicity, Non-Hispanic, n (%) 
 
55 (98.2)  
Marital status, n (%) 
     Married 





Education category, n (%) 
    Did not complete high school 
    Completed high school 
    Associate degree 







Employment status, n (%) 
    Employed 
    Unemployed 











Problems obtaining medications, n (%) 
   Yes 





Miles to primary care (n=56),  
mean (SD), median 
 
10.8+ 15.2, 5.0 
 
1-85 
Miles to specialty care (n=36), 
 mean (SD), median 
 
50.8 + 73.1, 16.0 
 
0-343 
Miles to emergency care (n=56), 
 mean (SD), median 
 
10.1 + 11.1, 5.0 
 
1-40 
Alcohol consumption frequency, n (%) 








     2-4 times per month 
     Monthly or less 




Smoker, n (%) 
     No 
     Yes 







 mean (SD), median 
 
7.7 + 1.6, 7.2 
 
5.3-12.4 
Years with DM,  
mean (SD), median 
 
12.6 + 9.9, 12.0 
 
1-44 
DM education status, n (%) 
     Yes 
     Yes, completed 






Neuropathy, n (%) 
     No 





Montreal Cognitive Assessment, 
 mean score (SD) 
Normal cognition (MoCA score > 26-30),  
n (%) 
Mild cognitive impairment  
(MoCA score 22-25), n (%) 
 







Patient Health Questionaire-8, 
 mean score (SD), median 
 
5.5 + 4.8, 4.5 
 
0-17 
Body Mass Index,  
mean (SD), median 
 
37.4 + 9.3, 35.9 
 
22-65.1 
Ten-year CV disease risk % 
   (for those 40-79 years of age, n=52), 
mean (SD), median 
 
 




Systolic Blood Pressure mmHg, 
 mean (SD), median 
 
135.9 + 20.0, 135.5 
 
               83-181 
Diastolic Blood Pressure mmHg, 
 mean (SD), median 
 
76.3 + 9.8, 78.5 
 
55-98 
Total Cholesterol, mg/dl 
 mean (SD), median  
 
182.3+ 43.2, 183.5 
 
96-296 
High Density Lipoprotein, mg/dl 
 mean (SD), median 
 










Figure 3.2. MoCA Mean Score (SD) by Age Category 
            Note. < 55years n=11, (26.5 (2.0)); 56-66 years n=29, (25.4(2.2)); 
            67-78 years n=12, (26.1 (2.5)); >79 n=4, (23.0 (1.4)). 































Summary of Scores for Cognitive Function Measures (N=56) 
 





Norms + SD 
Attention 
     Digit Span Total 
     Trailmaking Test A 
     (seconds to complete) 
     Trailmaking Test A 
     (# correct per second)  
 
8.77 + 2.5, 8.5 
36.9 + 13.4, 35 
 








10.5 + 1.0 
31.3+ 6.7  
Executive Function 
     COWA Raw Score    
     Trailmaking Test B  
    (seconds to complete) 
     Trailmaking Test B 
     (# correct per second) 
 
 
32.3 + 13.8, 33.0 
97.0 + 64.4, 71.0 
 










64.6 + 18.6 
 
Mental Processing Speed 
     Digit Symbol Coding 
     Letter Comparison 
     Pattern Comparison 
 
53.5 + 11.7, 54.0 
5.8 + 1.6, 6.0 






54.3 + 8.9 
n/a 
n/a 
Verbal Episodic Memory 
     HVLT-R Recall Total 
     HVLT –R % Retention 
 
 
19.6 + 6.5, 21.0 





20.6 + 5.2 
89.0 + 25.8 
 
Note. COWA=Controlled Oral Word Association Test; HVLT-R=Hopkins Verbal Learning Test-Revised 
Table 3.5. 
MoCA scores by Level of Depression 
Depression Category  MoCA 
Mean scores + SD 
No depression (PHQ 0-4), 
 n=30, 53.6% 
 25.7+ 2.3 
Mild (PHQ 5-9), 
 n=11, 19.6% 
 26.4 + 2.1 
Moderate (PHQ 10 - 14), 
 n= 11, 19.6% 
 25.5 + 2.3 
Moderate/Severe (PHQ 15-19), 
 n=4, 7.1% 
 23.0 + 1.4 






Hypotheses 1 & 2:  Relationship between Covariates, Cognitive Function, and Glycemic 
Control in Rural Adults with DM 
 Hypotheses one and two were tested using Spearman’s rank-order correlation to examine 
the relationship between covariates of age, years with DM, education category, CV risk, level of 
depression, cognitive function and HbA1c levels. Results of Pearson’s r correlations are shown 
for comparison. Preliminary analyses ensured no violation of the assumptions of normality, 
linearity, and homoscedasticity. The expected direction for the relationships between age, years 
with DM, CV risk score, level of depression, and cognitive function was negative, and for the 
relationships between age, years with DM, CV risk score, level of depression, and HbA1c levels 
were positive. The expected direction for the relationship between education category and 
cognitive function was positive, and for the relationship between education category and HbA1c 
levels was negative.  
 As seen in Table 3.6., for hypothesis one, there were moderate to large correlations 
between age and measures of attention (r= -.33, p<.05; r= -.36, p<.01), executive function (r= -
.42, r= -.47, both p<.01), mental processing speed (r= -.50, p<.05; r= -.49, r= -.43, both p<.01), 
and verbal episodic memory (r= -.42, p<.01). Years with DM was small to moderately correlated 
with attention (r= -.33, p<.05), executive function (r= -.37, p<.01; r= -.28, p<.05), mental 
processing speed (r= -.35, p<.01; r= -.30, r= -.27, both p<.05), and verbal episodic memory (r= -
.31, p<.05). Education category had small to moderate correlations with executive function (r= 
.29, p<.05), mental processing speed (r=.29, p<.05), and verbal episodic memory (r=.29, both p< 
.05). There were moderate to large correlations between CV risk and attention (r=. -.54, p<.01), 
executive function (r= -.34, p<.05; r = -.42, p<.01), mental processing speed (r= -.47, r= -.58, r= -





moderate correlation mental processing speed (r= -.43, p<.01). Results suggested that, in this 
sample, increased age, years with DM and CV risk were associated with decreased attention, 
executive function, mental processing speed, and verbal episodic memory.  Increased education 
was associated with increased performance in executive function, mental processing speed, and 
verbal episodic memory. Increased level of depression was associated with decreased mental 
processing speed. Results for hypothesis two showed that HbA1c had a moderate positive 







Results for Hypotheses 1 & 2 Correlations between Contributing Factors, Cognitive Function 




with DM  
Education 
category 




Attention       




























Executive Function       
COWA raw score 



























Mental Processing Speed       




































Verbal Episodic Memory       
 HVLT recall total              
 
 HVLT% retained      



































            
Note. Result of Pearson’s r are in parentheses. COWA=Controlled Oral Word Association Test; HVLT-






Hypotheses 3:  Relationship between Glycemic Control and Cognitive Function after 
Controlling for Covariates in Rural Adults with DM 
 The results for hypothesis three (glycemic control, after controlling for covariates age, 
years with DM, education category, CV risk, and level of depression, would independently 
predict cognitive function) hierarchical multiple regression model 4 are displayed in Table 3.7. 
None of the models with cognitive test Digit Span reached significance.  With testing hypothesis 
two, model 4 (all covariates plus HbA1c) explained between twenty-one and forty-three percent 
of the variance in cognitive measure performance with overall significance levels between <.001 
to .03.  After controlling for the non-modifiable and modifiable covariates age, years with DM, 
education category, CV risk score, and level of depression, HbA1c did not independently explain 
cognitive test performance in any of the cognitive domains.  Level of depression independently 
explained performance in mental processing speed (Digit Symbol) (B= -.36, p=.002), and verbal 
episodic memory (HVLT% retained) (B= -.26, p =.04).  CV risk also independently explained 
performance in verbal episodic memory (HVLT% retained) (B = .31, p=.04).  Non-modifiable 
variables age, years with DM, and education category, entered in model 1, accounted for fifteen 
to thirty-two percent of variance in cognitive measure performance with significance levels 
between <.001 to .01. The addition of CV risk in model 2 was significant only in verbal episodic 
memory (HVLT% retained) with an R2 change of .07 (p=.04).  The addition of level of 
depression in model 3 was significant only in mental processing speed (Digit Symbol) with an R2 





Table 3.7. Results for Hypothesis 3 Hierarchical Multiple Regression Explaining Cognitive Function Measures Attention, Executive 
Function, Mental Processing Speed, & Verbal Episodic Memory (N=56) 












 Betaa R2 
∆ 
Betaa R2  
∆ 
Betaa R2  
∆ 
Betaa R2 











Model 1          .16*            .20*            .24**               .33**              .36**         .30**            .29**        .33**           .21** 
Age (years) 
 




-.23  .16  -.27 -.01 -.10 -.16 -.22  -.22  .03  
Education 
Category 
.17  .13  .14  .22  .14  .08  .22  .11  .16  




.16  -.24  -.11  .07  -.11  -
.24 
 -.21  -.11  .31*  




.11  -.26  -.08  -.17  -.36** -.18 -.01 -.18 -.26* 
Model 4  .03  .00  .01  .05  .00  .03    .02  .04 
HbA1c 
 
-.18  .04  .13  -.23  -.01  .19  .17  .16  .20  
R2 
 
.21 .31 .26 .42 .50 .40 .33 .38 .35 
Adjusted 
R2 
.10 .21 .17 .35 .43 .31 .25 .30 .27 
Overall 
significance 
.09 .009** .03* <.001*** <.001*** .001*** .004** .001*** .002*** 
Note. COWA=Controlled Oral Word Association Test; HVLT-R=Hopkins Verbal Learning Test-Revised 





Hypothesis 4:  Relationship between Cognitive Function and Glycemic Control after 
Controlling for Covariates in Rural Adults with DM 
For hypothesis 4, with HbA1c as the dependent variable, and after controlling for the 
non-modifiable and modifiable covariates age, years with DM, education category, CV risk, and 
level of depression, and entering each cognitive measure individually in the final model, none of 
the models reached significance. With HbA1c as the dependent variable, after controlling for the 
non-modifiable and modifiable covariates and entering each cognitive measure concurrently the 
model nearly reached significance (p=.06), with executive function (Trailmaking Test B, 
 B= -.57, p = .009) and independently explaining HbA1c levels.  Results are displayed in Table 
3.8. 
Table 3.8. 
Results for Hypothesis 4 Hierarchical Multiple Regression Model 5 Explaining HbA1c 
Predictors HbA1c 
Age (years) -.29 
Years with DM .19 
Education Category .16 
CV risk score .39 
Level of depression .17 
Digit Span -.28 
Trailmaking Test A .33 
COWA .13 
Trailmaking Test B -.57** 
Digit Symbol -.25 
Letter Comparison .32 
Pattern Comparison .04 
HVLT Total Recall .33 
HVLT % Retained -.06 
 R2 .42 
Adjusted R2 .19 
Overall significance .06 
Note. COWA=Controlled Oral Word Association Test; HVLT-R=Hopkins Verbal Learning Test-








 As can be seen by the study data, the first hypothesis, that increased age, years with DM, 
levels of CV risk, and depression, and decreased years of education would correlate with 
declining function in cognitive domains of attention, executive function, mental processing 
speed, and verbal episodic memory was supported.  Age, years with DM, and CV risks were 
negatively correlated with one or more measures in each cognitive domain, with the magnitude 
for age and CV risk being medium to large, and years with DM being small to medium Level of 
depression had a medium and negative correlation with mental processing speed. Education 
category had a small positive correlation with executive function, mental processing speed, and 
verbal episodic memory. Interestingly, for hypotheses two, Hba1c had a moderate and positive 
correlation with depression, but no significant correlations with any cognitive measures. As 
indicated by MoCA test, which screened for dementia with assessment of global cognitive 
function, 48% of the participants had mild cognitive impairment. 
 Hypothesis three was not supported, that glycemic control, after controlling for the 
covariates, would independently predict cognitive function, as HbA1c did not independently 
account for cognitive test performance in any of the cognitive domains. The results of multiple 
regressions for model 4, which included non-modifiable and modifiable covariates and Hba1c 
levels did explain between twenty-one and forty-three percent of the variance in performance in 
all cognitive domains.  
 Hypothesis four, that cognitive function, after controlling for the covariates, would 
independently predict HbA1c, was also  not supported. The model with all covariates and 
cognitive measures entered simultaneously nearly reached significance (p=.06), and better 





It was expected that glycemic control, or a HbA1c at or below 7%, would contribute 
significantly to participant performance on cognitive measures. The cognitive function 
performance of these participants was below the norms in all of the cognitive domains. These 
findings could reflect prior changes in brain integrity and cognitive performance earlier in the 
course of DM that are not affected by current glycemic status, such as hippocampal function and 
functional connectivity to other areas of the brain (Bruehl et al., 2009; Hoogenboom et al., 2014; 
Musen et al., 2012; Zhou et al., 2010).  
  In addition to the model predictors in this study, sample characteristics of education 
category, rural status, DM education, presence of comorbidities, or other undetermined factors 
may have been influential. In the ACCORD-MIND trial (Cukierman-Yaffe, 2009) the 
relationship between HbA1c and cognition varied after controlling for age, sex, education, race, 
language, duration of DM, CV disease, and depression. The researchers concluded that HbA1c 
levels may not be a major determinant in cognitive test performance compared to other more 
influential sociodemographic and clinical factors. However, since HbA1c is a modifiable factor, 
whereas other factors such as age, duration of DM, history of CV disease, and education level 
are not, it is important to achieve glycemic control to maximize cognitive function. Still, even 
though good glycemic control is associated with better cognitive function, optimal glycemic 
control differs from individual to individual, and Ravona-Springer and colleagues (2014) suggest 
that considering a pattern or trajectory of glycemic control rather than a single HbA1c level 
might be more predictive of cognitive performance in persons with DM.          
 In this study, entering non-modifiable covariates age, years with DM, and education 
category in model one accounted for 15 to 32% of variance in cognitive measure performance 





predicting better executive function, verbal memory performance, and mental processing speed. 
An important consideration is that age influences performance on the cognitive tests used in this 
study, and commonly in other similar studies.  
 For this sample of rural adults with DM, the number of years with DM did not uniquely 
contribute to their performance on any of the cognitive measures. In model 4 results, the 
magnitude of the standardized coefficients for years with DM (mean 12.6 (9.9) years) ranged 
from -.27 to .16 (Beta).  Results on the written speed-based test were as anticipated in executive 
function (Trailmaking Test B B=-.01) and mental processing speed (Digit Symbol B= -.10; 
Letter Comparison B= -.16; Pattern Comparison B = -.22).  Results on verbal-based tests in 
executive function (COWA B= -.27) and verbal episodic memory (HVLT Total Recall B = -.22) 
were also as expected.  Results of this study were consistent with previous studies comparing 
cognitive performance over time in persons with DM and without DM (Fischer et al., 2009; 
Okereke et al., 2008; Spauwen et al., 2013).  With three-year longitudinal data (Fischer et al., 
2009), poorer performance in the DM group compared with the control group at baseline and at 
three years was maintained in executive function, mental processing speed, verbal episodic and 
semantic memory, and verbal fluency.  They (Fischer et al., 2009) also found group effects for 
deficits in speed based cognitive tasks in executive function (inhibition and task shifting) and 
mental processing speed (semantic speed and reaction time).  Of note, is that the speed-based 
tasks were measured through computerized testing, and the mean number of years with DM was 
not specified (Fischer et al., 2009).  The association between with DM groups (DM duration 0-4 
years, 5-14 years, > 15 years) and stronger decline in verbal episodic memory with increased 
DM duration was found over four years by Okereke and colleagues (2008).  In persons with DM, 





mental processing speed, and verbal episodic memory compared with controls.  Although 
participants’ mean years with DM were not specified, results of the analysis of the effect of DM 
duration on cognitive decline were significant only for mental processing speed.  
  Although the history of CV disease is a non-modifiable factor, the risk of future CV 
events is modifiable with treatment.  The 10-year cardiovascular risk calculation used in this 
study included age, gender, race, smoking status, systolic and diastolic blood pressure, total and 
high density lipid cholesterol level, treatment for hypertension (yes/no), and presence of DM 
(yes/no).  Hypertension has a cumulative effect over time on cognitive decline in DM (Reijmer et 
al., 2010).  The association between cholesterol levels and cognitive dysfunction in DM is 
unclear (Reijmer et al., 2010).  In this study, the 10-year CV risk score uniquely contributed to 
the performance of episodic verbal memory (HVLT% retained).  Factors that may have limited 
the contribution of the CV risk calculation included that the study participants had fairly well 
controlled blood pressure (mean systolic= 125.9 (20.0) mmHg; mean diastolic = 76.3 (9.8) 
mmHg) and cholesterol levels (total cholesterol = 182.3 (43.2) mg/dl; HDL = 42.3 (11.7) mg/dl). 
Also, the majority of the participants did not smoke tobacco cigarettes (86%), although 28.6% of 
all participants had a history of tobacco cigarette smoking.  
  The sample mean score for depression measure PHQ-8 was 5.5+ 4.8, indicating the 
presence of mild depression.  The level of depression uniquely contributed to the performance of 
mental processing speed (Digit Symbol) and verbal episodic memory (HVLT% retained).  And, 
level of depression and HbA1c had a moderate positive correlation (r=.34, p=.05).  These 
findings were similar to those of Sullivan et al., (2013), but differed from findings by Koekkoek 






Strengths and Limitations 
Strengths of this study include the examination of non-modifiable and modifiable 
sociodemographic and clinical variables that may influence cognitive function in rural adults 
with DM.  A wide age range of adults (ages 45 to 89) were included, and each cognitive domain 
was tested with at least two measures to increase the reliability of the findings.  Limitations 
included that study participants comprised a convenience sample from primary care and DM 
education centers, which may have biased the findings.  The participants had access to and were 
receiving regular healthcare and likely, regular lab tests and treatment adjustments.  Many were 
still employed and had health insurance and received DM education.  The findings may have 
differed with a sample that was unemployed and had limited or no access to healthcare.  Small 
sample size is also a limitation, and may have affected the nearly significant findings for 
hypothesis four.  A larger sample size may have increased the opportunity for the trend of 
cognitive function significantly predicting glycemic control.  In addition, because the study was 
cross-sectional, no longitudinal trends in the variables could be determined, nor any causality 
implied.  Lower, but normal cognitive function may be associated with other factors, such as 
poor performance of self-care, which may lead to poor glycemic control.  Other comorbidities 
not accounted for, such as heart failure, may contribute to poorer cognitive function.  Also, the 
results are not generalizable to the entire population of rural adults with DM.  The blood glucose 
level at the time of the administration of the cognitive tests was not determined.  Extremes in 
blood glucose levels can affect cognitive performance.  Also, the length and intensity of the 








 This study provides evidence that decreased cognitive function in domains of attention, 
executive function, mental processing speed, or verbal episodic memory in rural adults with DM 
does not independently explain glycemic control after controlling for the modifiable and non-
modifiable covariates.  The progression of cognitive decline may have two different patterns, a 
slow progressive decline beginning in pre-DM stages, and a severe faster decline associated with 
dementia.  The performance of this study's participants was below the norms in all four measured 
cognitive domains; however, it is unknown whether the results reflect a slow or rapid cognitive 
decline.  The study sample included participants from ages 45 years and older, and nearly 28% 
were employed.  It is concerning that performance in all cognitive domains were below the 
norms, and there was mild cognitive impairment present in some participants between the ages 
of 45 to 66 years old.  Understanding the impairment in cognitive function in persons with DM is 
important, not only because the ongoing self-care activities for maintaining glycemic control 
requires multiple cognitive processes, but also because job performance may be affected.   
 In examining modifiable and non-modifiable factors that influence cognition, age and 
years with DM, both non-modifiable factors, were highly associated with cognitive function, and 
age was predictive of cognitive function.  Modifiable factors of CV risk and the level of 
depression were predictive of cognitive function.  Some elements of CV risk, such as blood 
pressure control, lipid levels, and smoking status are modifiable with intervention.  Depression 
appears to be an important consideration.  Depression may precede the onset of DM, or be 
consequential to the brain changes that occur in DM.  Depression can impair one's ability to 
adhere to self-care regimens, potentially worsening the course and outcomes of DM.  Routine 





of early cognitive decline and enable implementing changes in treatment regimens to maximize 
glycemic control.  Medication and psychotherapy can decrease levels of depression, but it is yet 
to be determined which medications are most effective in persons with DM.  
   More research is required to identify how these findings impact one’s everyday ability 
to perform self-care, instrumental activities of daily living, and perhaps job performance. 
Findings from this study imply that health care professionals caring for persons with DM need to 
monitor levels of cognitive function and depression along with glycemic control and CV risk 
factors.  Decline in the cognitive domains needed for self-care planning and performance, such 
as attention, executive function, mental processing speed, and verbal episodic memory, varies 
with age and years with DM.  At the present time, methods for monitoring cognitive decline in 
persons with DM is not standardized.  Further research in this area is urgently needed, as it may 
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Cognitive Function and Self-Care in Rural Adults with Type 2 Diabetes 
Introduction 
Persons with type 2 diabetes mellitus (DM) are at high risk for multiple serious 
complications, including structural brain changes and decreased cognitive function that may 
impair their abilities to perform the self-care activities associated with DM management (Nguyen 
et al., 2010; Primozic, Tavcar, Avbelj, Dernovsek, & Oblak., 2012; Qiu et al., 2006) and the 
decision making and problem-solving abilities needed to maintain glycemic control (Cukierman-
Yaffe et al., 2009, Munshi et al., 2012, Thabit, Tun, McDermott & Sreenen, 2012). Effective 
self-care positively correlates with better glycemic control, health outcomes, and perceived 
health (Song, 2010). Impaired cognitive functions, including attention, executive function, 
mental processing speed, and verbal episodic memory, which are most often affected in persons 
with DM, are often overlooked in clinical practice but may be crucial to one’s ability to 
maximize their health and prevent further DM complications (Reijmer et al. 2010). 
Understanding the linkages between DM self-care and cognitive function is thus critical to 
supporting patients and families living with DM in community settings. Toward that aim, this 
study examined the cognitive processes associated with DM self-care tasks, and how DM 
associated cognitive changes and other factors influence self-care. Using the self-care model 





function, mental processing speed, and verbal episodic memory), after controlling for the 
contributing factors of age, years with DM, level of depression, years of education, and everyday 
problem solving, independently predicted level of self-care activity performance in the study 
population.  
Background 
 Song (2010) identified the main concepts of DM self-care as self-care maintenance and 
self-care management. Self-care maintenance refers to behaviors needed to sustain physiologic 
stability in DM, which include symptom monitoring and treatment adherence. Self-care 
management incorporates active decision making and problem-solving in response to sign and 
symptom changes that occur in DM (Song, 2010). Other factors that contribute to the 
performance of self-care activities include individual sociodemographic characteristics (e.g. age, 
level of education), one’s the functional ability to perform activities of daily living (ADLs) and 
instrumental activities of daily living (IADLs), and the presence of comorbidities (e.g. 
depression) (Feil, Zhu, & Sultzer, 2012). Adapted from Riegel and Dickson’s (2008) situation-
specific theory for self-care in heart failure patients, Song’s (2010) model is specific for DM 
self-care but, like the Self-Care of Heart Failure Model, emphasizes one’s ability to perform self-
care maintenance and self-care management activities. Self-care maintenance includes behaviors, 
such as symptom monitoring and treatment adherence to maintain physiologic stability.  Self-
care management represents how an individual responds to disease-related sign and symptom 
changes, and one’s ability to recognize, evaluate, decide to take action, implement treatment or 
action, and evaluate the treatment or action related to the perceived changes.  Song’s (2010) 
model adaptation reflects relevant DM monitoring activities and behaviors (diet, medications, 





routine and differ from higher level decision making and problem solving behaviors required in 
self-care management.  Routine DM self-care behaviors have been well studied while the latter 
have not (Song, 2010).   
Cognitive processes required for the performance of DM self-care 
      As previously noted, attention, executive function, mental processing speed, and verbal 
episodic memory are cognitive domains most often affected in persons with DM (Reijmer et al., 
2010).  Attention involves cognitive processes that utilize specialized brain networks that 
allocate limited information processing capacity towards sensitivity to and selection of incoming 
stimuli, and sustaining focus on other stimuli (Posner & Rothbart, 2007). Executive functions 
include inhibition and interference control (behavioral and cognitive inhibition, selective 
attention); working memory (holding and manipulating information in mind); and cognitive 
flexibility (mental flexibility or mental set shifting) (Diamond, 2013). These processes are 
dependent upon the frontal and pre-frontal cortices and allow goal formation, organization, 
sequencing, switching between tasks, conflict resolution and encoding information for short-term 
storage (Baddeley, 1998; Smith & Jonides, 1999). Mental processing speed is the rate of 
cognitive processes for information processing, and when (decision speed) and how quickly 
(perceptual speed) one responds to situations (Salthouse, 2000). Multiple neuropsychological 
tests are used to evaluate executive function, and differ in the cognitive abilities that are 
examined (Salthouse, 2005). 
 In an analysis of sixteen different tests that measured executive functions of perceptual 
speed, functions of vocabulary, reasoning, spatial visualization, and verbal episodic memory, it 
was demonstrated that perceptual speed and reasoning had the most significant associations with 





more to speed based and reasoning tasks (Salthouse, 2005). Studies examining the effects of 
aging on mental processing speed have shown varying results but demonstrate that age alone 
may not independently influence reduced mental processing speed (Salthouse, 2000; Schretlen et 
al., 2000). Verbal episodic memory involves the ability to learn, store, and retrieve information, 
and encompasses knowledge acquired through life experiences (Dickerson & Eichenbaum, 2010; 
Squire & Kandel, 2009).  It is highly dependent on the medial temporal lobe memory system, 
which also regulates critical functions in the processes of sensory perception (visual, auditory, 
olfactory, taste), learning, and memory consolidation (Dickerson & Eichenbaum, 2010; Squire & 
Kandel, 2009; Yang & Li, 2012). A useful analogy for conceptualizing the interplay between 
different cognitive processes is to consider the frontal cortex as a " file clerk" for the memory 
system, the medial temporal lobes as the "recent memory files," and other cortical regions (i.e. 
amygdala, basal ganglia, cerebellum, lateral temporal lobes, thalamus) as the "remote memory 
files" (Budson, 2009). If one of the regions are impaired, the " files" may be difficult to retrieve 
or, if available, distorted in some way (Budson, 2009).  
 The hippocampus is highly vulnerable to the effects of hyperglycemia in individuals with 
DM, with damage shown early in the course of the disease (Bruehl et al., 2009). Hippocampal 
based cognitive functions, such as verbal episodic memory may be initially affected and show 
further decline as the level of DM progresses to later stages (Bruehl et al., 2009). Recent studies 
have documented reduced functional connectivity between the hippocampus and several 
associated regions and the appearance of decreased functional connectivity prior to the 
appearance of identifiable structural deficits ((Hoogenboom et al., 2014; Musen et al., 2012; 
Zhou et al., 2010). Decreased neuronal connectivity disturbances are thought to be widespread in 





controls, persons with DM have increased white matter lesion in tracts connecting frontal, 
parietal and temporal brain regions, areas associated with attention, executive function, mental 
processing speed, and verbal episodic memory, that significantly reduce mental processing speed 
and memory (Reijmer et al., 2013). Other comorbid conditions, such as heart failure, 
demonstrate similar declines in cognitive function that may compound the pattern of decline seen 
in DM (Dickson, Tkacs, & Riegel, 2007). 
DM self-care knowledge. 
Important antecedents to symptom monitoring include having adequate knowledge about 
DM and mastery of self-monitoring skills (Song and Lipman, 2008). The ability to acquire new 
knowledge and form memories to retain that knowledge over time is referred to as declarative 
memory, which includes verbal episodic memory (Dickerson & Eichenbaum, 2010; Squire & 
Kandel, 2009). Memory formation requires interaction with cognitive functions of attention, 
language and perception, and functional neuronal connectivity is essential for learning, memory 
storage and recall. Multiple factors influence long term memory formation including focus, 
perception, organizational ability, and existing knowledge (Squire & Kandel, 2009; Yang & Li, 
2012).  
 Hewitt and colleagues (2011) reported that insulin-dependent older persons (mean age 
80.9 years) with global cognitive impairment had poorer knowledge about managing 
hypoglycemia (p=.013, p = .008) and medications during an acute illness (p=.017) than did 
individuals without impairment. Another study, which examined the relationship of self-care to 
the conceptualization and understanding of self-care in DM patients (mean age [SD] = 53.9 [+ 
17.3] years), found that participants with poor glycemic control lacked understanding of basic 





of exercise, dietary instructions, and behavior-lifestyle adjustment), and had difficulty detecting 
and solving problems (Lippa and Klein, 2008). Individuals with moderate glycemic control 
demonstrated a vague understanding of medications, monitored their blood glucose regularly, 
and inconsistently applied results to events. For example, while many individuals could detect 
symptoms of hyper- or hypoglycemia, they often lacked the ability to correct for these states. 
Dietary rules tended to be broadly followed by these individuals and they demonstrated poor 
understanding of the role of exercise in managing their disease, often only exercising to 
minimally perform activities of daily living.  Individuals with good glycemic control either had a 
fixed routine or utilized in-depth medication knowledge to modify routines.  They tended to 
monitor blood glucose several times daily, and understood the relationship between exercise and 
glucose levels (although exercise frequency was no greater than in the other two groups). 
Individuals in this group also regularly monitored their diets and could effectively identify and 
manage episodes of hypo- and hyperglycemia (Lippa & Klein, 2008). 
Treatment adherence in DM self-care.  
Treatment adherence in DM self-care involves multiple activities and behaviors for 
controlling glucose levels and managing signs and symptoms.  Included among these is 
medication adherence, or taking medications at the times and dosages prescribed, which requires 
that one has intact processes of executive function and working memory needed to develop and 
implement plans for and recall of adherence (Insel, Morrow, Brewer, & Figueredo, 2006). When 
a task is repetitive, such as routinely taking daily medication, remembering if the medication was 
taken becomes difficult in those with impairment in those cognitive domains.  Medication 
adherence involves working memory functions of keeping the intention in mind until conditions 





swallow pills or injection supplies for insulin administration (Insel, et al., 2006). Executive 
function is also essential for establishing new behaviors, suppressing old behaviors, and self-
regulation (Tran et al., 2014). 
 Insel et al. (2006) examined the relationship between cognitive function and medication 
adherence among adults over the age of 67 years with multiple medical conditions.  They found 
that executive function and working memory were significantly related to adherence (p<.05) 
while global cognition and memory composite scores were not.  These findings support the 
importance of intact prefrontal cortex functions in self-care performance, which distinctly differ 
from global cognition and memory performance (Insel et al., 2006). In persons with DM, 
impaired executive function may co-exist with normal global cognitive performance and may not 
be detected with global cognition and memory measures (Thabit et al., 2012). 
Sign and Symptom Recognition in DM. 
Mechanisms behind how sign and symptom changes trigger decision making and 
problem-solving are not well understood.  In order to recognize and interpret symptom changes, 
knowledge and understanding of the implications of the symptoms, and the ability to sense 
changes in body homeostasis are necessary (Dickson, Tkacs, & Riegel, 2007).  An individual’s 
inability to recognize altered homeostasis may also reflect impaired interoception or autonomic 
or peripheral neurological deficits (Dickson et al., 2007). For example, peripheral neuropathy is 
common in persons with DM, causing decreased pain sensation in the extremities that often 
results in skin breakdown and invasive infections (ADA, 2016).  Autonomic neuropathy in DM 
can cause decreased cardiac responsiveness to exercise, postural hypotension, impaired 
thermoregulation and pupillary reactivity, and autonomic failure in response to hypoglycemia. 





erratic blood glucose control (ADA, 2016). Intact mental processing and cognitive processes of 
attention, executive function; memory and perception are key factors connecting these changes 
to the need for self-care action (Dickson et al., 2007). Symptom detection differs among persons 
with DM, as past experiences and DM knowledge vary between individuals and can be 
influenced by their health beliefs and cultural perceptions of disease (Kirk et al. 2011; Song & 
Lipman, 2008).  Indeed, some individuals with DM may interpret their lack of symptoms to 
mean that they no longer need to self-monitor their glucose levels at all (Song & Lipman, 2008). 
Kirk et al. (2011) examined how older adults with DM (> 60 years of age) identified 
symptoms related to high and low blood glucose levels.  Grouping symptoms into four major 
areas:  nerve perception, lightheadedness, energy levels and vision changes, they found that 
participants described nerve perception as "tingling," "numbness," or "nervousness," and 
reported these symptoms with more frequency than the symptoms in the other three categories. 
Lightheadedness was most often described by participants as "dizziness," and several described it 
as a feeling that "made it hard to think."  Descriptions of low energy level included feeling tired 
and weak, which were sometimes attributed to old age.  Many participants were unable to 
distinguish whether the symptoms of lightheadedness/dizziness, low energy levels, and vision 
changes occurred with high or low blood glucose levels, exemplifying the multiple variations in 
symptom perception experienced by persons with DM (Kirk et. al, 2011). 
Decision making and self-care in DM.  
Mechanisms behind how sign and symptom changes trigger decision making and 
problem solving are also not well understood. What is known is that the neural basis of decision 
making is centered in the prefrontal cortex, with connectivity to other brain areas for integration 





Schubotz, & vonCramen, 2006).  Damage to the prefrontal cortex affects problem structuring 
and solution generation, creating difficulty in one’s ability to consider the consequences of 
immediate actions or activities on the future, and rendering one incapable of connecting 
behavioral choices and corrective actions (Krawczyk, 2002; Munshi et al., 2012, Thabit et al., 
2012). Impaired executive function interferes with one’s processes of reasoning, association, 
insight, planning and decision making (Munshi et al., 2012, Thabit et al., 2012). These highly 
integrated processes are essential for complex tasks required for DM self-care such as dietary 
adjustments requiring carbohydrate counting, managing insulin based on sliding scales and meal 
timing, and activity adjustment based on blood glucose levels (Munshi et al., 2012, Thabit et al., 
2012).  
Lippa and colleagues (2008) examined the relationships between levels of decision 
making and DM control, and the use of declarative (factual) and applied (procedural) knowledge 
in DM self-care. Eighteen participants (mean age =53.9, range = 19-76 years, 33% female) were 
interviewed and asked to make decisions related to routine but critical DM self-care incidents. 
Three levels of decision making expertise (novice, intermediate, expert) were determined by the 
number of relevant answers given in categories of problem detection and cue utilization, 
functional relationship comprehension (ability to explain the decision), and problem solving 
(what action to take in response to the incident). Level of self-care adherence was measured 
using the Summary of Self-care Activity Scale, a 17 item self-report scale that queries frequency 
of performing activities of diet, exercise, blood glucose testing, foot care, and medications.  
Glycemic control was determined by rank ordering of either the highest reported blood glucose 
value in the past week, or by glycohemoglobin results. The relation between each decision-





decision-making utilized more superficial organizational patterns when applying knowledge to 
functional relationships, and exhibited less efficient problem-solving strategies than expert level 
decision making.  Greater use of problem detection cues was associated with better treatment 
adherence and lower blood glucose levels; more expert participants combined multiples cues to 
increase problem detection.  Participants who identified more functional relationships and had 
better problem-solving abilities also exhibited better adherence, but not necessarily better 
glycemic control. The probability of whether a participant had accurate knowledge to give an 
effective solution for the incident (declarative knowledge) predicted the probability of applying 
an effective solution (applied knowledge).  The probability of having accurate declarative 
knowledge was greater than the probability of applying that knowledge in critical situations of 
hyper and hypoglycemia. The study showed that DM knowledge alone does not lead to greater 
decision-making ability related to DM self-care actions (Lippa et al., 2008).  
Contributing Factors to DM Self-Care Performance 
Age, duration with DM, level of education, glycemic control, rurality and DM self-
care. 
 While increased age is associated with a decline in one’s ability to perform DM self-care 
(Munshi et al., 2006; Tomlin & Sinclair, 2016), the length of time of DM diagnosis (Tomlin & 
Sinclair, 2016) and level of education (Insel et al., 2006; Lin et al., 2014; Tomlin & Sinclair, 
2016) has not. Results of studies examining the relationship between self-care performance and 
glycemic control are varied (Lin et al., 2014; Lippa et al., 2008; Nguyen et al., 2010; Primozic et 
al., 2012).  Women are more likely than men to encounter barriers to self-care, including income, 





Unden et al. (2008) found no difference in glycemic control between women and men, however, 
compared with men, women reported lower quality of life and less satisfaction with DM care. 
Individuals living in rural communities, defined as areas with a population below 50,000 
and a core population density of fewer than 1000 persons per square mile (Hart, Larson, & 
Lishner, 2005), may experience limited access to DM resources and greater challenges to 
proximal health care (Hale, Bennett, & Probst, 2010; Quandt et al., 2005; Utz, 2008).  Rural 
residents across the United States comprise nearly 21% of the population (Bureau of the Census, 
2010), with adults over the age of eighteen years old demonstrating greater risk for poorer 
glycemic control than adults in non-rural communities (Hale, Bennett, & Probst, 2010).  Data 
from the 2006 Behavioral Risk Factor Surveillance System (n=29,501) explored differences in 
DM care and DM outcomes associated with rural residence and found that rural residents with 
DM had lower levels of education, income and health insurance coverage when compared to 
non-rural peers (Hale et al., 2010).  Rural residents were also less likely to report having had 
screening foot or eye examinations, and more likely to report occurrence of retinopathy and foot 
ulcers (Hale et al., 2010).  
 Brown et al. (2009) and Kilbourne and colleagues (Kilbourne, Switzer, Hyman, Crowley-
Matoka, & Fine, 2006) proposed socioeconomic status as a major health outcomes determinant 
among vulnerable populations.  More specifically, Brown et al. (2009) included individual, 
household, and community factors as part of one's overall socioeconomic status and proposed 
that the progression of a chronic disease, such as DM, is likely influenced by these factors over 
time, especially as they may influence health outcomes through healthcare access and health 
behaviors (Brown et al., 2009).  Gender, age, and racial/ethnic factors are considered as 





Indeed, according to Brown and colleagues (2009), access to healthcare encompasses the 
availability of a consistent source of adequate care and financial and insurance resources.  Health 
behaviors refer to performance of self-care and reduction behaviors such as exercise and 
smoking abstinence and smoking cessation. Better access to care decreases the negative effects 
of income inequality and frequency of poor self-reported health status. Lower frequency of blood 
glucose monitoring and exercise, and higher rates of smoking are associated with lower 
socioeconomic status and education levels. Compared with uninsured adults with DM, insured 
persons have greater odds of having foot and dilated eye examinations, and preventative care.  
Communication barriers such as poor interaction with health care staff, language barriers, and 
inability to understand instructions are linked with lower socioeconomic status. Also, the risk of 
social isolation and limited social support is greater in poorer populations, and is linked to poorer 
adherence to self-care (Brown et al., 2009). 
Everyday problem-solving ability in IADLs and self-care in DM.  
The inability or diminished ability to perform complex daily tasks, such as those required 
for instrumental activities of daily living (IADLs), has been shown to be an early indicator of 
cognitive decline, and has stronger correlations with cognition than do activities of daily living 
(ADLs) (Royall et al., 2007).  ADLs refer to essential abilities for autonomous function at home, 
such as dressing, bathing and toileting.  IADLs are cognitively complex daily tasks required for 
autonomy within society and include managing finances, medications, transportation, meal 
preparation and telephone use and which are commonly measured by performance-based and 
self-report tools (Lawton & Brody, 1969; Royall et al., 2007; Willis et al., 1998). Still, the 
relevance of specific cognitive domains to performance of IADLs is unclear. Royall et al. (2007) 





testing associations between cognitive and functional outcome measures, including IADLs. 
Overall results reported weak to moderate associations (r<.40) between cognitive measures and 
functional outcomes, with executive function and global cognitive measures explaining more 
variance than attention, memory, verbal or visuospatial measures (p<.001). Cahn-Weiner et al. 
(2007) examined cognitive and neuroimaging (MRI) predictors of change in IADL performance 
over 5 years in a community-based sample of persons with normal cognitive function (n=52, 
mean age (SD) = 72.5 + 7.4 years), mild cognitive impairment (n= 35, mean age (SD) = 72.8 + 
8.4 years), and moderate dementia (n= 37, mean age (SD) = 73.1 + 8.4 years) and moderate 
dementia (n=124, mean age 72.5 +7.4 years). At baseline, lower episodic memory and executive 
function were associated with poorer IADL performance (p<.001), with executive function 
associated with decreased IADL performance over time (p<.01). Baseline MRI measures of 
cortical gray matter and hippocampal volume were associated with baseline IADL performance 
(both p<.001). Hippocampal volume was significantly associated with decreased IADL 
performance over time (p<.01), cortical gray matter nearly reached significant association 
(p=.05), and white matter lesions and lacunar infarcts had no association. The researchers 
speculated that executive function plays more of a role in daily IADL performance than episodic 
memory, and compensates for dysfunction in other cognitive domains until other cortical-
dependent processes begin to fail and compromise everyday functional performance. Many 
persons have “mixed dementia,” or dementia with multiple causative factors including vascular 
disease and other factors.  In Alzheimer’s dementia, episodic memory is affected early and 
progressively declines along with the disease. Hence, if executive function is poor at baseline, it 





 In two studies by Munshi and colleagues (2006, 2012) examining the association between 
cognitive dysfunction and glycemic control in persons with DM, decreased performance as an 
objective measurement of executive function was associated with poorer IADL performance and 
glycemic control. Depression was associated with decreased IADL performance, but not 
glycemic control (Munshi et al., 2006). Interestingly, a self-reported measure of executive 
function was not associated with glycemic control or IADL performance (Munshi et al., 2012), 
but was associated with depression.  Although DM self-care performance was not measured by 
Munshi and colleagues, their results emphasized the importance of objective assessment of 
executive function and depression when someone with DM exhibits problems with performing 
complex self-care tasks such as managing insulin sliding scales, carbohydrate counting, and diet 
management.  
Depression and self-care in DM. 
Depression can impair one's ability to adhere to self-care regimens, potentially worsening 
the course and outcomes of DM (Lamers et al., 2008; Lin et al., 2004; Munshi et al., 2006; 
Primozic). The presence of depression has been associated with cognitive dysfunction in persons 
with DM (Sullivan et al., 2013). Compared with control groups, higher prevalence and 
persistence of depression has been shown in persons with DM (Degmecic et al., 2014; Trento et 
al., 2013) with estimates of depression prevalence between 8-31% (mean 18%) in persons with 
DM, and 5-24% (mean 10%) in persons without DM (Koekkoek et al., 2012).  Depression in DM 
may result from coping with a chronic disease or from damaging metabolic consequences 
affecting cerebral neurotransmitter levels or vascular integrity (Reijmer et al., 2010). Others 





influenced by biologic and behavioral factors (Degmecic et al., 2014; Sullivan et al., 2013; 
Trento et al., 2013).  
 Dysregulation and over activation of the hypothalamus-pituitary-adrenal axis (HPA-axis) 
and sympathetic nervous system (SNS) has been shown to be a common pathway for both 
depression and DM, and may increase the risk for both (Badescu et al., 2016; Champaneri, 
Wand, Malhotra, Casagranda, & Golden, 2010; Tataru et al., 2016). Depression and chronic 
stress activate the HPA-axis and SNS, causing increases in production of cortisol, adrenalin and 
noradrenaline, and chronic hypercortisolemia and prolonged SNS activation. This, in turn, 
promotes insulin resistance, obesity, and metabolic syndrome, a constellation of risk factors that 
includes elevations in blood pressure, blood sugar, and triglycerides; low levels of HDL 
cholesterol; and increased abdominal fat that increase the risk for cardiac and DM disease. 
Depression and chronic stress also induce immune dysfunction through SNS activation, causing 
increased production of inflammatory cytokines (Interleukin-6), which also promotes insulin 
resistance and leads to the development of DM, (Badescu et al., 2016; Champaneri et al., 2010). 
Hypercortisolemia disrupts hippocampal neurogenesis, and inflammatory cytokines interfere 
with normal functioning of the pancreatic B-cells, where insulin is stored and released (Badescu 
et al., 2016). 
Aims and Hypotheses 
It appears that every aspect of self-care can potentially be affected by DM-associated 
brain changes, making it difficult to determine which cognitive processes are problematic.  How 
these processes relate to patient characteristics is also unclear.  For example, there is no clear 
understanding concerning the relationship between cognitive function and self-care in rural 





Guided by an adapted self-care model developed by Song (2010) and Riegel and Dickson (2008) 
and depicted in Figure 4.1, this study aims to address this gap, specifically examining the 
cognitive processes associated with DM self-care tasks and how DM-associated cognitive 
changes and other factors influenced self-care in this population.  Towards these aims, this study 
explored rural-related sociodemographic factors (education level, employment, healthcare 
access, healthcare insurance) that potentially influence self-care performance.  Next, it examined 
the relationship between performance in cognitive function measures (attention, executive 
function, mental processing speed and verbal episodic memory), levels of self-care activity (diet, 
blood glucose testing, exercise, foot care, and medication), and contributing factors (age, years 
with DM, education category, everyday problem-solving, HbA1c, level of depression).  Finally, 
it tested whether cognitive function measures, after controlling for the contributing factors of 
age, years with DM, level of depression, years of education, and everyday problem solving, 
predicted DM self-care activity levels.  As shown in Figure 4.2, the study hypotheses were that 
1) increased age, years with DM, and level of depression, and decreased years of education, 
everyday problem-solving, glycemic control, and cognitive function would correlate with poorer 
levels of DM self–care adherence in a sample of rural adults with DM, and that: 2) cognitive 
function, after controlling for the afore noted contributing factors, would independently predict 
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Figure 4.1. DM Self-Care Framework for Guiding Analysis  
Adapted from:  Song (2010). Journal of Cardiovascular Nursing; 25(2): 93-98.  
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Participants and settings 
 Using a descriptive and prospective design, and with approval from the University of 
Michigan Institutional Review Board (Study HUM00085816), 56 rural-dwelling men and 
women with DM were recruited from primary care providers and diabetes education centers in 
three rural counties located in the Upper Peninsula of Michigan and two rural counties in 
northeastern Wisconsin.  The prevalence of DM in the Michigan and Wisconsin counties is 10-
12% and 8.9-10.6%, respectively, which exceeds the 9.3% national prevalence rate of DM 
among adults (CDC, 2014).  Available healthcare in each county includes public hospitals, 
community and rural health clinics, primary and specialty care (e.g. internal medicine, 
cardiology, neurology, nephrology, diabetes education).  
Inclusion and exclusion criteria 
  Participants were included if they had an established medical diagnosis of type 2 DM, 
were over the age of 45 (due to increased DM prevalence after age 45 years), had a documented 
HbA1c level within two months of their interview for the study, had a documented total 
cholesterol and HDL within the past twelve months, completed at least the ninth grade, were able 
to read the English language, were available by telephone or mail for scheduling, and consented 
to participate in the study.  
 To limit confounding factors that could affect the relationship between study variables or 
affect cognitive function and the ability to perform the neuropsychological tests, participants 
were excluded if they had a diagnosis of dementia (MoCA score <22), history of stroke, or 
degenerative neurological conditions (e.g. Huntington’s, Parkinson’s, or Lewy Body disease, 
amyotrophic lateral sclerosis), current or recently treated (within the past 5 years) major 





acuity to read printed study materials, history of or current major alcohol or substance abuse as 
measured by the CAGE test (NIAAA, 2003), hepatic encephalopathy, terminal illness, dialysis 
dependence, or prisoner status.   
Measures and Instruments 
  Sociodemographic and clinical data. 
 Sociodemographic data characterized the sample and included age, gender, level of 
education, work and marital status, race and ethnicity, and distance to health care. Clinical data 
included years with DM, and presence of neuropathy (a complication of DM), height, weight, 
body mass index blood pressure, smoking status, HbA1c, and total and HDL cholesterol levels. 
The length of the interview was 60-90 minutes, which included all of the data collection listed 
below. 
Dementia screen for exclusion criteria. 
The Montreal Cognitive Assessment (MoCA) was used to screen potential study 
participants for the presence of dementia, and thus, exclusion from the study.  The MoCA has 30 
items that briefly measure multiple cognitive domains that are affected in dementia including 
short-term memory, visuospatial abilities, executive functions, verbal memory, attention and 
working memory, language, and orientation.  The test takes approximately 10 minutes to 
administer and points are allocated for successful completion of various tasks.  A perfect score is 
30 with a score of 26 or greater considered normal.  Scores between 22 and 26 indicate mild 
cognitive impairment, and scores below 22 indicate the likelihood of dementia, and provided the 








 The revised version of the Summary of Diabetes Self-Care Activities Measure (SDSCA) 
was used to measure levels of self-care activities across six components of the DM regimen 
(Toobert, Hampson & Glasgow, 2000).  The SDSCA is a brief self-report instrument that asks 
participants to identify the frequency with which they perform activities related to diet, exercise, 
blood glucose testing, foot care, and medications.  Questions for general diet include the number 
of days per week that they follow a healthful eating plan and the number of days per week that 
they follow their prescribed eating plan.  Specific questions ask about the frequency per week of 
eating five or more servings of fruits and vegetables, eating high fat foods, and spacing 
carbohydrates evenly throughout the day as recommended by one’s healthcare provider.  
Exercise questions ask participants about the number of days per week in which they participate 
in at least 30 minutes of physical activity, and specifically whether they participate in a specific 
exercise session other than their usual activities around home or work.  Similarly, the SDSCA 
asks how many days per week one tests his/her blood glucose and the frequency with which it 
corresponds to the frequency recommended by one’s healthcare provider.  Foot care questions 
ascertain the number of days participants checked their feet, inspected the inside of their shoes, 
washed and/or soaked their feet, and dried the spaces between their toes after washing. 
Medications questions included the number of days DM medications were taken, or if on insulin, 
the number of days recommended insulin injections were taken. Scores were calculated for each 
regimen area, creating a subscale for each area, and means and standard deviations were 
calculated for each subscale. The SDSCA has been widely used in adults with DM. Instrument 
reliability of the original 11-question SDSCA was demonstrated across seven different studies 





internal consistency of the scales, and test-retest Pearson’s correlations mean r=.40. Evidence of 
criterion validity was shown with validity coefficients significant with p ranges for Pearson’s 
correlations r=.001 to .05, using SDSCA dietary and exercise subscales and criterion variables 
from 5 of the 7 reviewed studies.  Sensitivity to change results varied widely with a 
responsiveness index score (range -0.09-.43). The revised version of the SDSCA has 14 
additional questions that included items pertaining to self-care recommendations and 
medications, although there is no currently available reliability or validity data (Communication 
with SDSCA developer, Dr. Deborah J. Toobert, PhD, 10/21/2013). 
Glycemic control. 
 Glycemic control, defined as the optimal level of average blood glucose levels associated 
with the reduction of DM complications, was measured with glycosylated hemoglobin, or 
HbA1c levels (ADA, 2016).  HbA1c is a form of hemoglobin that is measured primarily to 
identify the 3-month average plasma glucose concentration, and which has a strong predictive 
value for DM complications (ADA, 2016). The average, presented as a percentage, indicates 
how much glucose is adhering to red blood cells over their average life span (3-4 months).  For 
people without DM, a normal range of 4-6% equates to blood glucose level of between 70-126 
mg/dl. A HbA1c of 7%, or a blood glucose level of 154 mg/dl, indicates consistently elevated 
blood glucose levels, and maintaining HbA1c levels at 7% or below is thought to reduce 
microvascular and neuropathic complications (ADA, 2016). 
As per the inclusion criteria, all participants had documentation of an HbA1c level from a 
Clinical Laboratory Improvement Amendments certified laboratory done within two months 






 Cognitive function measures. 
 The variables representing aspects of cognitive function included attention, executive 
function, mental processing speed, and verbal episodic memory. A brief description of the 
variables and measures follow. A more comprehensive discussion of the measures is included in 
Table 3.2. on page 102. 
  Digit Span.  The Digit Span Test was used to measure participants’ attention capacity by 
exposing them to increasingly larger amounts of information and then asking them to 
immediately recall or process that information. Digit Span is comprised of two tests, Digits 
Forward and Digits Backward, which involve different cognitive activities of sustaining focus 
and short-term storage capacity (Choi et al., 2014; Strauss et al., 2006). Participants repeat 
number sequences that the examiner reads aloud, with increasingly longer sequences being tested 
in each trial.  In the forwards series, the sequences are repeated forwards, and in the backwards 
series, the sequences are repeated backwards.  Raw scores for Digits Forward indicate length of 
digit span (possible score range is 0 to 8) and Digits Backward (possible score range is 0-7) were 
analyzed as a total sum (possible score 0 to 15). The effects of age, education, and gender have 
varied between studies (Choi et al., 2014).  Reliability and validity have been supported (Strauss et 
al., 2006).  
                   Trailmaking Test Part A. Trailmaking Test Part A (Trails A) was used to measure 
participants' attentional processes of scanning and visuomotor tracking of a sequence and their 
overall speed of performance (Lezak et al., 2004; Reitan, 1992). The test requires that the 
participant draw lines to connect randomly placed numbered circles into a consecutive numerical 
order. The test is timed and scored based on the time it takes for the individual to complete the 





cognitively intact individuals, with greater than 78 seconds indicating cognitive decline.  To 
account for participants that could not complete the test, the scores were converted to a ratio of 
number correct per second, where a higher ratio indicated better performance (Reitan, 1992). 
Problems with visual scanning and tracking on Trails A can indicate difficulties with conceptual 
sequencing of numbers and decreased mental flexibility.  Increased age and depression, as well 
as lower education level, are associated with decreased performance (Lezak et al., 2004).  
Executive function. 
 Several instruments were used to measure executive function given that, as previously 
discussed, it comprises a wide array of processes and includes visuospatial and auditory and 
speech functions (Baddeley, 1998; Diamond, 2013; Smith & Jonides, 1999).  
    Controlled Oral Word Association Test (COWA).  The COWA was used to test 
participants’ verbal fluency as a measure of frontal and pre-frontal cortex function.  The test 
requires that the participant generate as many words as possible (excluding proper nouns and 
numbers) beginning with a letter given by the tester.  Raw scores reflect the total number of 
acceptable words generated with three different letters (in this case: C, F, and L) during three 
separate 60 second trials.  Scores adjusted for age and education are then converted to a 
percentile.  Lower scores indicate greater impairment (Lezak et al., 2004).  Reliability and 
validity have been supported (Lezak et al., 2004). 
  Trailmaking Test Part B. The Trailmaking Test Part B (Trails B) measures processes of 
scanning and visuomotor tracking of a sequence, speed of performance, divided attention, and 
mental flexibility and mental set shifting (Lezak et al., 2004).  The test requires participants to 
draw lines to connect randomly placed numbered and lettered circles into an alternating sequence 





participants to complete the task, including time to correct errors.  The average completion time 
is 75 seconds for cognitively intact individuals, with greater than 270 seconds (4.5 minutes) 
indicative of cognitive decline.  Scores are converted to a ratio of number correct per second, 
where a higher ratio indicated better performance, in order to accommodate participants that are 
unable to complete the test after 270 seconds.  Older adults who perform poorly on Trails B tend 
to have problems with complex activities of daily living (Lezak et al., 2004).  
 Mental processing speed. 
  Participants’ decision speed and perceptual speed were measured using two instruments.  
 Digit Symbol-Coding.  Digit Symbol-Coding is a timed paper-and-pencil test that asks 
participants to match numbers with paired symbols and then copy the symbols into rows 
containing blank squares under its corresponding number. The score is determined by counting 
the number of correctly drawn symbols in the allotted 120 seconds. The maximum score is 133 
points (Lezak et al., 2004).  Age and depression have been shown to negatively affect test 
performance, while level of intellect, memory or learning capability does not. It is particularly 
sensitive to dementia with demonstration of rapidly declining performance rates associated with 
dementia progression (Lezak et al., 2004). 
 Letter and Pattern Comparison. The Letter Comparison task consists of a timed test 
where participants are asked to quickly determine whether two side-by-side strings of letters are 
the same or different, then write ‘S’ (for same) or ‘D’ (for different) on a line between the pairs.  
The Pattern Comparison task is similar, except that the pages contain pairs of line segment 
patterns that require rapid classification as “same” or “different”.  Two separately timed (20 
seconds each) trials of 21 pairs of letters and 30 pairs of patterns were administered, with the 





average of the two attempts for each task (Salthouse & Babcock, 1991). Advancing age 
significantly reduces overall performance (Salthouse, 2000). Both the letter and pattern 
comparison tasks are established measures of information processing speed that have been used 
extensively in a number of previous studies (Fisk & Warr, 1996; Salthouse, 2005). 
 Verbal episodic memory. 
  Verbal episodic memory is the ability to learn, encode, store and retrieve information 
about everyday personal experiences.  Dysfunction in episodic memory causes disruption in the 
ability to learn and recall new information (Budson, 2009; Cansino, 2008). Core brain areas 
associated with episodic memory are the medial temporal lobe and hippocampus, which have 
been shown to be damaged in DM (denHeijer et al., 2003; Manschot et al., 2007).  
 Hopkins Verbal Learning Test-Revised (HVLT-R).  The HVLT-R Total and Percent of 
Retention scores measured verbal memory functions of word list learning and recall. In this test, 
participants are asked to learn and remember a list of 12 words that are verbally presented in 
three learning trials and a delayed recall (after 20-25 minutes) trial. Immediately after each of the 
three learning trials, participants in this study were asked to repeat the words they remembered. 
Scores were calculated for a total list learning score (the sum of the 3 trials), along with the  
percentage of words remembered after the 20-25-minute delay. The score range for the total list 
learning score was 0 to 36, and for the percent of retention delayed recall 0 - 100 percent 
(Benedict et al., 1998; Strauss et al., 2006). The HVLT-R discriminates between patients with 
mild cognitive impairment and cognitively healthy persons (Strauss et al., 2006; Woods et al., 








Participants’ level of depression was measured with the Patient Health Questionaire-8 
(PHQ-8), an eight-item self-administered questionnaire asking about depression symptoms over 
the last 2 weeks. Response options are “Not at all,” “Several days,” “More than half the days,” 
and “Nearly every day,” with 0 – 4 points associated for each option, respectively. The score is 
the sum of responses, with an overall range from 0-24. The levels of depression symptom 
severity levels are: none (1-4), mild (5-9), moderate (10-14), moderately severe (15-19), and 
severe (20-24). The PHQ-8 is valid for screening for depression and determining the severity of 
depression in primary care settings (Lamers et al., 2008)   
Everyday problem-solving in instrumental activities of daily living (IADLs). 
 Problem-solving ability in IADL performance was assessed using the Everyday 
Problems Test for Cognitively Challenged Elderly (EPCCE) (Allaire and Willis, 2006). The 
EPCCE is an objective performance-based measure of tasks that require cognitive processes of 
executive function to solve problems associated with IADLs. Willis et al. (1998) support the use 
of the EPCCE as an adjunct to self-report measures of functional status and cognitive measures. 
It was developed for use with non-demented older adults at risk for cognitive decline.  It is a 32-
item performance-based measure that uses printed material describing 16 everyday scenarios, 
such as use of the telephone, medication label interpretation, meal preparation, household chores, 
financial issues, and driving.  The test requires solving a problem related to each example, and 
choosing an answer.  The score range for correct answers is 0-32, with higher scores indicating 
better performance. Two-month test-retest reliability was r=.93 with Spearman-Bowman 
correction.  Internal consistency demonstrated with Cronbach’s alpha was r=.90) (Allaire and 





retest stability was r=.81.  Validity was examined by comparing the parent Everyday Problems 
Test, from which the EPCCE was derived, to two other functional measures with significant 
correlations of r = .67 and r = .87 (Willis et al., 1998).  
Statistical Analysis 
 Data analysis was performed using IBM SPSS statistics (version 22).  Descriptive 
statistics (means, standard deviations, ranges and frequencies), were generated to summarize the 
sociodemographic, clinical, neuropsychological test, self-care measure and everyday problem 
solving data.  To test hypothesis one, Spearman’s rank-order correlation, a nonparametric 
statistic with no requirement of normality, was used to examine the relationship between age, 
years with DM, education category, level of depression, HbA1c level, everyday problem solving, 
each cognitive function measure (attention, executive function, mental processing speed, verbal 
episodic memory), and levels of self-care. Preliminary analyses were performed to ensure no 
violation of the assumptions of normality, linearity, and homoscedasticity.   
 To test hypothesis two, hierarchical multiple regression was used to estimate the 
independent relationship between each cognitive measure, and each self-care activity after 
controlling for age, years with DM, education category, level of depression, and everyday 
problem solving.  The dependent variable, each self-care activity measure (general diet, specific 
diet, actual blood glucose testing, recommended blood glucose testing, foot care, exercise, 
medication adherence) was entered in individual equations after first controlling for 1) age, years 
with DM, education category (model 1); 2) model 1 variables plus level of depression; 3) model 
2 variables plus every day problem solving; 4) model 3 variables plus each cognitive measure 








 A convenience sample of 56 rural adults with DM from 5 counties across two 
Midwestern states was enrolled into this study.  Table 4.1. displays the sample characteristics 
and a summary of the clinical data.  Among this sample, 53.6% were female, 96.4% were White, 
96.4% completed high school, and 30.4% had a bachelor’s degree or higher.  Nearly 27% were 
employed, 3.6 % were unemployed, and 57.1% were retired.  Almost 52% consumed no alcohol 
and 86% were non-smokers.  The majority had health insurance (98.2%) and had no problems 
obtaining their medications (89.3%).  For the 10.7% that had problems obtaining medications, 
reasons included high co-pays and insurance non-coverage for medications that were not generic.  
 Compared with national data (United States Census Bureau, 2015), which estimates that 
the U.S. population is 77.1% White, 13.3% African American, 5.6% Asian, 1.2% Native 
American, and 17.6% of Hispanic ethnicity, the study sample had a higher percentage of White 
residents.  The sample also slightly exceeded estimates from the 2009-2014 Health Indicators 
Warehouse (HIW) (Health Indicators Warehouse, 2016) that 78% of the U.S. population 
completed high school with a diploma by age 18 years, that 30% of adults ages 25 years and 
older had completed a bachelor’s degree, that 6.2% of the population was unemployed, that 
10.4% of the U.S. population was unable to obtain medical or dental care or prescriptions, and 
that nearly 16% of the U.S. population under the age of 65 years had no health insurance (HIW, 
2016). Also of interest was that the study samples’ reported rates of smoking was 7% lower than 
the reported national average of 21.9% of all individuals over the age of sixteen HHIW, 2016). 
 Participants’ mean number of years with DM was 12.6, and their mean HbA1c was 7.7%.   





diabetes education participation, 34% had participated in some DM educational programming, 
39% had completed it, and 27% had never participated in it.  National data from the HIW (2016) 
reported that in persons over 18 years of age with DM, 48.2% had a HbA1c lower than 7% and 
21% had a HbA1c greater than 9%.  However, the report did not specify whether they had type 1 
or type 2 DM.  Also, the HIW (2016) reported that 57.6% of adult with DM ages 45-64 years 
received diabetes education. In adults with DM between ages 65-84 and 85 years and older, 
51.6% and 38.4% respectively, received DM education.  Compared with HIW data, the study 
sample had lower percentages of HbA1c below 7 and HbA1c greater than 9, and appeared to 
have more access to DM education. 
Nearly 61% of the study participants reported having neuropathy.  The mean score on the 
PHQ-8 was 5.5 (mild depression), with 53% having no depression, and 19% having either mild 
or moderate depression.  Mean systolic and diastolic blood pressure was 135.9 and 76.3, 
respectively, which was within the ADA guidelines for BP management in persons with DM that 
did not have multiple cardiovascular risk factors (ADA, 2016).  The mean scores for all 
cognitive function measures were below the established norms, and are displayed in Table 4.2.  
 Table 4.3. displays a summary of scores for the self-care and everyday problem solving 
measures.  Self-care activities most frequently performed were taking medications (mean 6.7 
days) and performing foot care (mean 5.2 days).  Diet was adhered to on average 4.5 days out of 
seven for general diet (following a healthful eating plan) and 4 days out of seven for diets 
specific for the consumption of fruits and vegetables, avoiding high fat foods, and evenly spacing 
carbohydrates.  Participants reported actual blood glucose testing 4.9 days per week on average 
and the frequency of blood glucose testing as recommended by their health care provider, and 





exercise performance compared to other self-care activities, with a mean of 2.9 days of exercise 
per week. 
Table 4.1.  
Sample Characteristics and Clinical Data (N=56) 
Characteristic/Clinical Data Result 
 
Range 
Age, mean (SD), years 62.6 + 9.3 45-89 
Gender, n (%) 
       Male 





Race, n (%) 
       African American 
       Native American 






Ethnicity, Non-Hispanic, n (%) 
 
55 (98.2)  
Marital status, n (%) 
     Married 





Education category, n (%) 
    Did not complete high school 
    Completed high school 
    Associate degree 







Employment status, n (%) 
    Employed 
    Unemployed 











Problems obtaining medications, n (%) 
   Yes 





Alcohol consumption frequency, n (%) 
     2-3 times per week 
     2-4 times per month 
     Monthly or less 







Smoker, n (%) 
     No 
     Yes 






HbA1c, mean (SD) 
 
     HbA1c <7, n (%) 
     HbA1C > 7 & < 9, n (%) 
      HbA1c > 9, n (%) 







Years with DM, mean (SD) 
  





DM education status, n (%) 
     Yes 
     Yes, completed 






Neuropathy, n (%) 
     No 





MoCA, mean score (SD) 
 
Normal cognition, n (%) 
 (MoCA score > 26-30) 
Mild cognitive impairment, n (%) 
 (MoCA score 22-25) 






PHQ-8, mean score (SD) 
 
No depression, n (%) 
(PHQ-8 score 0-4) 
Mild depression, n(%) 
(PHQ-8 score 5-9) 
Moderate depression, n (%) 
(PHQ-8 score 10-14) 
Moderate/Severe depression, n(%) 
(PHQ-8 score 15-19) 










Body Mass Index, mean (SD)  37.4 + 9.3 22-65.1 
Systolic Blood Pressure, mean (SD), mmHg 135.9 + 20.0 83-181 
Diastolic Blood Pressure, mean (SD), mmHg 76.3 + 9.8 55-98 
Total Cholesterol, mean (SD), mg/dl  182.3+ 43.2 96-296 
High Density Lipoprotein, mean (SD), mg/dl 42.3 + 11.7 25-84 




































Norms + SD 
Attention 
     Digit Span Total 
     Trails A 
  
    (seconds to complete) 
     Trails A 
     (# correct per second)  
 
8.77 + 2.5 
36.9 + 13.4 
 








10.5 + 1.0 
31.3+ 6.7  
Executive Function 
     COWA Raw Score    
     Trails B  
    (seconds to complete) 
     Trails B 
     (# correct per second) 
 
 
32.3 + 13.8 
97.0 + 64.4 
 










64.6 + 18.6 
 
Mental Processing Speed 
     Digit Symbol Coding 
     Letter Comparison 
     Pattern Comparison 
 
53.5 + 11.7 
5.8 + 1.6 






54.3 + 8.9 
n/a 
n/a 
Verbal Episodic Memory 
     HVLT-R Recall Total 
     HVLT –R % Retention 
 
 
19.6 + 6.5 





20.6 + 5.2 
89.0 + 25.8 
 
EPCCE- number correct (SD) 
      
 





Note. COWA=Controlled Oral Word Association Test; EPCCE=Everyday Problems Test for Cognitively 






















Summary of Scores for Self-Care & Problem Solving Measures (N=56) 
Measure Mean Scores + SD Score Ranges 
Summary of Diabetes Self-Care Activities Measure   
    (number of days each activity was performed (SD)) 
 
     General Diet 
     Specific Diet 
     Exercise 
     Actual Frequency of Blood Glucose Testing 
     Recommended Frequency of Blood Glucose Testing 
     Foot Care 
     Medication Adherence  




4.5 + 1.7 
4.0 + 1.5 
2.9 + 2.3 
4.9 + 2.8 
4.2 + 2.9 
5.2 + 1.4 
















Hypothesis 1:  Increased age, years with DM, and level of depression, and decreased years 
of education, everyday problem-solving, glycemic control, and cognitive function would 
correlate with poorer levels of DM self–care adherence in a sample of rural adults with 
DM,  
 Hypothesis one was tested using Spearman’s rank-order correlation to first examine the 
relationship between contributing factors of age, years with DM, education category, level of 
depression, everyday problem solving, HbA1c, and levels of self-care.   Next the relationship 
between cognitive function, everyday problem solving, and levels of self-care were examined. 
Preliminary analyses ensured no violation of the assumptions of normality, linearity, and 
homoscedasticity occurred.  The expected direction of the relationships between age, years with 
DM, level of depression, HbA1c, and levels of self-care were negative.  The expected direction 
of the relationships between education category, everyday problem solving, cognitive function, 
and levels of self-care were positive. 
 As seen in Table 4.4., age, years with DM, and education category were moderately 
correlated only with everyday problem solving (r= -.44, r= -.36, r= .45, all p<.01 respectively).  
There were small to moderate correlations between depression and adherence to general diet (r = 
-.38, p <.01), specific diet (r= -.46, p<.01), and exercise (r= -.34, p<.05).  HbA1c was moderately 
correlated with level of depression (r=.34, p<.05), general diet (r= -.43, p<.01), and actual blood 
glucose testing (r=.35; p<.01).  As depicted in Table 5, there were moderate to large correlations 
between all cognitive domains and everyday problem solving as follows: attention (r= .36 p<.05; 
r= .61, p<.01), executive function (r= .41, p <.01, r= .49, p<.001), mental processing speed (r= 
.31, p<.05; r= .37, r= .40, both p<.01), and verbal episodic memory (r= .35, p<.01; r= .56, 





= .28, r = .27, both p<.05 respectively). Verbal episodic memory had a small correlation with 
foot care (r = .27, p<.05).  Results suggest lower age, fewer years with DM, and higher education 
category are associated with better performance in everyday problem solving in IADL tasks. 
Also, higher function in all measured cognitive domains was associated with better performance 
in everyday problem solving in IADL tasks.  Increased level of depression was associated with 
decreased adherence to general and specific diet, and exercise. Poorer glycemic control was 
associated decreased adherence to general diet, increased frequency of blood glucose testing, and 
higher level of depression. Increased frequency of blood glucose testing may reflect the 
recognition of poor diet and hyperglycemia, and attempts to try to achieve better glycemic 



























  -.18 
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-.38** -.46**    .28* .04 -.11 -.34* -.19 -.13 .34* 
Years with 
 DM 
-.004 -.01    .21 .13 .05 .04 -.12 -.36** .17 
HbA1c -.43** -.25  .35** .14 .24 -.23 -.18 .06  
EPCCE 
 
.06 -.14   -.16          -.09 .01 -.03 -.06 
 
 
Note.  EPCCE=Everyday Problems Test for Cognitively Challenged Elderly.  



























































































































































Verbal Episodic Memory 
 






































Note. COWA=Controlled Oral Word Association Test; EPCCE=Everyday Problems Test for Cognitively Challenged Elderly; HVLT-R=Hopkins 






Hypothesis 2:  Cognitive function, after controlling for the contributing factors, would 
independently predict level of self-care activity performance  
The results of multiple regression models 4 (all variables plus each cognitive measure 
individually) reaching significance are in Tables 4.6., 4.7., and 4.8.  With testing hypothesis two, 
the models explained between 13-14% of the variance in specific diet adherence, 23% of the 
variance in actual frequency of blood glucose testing, and 22-24% of the variance in frequency 
of exercise.  After controlling for age, years with DM, and education category, level of 
depression independently explained specific diet adherence when entered with all cognitive 
domains, and had the highest Beta values (-.41 to -.49, p<.01 and p<.001).  Level of depression 
also independently explained performance in the actual frequency of blood glucose testing when 
entered with measures of mental processing speed (B = .36, p<.01).  Level of depression also 
independently explained adherence to exercise when entered with measures of attention (B= -.37, 
p<.05), mental processing speed (B= -.38, p<.01), and verbal episodic memory (B= -.29, p<.05).  
None of the models with adherence to general diet, recommended frequency of blood glucose 
testing, foot care or medications reached significance. In model 5, where all variables and all 
cognitive function measures were entered simultaneously, the equations with frequency of 
exercise and actual blood glucose testing were significant (adjusted R2=.25, p=.02, adjusted R2= 
.23, p = .03, respectively).  Everyday problem solving independently explained exercise 
frequency (B=-.49, p=.02), and level of depression independently explained frequency of actual 






Results of Hierarchical Multiple Regression—Contributing Factors and Cognitive Measures Explaining Self-Care Measures— 
Dependent Variable Specific Diet (n=56) 
 Attention Executive Function Mental Processing Speed Verbal Episodic 
Memory 








 Betaa R2 
 ∆ 
Betaa R2  
∆ 
Betaa R2  
∆ 
Betaa R2 
  ∆ 






Betaa R2 ∆ 
Model 1               .001           .001            .001          .001                  .001               .001           .001              .001           .001 
Age (years) 
 
-.10 -.02 -.13 -.03  .01 -.05 -.07 -.13 -.10 
Years with 
DM 
.15  .10   .11   .14  .15  .15 .15  .13  .14  
Education 
Category 
.01  -.01  .01  -.02  -.02  -.01 -.02  .00  .00  
Model 2  .22***  .22***  .22***  .22***  .22***          .22*** .22***           .22***          .22*** 
Level of 
depression 
-.49***           -43***       -.49***       -.45**        -.41**         -.46**         -.48**      -.49***       -.48** 
Model 3  .00  .00  .00  .00  .00  .00  .00  .00  .00 
EPCCE 
 
-.06  -.05  -.01  -.06  -.03                 -.04 -.02 .01 -.01 




.09  .19  -.11  .17  .20  .12  .09                -.10  -.01  
R2 
 
 .22 .24 .23 .24 .24 .23 .22 .22 .22 
Adjusted 
R2 
.13 .15 .13 .14 .14 .14 .13 .13 .12 
Overall 
significance 
.04* .03* .04* .03* .03* .04* .04* .001*** .05 
Note. COWA=Controlled Oral Word Association Test; EPCCE= Everyday Problems Test for Cognitively Challenged Elderly; 
 HVLT-R=Hopkins Verbal Learning Test-Revised. 






Results of Hierarchical Multiple Regression--Contributing Factors and Cognitive Measures Explaining Self-Care Measures— 
Dependent Variable Actual Blood Glucose Testing (n=56) 
Mental Processing Speed 
 
Predictors Digit Symbol 
 Betaa R2 
 ∆ 
Model 1               .11 
Age (years) 
 




































Results of Hierarchical Multiple Regression--Contributing Factors and Cognitive Measures Explaining Self-Care Measures— 
Dependent Variable Exercise (n=56) 
                                              Attention                        Mental Processing                   Verbal Episodic 
                                                                                              Speed                                   Memory 
Predictors               Digit Span      Trails A                Digit                Letter              HVLT            HVLT %                     
                                                                                 Symbol          Comparison     Total Recall      Retained 
 Betaa R2 
∆ 
Betaa        R2  
           ∆ 
Betaa R2 
∆ 
Betaa          R2    Betaa      R2     Betaa         R2                                               
               ∆                    ∆                        ∆          
Model 1                  .06                 .06                      .06                   .06                 .06                      .06                
Age (years)  -.37*        -.26        -.24      -.48**     -.30         -.30         
Years with 
DM 
  .25 .      .16          .24                    .20        .24            .16 
Education 
Category 
  .00       -.03         -.05            .00        -.02 
 
 -.01  
Model 2                .10*        .10*            .10*                       .10 *              .10*                    .10* 
Level of 
depression 
-.37*       -.27  -.24          -.38**              -.31*           -.29* 
Model 3                 .03        .03            .03         .03         .03                       .03 
EPCCE -.35        .28        -.25                   -.20                 -.30                   -.36         
Model 4                 .04  .05            .04         .04         .03                       .05 
Cognitive 
function 
 .23 .27   .28           -.25  .23             .28 
R2       .22             .24                    .23           .22            .22                .24 
Adjusted R2 
 
.13          .14              .13           .13            .12                .14 
Overall 
significance 
 .04*           .03*         .04*            .04*            .05                .03*  







The framework by Song (2010) used to guide the analysis portrayed the complexity of 
DM self-care. In this study, cognitive function was applied to the framework as a situation-
specific influence on DM self-care. This approach attempted to link theory, research and clinical 
practice in a way that would be useful to clinicians who provide care to persons with DM.  Based 
on the measures used, this analysis was limited to the evaluation of DM self-care activities that 
reflected adherence (diet, exercise, foot care, medications) and monitoring (blood glucose 
testing).  Measurement of symptom awareness and recognition, direct self-care management, and 
decision making was not included, as it was beyond the scope of this study.  Knowledge of DM 
self-care was also not directly measured, but the capacity for gaining knowledge was reflected by 
examining cognitive processes essential for learning (attention, executive function, verbal 
episodic memory). Level of depression and everyday problem solving ability for IADL tasks 
were included as factors that may influence DM self-care.  
Rural-related sociodemographic factors that can influence self-care performance were 
also explored.  The characteristics of the sample were slightly higher in levels of education, 
employment, healthcare access, and healthcare insurance when compared to national trends, 
suggesting that this population had no disparities in education, employment, or healthcare access.  
Adherence to medication and foot care were the most frequently performed self-care 
activity among the study participants.  The frequency of recommended glucose testing being 
lower than the actual number of days blood glucose was tested could be due to the lack of blood 
glucose testing supplies available due to insurance non-coverage, forgetting to test multiple times 






The first hypothesis was not supported.  Age, level of education, and number of years 
with DM were associated with everyday problem solving, but with none of the self-care 
activities.  Lower level of depression was associated with higher diet and exercise adherence, and 
better glycemic control.  As expected, all cognitive domains were positively associated with 
everyday problem solving ability, which illustrates the cognitive complexity of performing 
IADLs.  Contrary to expectations, cognitive function was minimally associated with self-care 
activity performance, and the number of years with DM had no association with self-care 
activities.  Better glycemic control was associated only with general diet adherence.   
  The second hypothesis was not supported, that cognitive function, after controlling for 
the contributing factors, would independently predict level of self-care activity performance.  
The results of hierarchical multiple regression models (model 4 with all variables plus each 
cognitive measure individually) with specific diet adherence as the dependent variable explained 
13-15% of the variance in adherence to specific diet.  Only the level of depression independently 
explained adherence to specific diet.  Higher levels of depression independently accounted for 
decreased self-reported adherence to the specific diet parameters (eating fruit and vegetables, 
avoiding high fat foods, and evenly spacing carbohydrate intake throughout the day).  With 
actual blood glucose testing as the dependent variable, results of regression model 4 (cognitive 
domain mental processing speed) explained 13% of the variance in the model.  Unexpectedly, 
higher levels of depression independently accounted for increased frequency of blood glucose 
testing with faster mental processing speed and lower education.  With exercise frequency as the 
dependent variable in regression model 4, results showed that 13-14% of the variance was 





Lower levels of depression independently explained higher frequency of exercise in models with 
all three cognitive domains.  
 Age independently explained only exercise frequency (B= -.37, p<.05, B = -.48, p<.01), 
which likely reflects decreased physical ability in older age.  Another factor that may have 
impeded the ability to exercise was the high incidence of neuropathy or presence of foot ulcers in 
the study population.  Number of years with DM did not independently explain any of the self-
care activities, which was consistent with a systematic review of 12 studies regarding DM self-
care by Tomlin & Sinclair (2016). Level of education independently accounted for variance only 
in actual blood glucose testing frequency in one model with mental processing speed (B= -.32, 
p<.05).  Everyday problem solving also did not independently explain variance in any self-care 
activity, and mainly had negative beta values.  These findings could be due to the nature of the 
self-care activities that were measured, which were monitoring and adherence tasks that do not 
require problem-solving or decision making.  Also, the problem-solving tasks in the EPCCE 
were not specific to DM, but were general IADL tasks concerning finances, meal preparation, 
medications, household maintenance, telephone use, and transportation.  The EPCCE score 
reflected total performance in all categories.  Perhaps if the categories were analyzed separately 
the results would be different. 
In this group of 56 rural adults with DM, level of depression was highly influential in 
adherence to specific diet recommendations.  Higher levels of depression predicted decreased 
healthy diet choices (i.e. specific recommendations), and also decreased frequency of exercise.  
In this study, potential participants were screened and excluded if they had a major depressive 
disorder. Hence, the results pertaining to the affected self-care activities were moderated by the 





 In previous studies using the SDSCA to assess self-care activity levels (Lin et al., 2004; 
Primozic et al., 2012), results of comparison of persons with DM with major depression (n=536) 
and no depression (n=3927) by Lin and colleagues (2004) showed that major depression was 
associated with infrequent fruit and vegetable intake, more frequent fat intake, and infrequent 
exercise.  Differences in adherence to blood glucose testing and foot care were not significant 
between those with and without major depression (Lin et al., 2004).  Primozic and colleagues 
demonstrated that absence of major depression, better executive function, and lower body mass 
index, were predictive of better self-care (diet, exercise, foot care). 
 The dysregulation and over activity of the HPA-axis and SNS that co-exist in depression 
and DM may help explain these findings.  Behavioral consequences of HPA-axis and SNS 
dysfunction include anxiety and food craving (Badescu et al., 2016). And, as a consequence of 
the inflammatory effects of depression on hippocampal function, neurotransmitter metabolism, 
neuroendocrine function and synaptic plasticity are affected (Badescu et al., 2016). Decreased 
neuronal connectivity between the hippocampus and several brain regions has been documented 
with persons with DM (Hoogenboom et al., 2014; Zhou et al., 2010), and has been shown to be 
associated with dysfunction in executive function (Zhou et al., 2010). Also, insulin resistance has 
been associated with decreased functional connectivity of the posterior cingulate cortex (which is 
associated with attentional functions) to other brain areas (Chen et al., 2014). Treatment 
adherence is dependent on prefrontal cortex based executive functions and working memory 
(Insel et al., 2006), and depression has been associated with decline in executive function and 
mental processing speed in persons with DM (Sullivan et al., 2013).  Perhaps the disruption in 
the functional connectivity between key brain areas involved in treatment adherence is an 





 Self-motivation is strongly association with good glycemic control (Bruce et al., 2015; 
Padala et al., 2007).  Presence of apathy, defined as lack of motivation, manifests as decreased 
goal-directed behavior, and symptoms of apathy frequently overlap with depression. Apathy is 
considered to be a syndrome distinct from depression, can exist in the absence of depression, and 
may be a major factor in one’s ability to adhere to DM self-care (Bruce et al., 2015; Padala et al., 
2007).  In a sample of predominately males with DM (N= 81, mean age (SD) = 58.6 + 11.9 
years), 50 tested positive for apathy without depression, and were less likely to follow an 
exercise plan and take their insulin as instructed (Padala et al, 2007). Apathy was found to have a 
higher incidence in adults (without dementia) with DM (n = 122, mean age (SD) = 73.5+ 7.0), 
than adults without DM (n = 69, mean age (SD) = 74.6 + 7.0) (Bruce et al., 2015). Using the 14-
item Apathy Scale, the with DM group, 13.9% had apathy versus 1.4% in the without DM group. 
In the with DM group, apathy was significantly associated with mild cognitive impairment, 
depression and poorer glycemic control. After approximately 18 months, the group with DM had 
a clinically relevant decrease in glycemic control, and significant cognitive decline since 
baseline. The researchers concluded that apathy is an important syndrome in older persons with 
DM that likely is a barrier to effective self-care (Bruce et al., 2015; Padala et al, 2007). 
Strengths and Limitations 
 An important aspect of this study was conducting face-to-face interviews to examine 
cognitive function, self-care activities, performance-based everyday problem solving, and 
glycemic control in rural adults with DM. Each cognitive domain was tested with at least two 
measures that assessed slightly different cognitive processes. Cognitive function was applied to a 
situation-specific theory based framework for self-care in persons with DM to guide analysis. 





focused on an older population (age 55 years and older). Also, other factors that may impact self-
care performance, such as education category and depression were included. Of note is that the 
depression measure, the PHQ-8, referred to signs of depression within the last two weeks of the 
interview, and the HbA1c could have been done up to 2 months prior.  And, an exclusion 
criterion for participation was a diagnosis of major depression. Limitations include selection bias 
in sample recruitment due to a limited rural area with a racial majority of white residents. Also, 
these participants were receiving health care in primary care and specialty DM clinics, and did 
not appear to have barriers to health care access, which may have skewed the results more 
positively. Everyday problem-solving IADLs was not specific to DM, but was of a general 
nature. Self-care activities were self-reported, and not performance-based. Acquisition of DM 
knowledge was not measured, but may have been influential in assessing self-care performance.  
In addition, because the study was cross-sectional, no longitudinal trends in the variables could 
be determined. 
Conclusion 
 This study provides evidence that the frequency of DM self-care activity performance by 
rural adults with DM is not independently explained by cognitive function in domains of 
attention, executive function, mental processing speed, or verbal episodic memory. A 
consideration is that the self-care measure was self-reported, not observed, and the reporting 
could be affected by memory or poor understanding of the instrument. Increased years with DM 
did not uniquely explain self-care activity, but appeared to have a positive influence on 
adherence to specific diet, blood glucose testing and exercise. Of concern is that 48% of the 
participants had mild cognitive impairment, including those under the age of 65 years. Although 





persons with DM of all ages, not just the elderly. Knowledge of DM self-care, which is likely 
associated with cognitive function, was not measured, and may influence self-care performance. 
It is unclear whether decreasing cognitive function leads to poor self-care, or whether poor self-
care leads to decreasing cognitive function. In either case, in clinical practice both need to be 
addressed as a potential contributor to lack of adherence to treatment plans. 
 Increased global cognitive impairment was associated with higher depression levels, and 
level of depression was influential in diet and exercise adherence.  The dynamics of the structural 
brain changes that occur in DM may contribute to the effect that depression has on self-care 
performance, which emphasizes the importance of screening for depression in persons with DM.  
As was emphasized by Bruce et al. (2015) and Padala et al. (2007), apathy may be present 
without depression in persons with DM, and may contribute to decreased self-care performance. 
Screening for apathy, and differentiating it from true depression, may provide insight into poor 
adherence to self-care. Further research is needed to examine whether treating depression and 
apathy has an effect on treatment adherence, and ultimately glycemic control. 
 Everyday problem solving in IADL tasks did not influence DM self-care performance, 
but as mentioned previously, the self-care activities that were evaluated may not be highly 
dependent on problem-solving. Each IADL category could be evaluated separately, which may 
provide different results. A performance based measure of problem solving related specifically to 
DM self-care would be beneficial. Further study is needed to examine the self-care management 
processes of sign and symptom recognition and treatment implementation, which do require 
decision making and problem solving.  Klein and Lippa (2008) proposed that DM education 
should be based on decision-making research that assists persons with DM to develop cognitive 





DM education should strive to conceptualize DM self-care as a dynamic and complex process 
that requires problem solving, and not merely adherence to set rules and procedures. The process 
of DM education should include simulations and scenarios that allow practice in progressively 
difficult situations, and consider each individual’s cognitive abilities (Klein & Lippa, 2008). 
Finding ways of including support systems, such as family, friends, and significant other, may 
facilitate the patient’s expertise in problem detection and management.  
These findings provide a foundation for further studies that can impact clinical practice. 
As the prevalence of DM rises and affects younger people, there is an urgent need to further 
understand how DM impacts learning, memory, job performance and quality of life. Future 
research is needed to validate the importance of cognitive, depression and apathy screening as 
part of the overall DM management regimen for all age groups. 
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 This research adds to the growing knowledge base of the relationships between cognitive 
function, self-care and glycemic control in rural adults with DM, and offers insights for health 
care professionals seeking to improve care for persons with DM.  This chapter provides a 
summary of the findings, strengths and limitations of the study, and implications for future 
research and nursing practice.  The overall purpose of the study was to examine the relationship 
between cognitive function in domains of attention, executive function, mental processing speed 
and verbal episodic memory, self-care performance and glycemic control among rural adults 
with DM age 45 years and older.  Based on the literature, a conceptual framework was developed 
to describe the relationships among these factors, and is presented in Figure 1.1. 
The framework incorporates biological, environmental and behavioral influences on 
cognitive function, self-care, and glycemic control in DM, and identifies the reciprocal 
associations among cognitive function, self-care, glycemic control, and contributing factors. 
Structural brain changes in DM are associated with multiple pathophysiological factors that play 
a role in the profile of cognitive decline.  Declining cognitive function can create barriers to 
performing self-care, which is an important part of achieving glycemic control and reducing 





decline.  Embedded in the framework is a model for DM self-care based on the self-care model 
by Song (2010).  Song’s model for DM self-care is based on a situation-specific theory for self-
care in heart failure patients (Riegel and Dickson, 2008).  Situation-specific theories focus on 
specific phenomena seen in clinical practice, and are limited to a specific population (Im & 
Meleis, 1999).  The DM self-care model by Song (2010), self-care consists of two components:  
Self-Care Maintenance and Self-Care Management.  Self-care maintenance includes behaviors to 
maintain physiologic stability:  symptom monitoring and treatment adherence (diet, medications, 
blood glucose testing, exercise, and foot examination), and self-care management incorporates 
active decision making in response to awareness of sign and symptom changes.  In this 
dissertation research, cognitive function was applied to the framework as a situation-specific 
influence on DM self-care.  
 First, a scoping review of the literature was conducted to summarize the existing state of 
knowledge about cognitive function in DM and DM self-care.  The main findings of a review of 
74 publications were:  1) documentation of the interplay between pathophysiological brain 
changes, cognitive function, and modifiable and non-modifiable risk factors for cognitive 
decline, 2) clarification of the presence of cognitive decline in pre- and early DM, and 3) 
evidence relating cognitive decline to DM self-care.  Risk factors of hypertension and 
hyperlipidemia are interrelated, may affect cognition at various times for various durations, and 
are modifiable with treatment.  Depression, which is also modifiable, has a high prevalence in 
persons with DM, and is associated with cognitive decline.  Other factors that contribute to 
cognitive decline, and are not modifiable, include sociodemographic variables (i.e. age, gender, 
education level) and the duration of having DM.  Because early stages of DM are often 





cognitive decline may follow two different processes in DM: 1) mild slowly progressing decline 
beginning in pre-DM stages, and 2) severe faster decline with high prevalence of vascular and 
Alzheimer’s dementia. 
Intact cognitive ability is necessary for the complex tasks necessary for daily DM self-
care, and cognitive decline interferes with understanding, recalling, and applying instructions, 
and contributes to impaired sign and symptom recognition.  Decline in cognitive domains of 
attention, executive function, mental processing speed and verbal episodic memory may be 
present with normal global cognition.  Knowledge gaps exist concerning the cognitive processes 
underlying the different self-care behaviors, and the link between cognition, DM knowledge and 
DM self–care performance. 
  Chapter three, the second manuscript, investigated the relationships between cognitive 
function, contributing factors, and glycemic control.  First, Pearson’s r and Spearman’s rank-
order correlations were used to examine the relationship between age, years with DM, education 
category, CV risk, level of depression, and each cognitive function measure and HbA1c level. 
Older age, more years with DM, and higher CV risk were correlated with poorer performance in 
each cognitive domain, with a medium to large magnitude for age and CV risk, and small to 
medium magnitude for years with DM.  Higher level of depression was moderately correlated 
with slower mental processing speed, and poorer glycemic control.  Higher education category 
had a small correlation with better executive function, mental processing speed, and verbal 
episodic memory.  HbA1c had no significant correlations with any cognitive measures.  Next, 
hierarchical multiple regression was conducted to determine whether HbA1c, after controlling 
for non-modifiable (age, years with DM, education category) and modifiable covariates 





all covariates plus HbA1c and each separate cognitive measure, the models explained between 
21 and 43 percent of the variance in cognitive performance with overall significance levels 
between <.001 to .03.  HbA1c did not independently explain cognitive test performance in any of 
the cognitive domains.  Level of depression independently explained performance in mental 
processing speed (Digit Symbol), and level of depression and CV risk independently explained 
performance in verbal episodic memory (HVLT% retained).  It was concluded that HbA1c levels 
may not be a major determinant in cognitive test performance, rather other sociodemographic 
and clinical factors are more influential.  However, HbA1c is a modifiable factor, whereas other 
factors such as age, duration of DM, history of CV disease, and education level are not.  Last, 
hierarchical multiple regression was conducted to determine whether cognitive function, after 
controlling for the covariates, would independently predict HbA1c.  Only the model with all 
covariates and cognitive measures entered simultaneously nearly reached significance (p=.06), 
and better executive function independently explained lower HbA1c, which was anticipated. 
Chapter four, the third manuscript, investigated the relationships between cognitive 
function, self-care, contributing factors, and glycemic control.  The DM self-care model by Song 
(2010) was used to guide the analysis and portrayed the complexity of DM self-care.  Self-care 
activities most frequently performed were taking medications and doing foot care, followed by 
diet adherence and blood glucose testing.  Exercise was the least performed self-care activity and 
exhibited low frequency levels consistent with other research and national samples.  The 
education level, employment, healthcare access, and healthcare insurance profiles of the study 
sample also appeared to be similar to national data, suggesting that this population had no 
disparities in education, employment, or healthcare access.  Spearman’s rank-order correlation 





depression, HbA1c level, everyday problem solving, each cognitive function measure (attention, 
executive function, mental processing speed, verbal episodic memory), and levels of self-care. 
Lower age, and number of years with DM, and higher level of education, was moderately 
correlated with everyday problem solving, but with none of the self-care activities.  Lower level 
of depression was moderately correlated with higher diet and exercise adherence, and better 
glycemic control.  Better performance in all cognitive domains was moderate to largely 
correlated with better everyday problem solving ability, and was minimally associated with self-
care activity performance.  Better glycemic control was associated only with general diet 
adherence.  Next, hierarchical multiple regression was used to estimate the independent 
relationship between each cognitive measure, and each self-care activity after controlling for age, 
years with DM, education category, level of depression, and everyday problem solving.  The 
results of the hierarchical multiple regression models that included all variables, plus each 
cognitive measure separately, explained 13-15% of the variance in adherence to specific diet.  In 
all cognitive domains, higher levels of depression independently predicted decreased self-
reported adherence to the specific diet parameters (eating fruit and vegetables, avoiding high fat 
foods, and evenly spacing carbohydrate intake throughout the day).  Only the model with mental 
processing speed explained 13% of the variance in actual blood glucose testing.  With exercise 
frequency as the dependent variable, 13-14% of the variance was explained with attention, 
mental processing and verbal episodic memory as cognitive measures, and level of depression 
independently explained lower frequency of exercise in models with all three cognitive domains.  
Strengths of the Study 
An important strength of this study was that face-to-face interviews were conducted that 





performance-based everyday problem solving, and glycemic control in rural adults with DM. 
Performance in multiple cognitive domains was tested using at least two measures per domain. 
Non-modifiable and modifiable sociodemographic and clinical variables that influence cognitive 
function and self-care performance in rural adults with DM were investigated.  To guide analysis 
of self-care performance, cognitive function was applied to a situation-specific theory based 
framework for self-care in persons with DM. 
Limitations of the Study 
Study limitations include recruitment of a convenience sample from primary care and 
DM education centers, which may have biased the findings.  The participants had access to 
regular healthcare and lab work, DM education, and treatment adjustments.  Many were 
employed and had health insurance.  These factors may have skewed the results more positively, 
and would likely differ from a sample that was unemployed and had limited or no access to 
healthcare.  The blood glucose level at the time of the administration of the cognitive tests was 
not determined, and extremes in blood glucose levels may have affected cognitive performance. 
Lower, but normal cognitive function may be associated with other factors, such as poor 
performance of self-care, which may lead to poor glycemic control, and other comorbidities not 
accounted for such as heart failure.  Also, the length and intensity of the interview could have 
caused fatigue or anxiety.  Self-care activities were self-reported, and not performance-based. 
Small sample size is also a limitation, as some nearly significant results may have been 
significant in a larger study population.  Because the study was cross-sectional, no longitudinal 
trends in the variables could be determined, nor any causality implied. In addition, the results are 






Implications for Future Research and Clinical Practice 
This study provides evidence that cognitive function in domains of attention, executive 
function, mental processing speed, or verbal episodic memory in rural adults with DM, after 
controlling for modifiable and non-modifiable covariates, does not independently explain 
glycemic control or the frequency of DM self-care activity performance by rural adults with DM. 
These findings suggest that exposure to risk factors and comorbidities are more influential in 
explaining glycemic control and self-care performance.  Higher CV risk and level of depression, 
both modifiable factors, were predictive of poorer cognitive function.  Higher levels of 
depression were predictive of decreased adherence to blood glucose testing, diet, and exercise. 
Some elements of CV risk, such as blood pressure control, lipid levels, smoking status, and 
depression are modifiable with intervention. 
 Increased global cognitive impairment was associated with higher depression levels, and 
although depression can impair one's ability to adhere to self-care regimens, it is unclear whether 
decreasing cognitive function leads to poor self-care, or whether poor self-care leads to 
decreasing cognitive function.  Apathy may be present without depression in persons with DM, 
and may contribute to decreased self-care performance.  Further research is needed to examine 
whether treating depression and apathy has an effect on treatment adherence, and ultimately 
glycemic control.  In either case, it is imperative for clinicians to routinely screen for depression 
and mild cognitive impairment, and both need to be addressed as a potential contributor to lack 
of adherence to treatment plans.  
 Of concern is that 48% of the participants had mild cognitive impairment, including 
those under the age of 65 years.  Although self-care performance was not predicted by cognitive 





especially given that DM is a chronic disease and associations have been made between 
declining cognitive function and poorer glycemic control.  More research is required to identify 
how these findings impact one’s everyday ability to perform self-care, instrumental activities of 
daily living, and required job tasks.  Decline in the cognitive domains of attention, executive 
function, mental processing speed, and verbal episodic memory, varies with age and years with 
DM.  Presently, there is no standardized method to monitor for cognitive decline in persons with 
DM.  Further research in this area is greatly needed, as it may be possible to improve some 
aspects of cognition with cognitive interventions such as training in memory, reasoning, problem 
solving, and mental processing speed.  
Everyday problem solving in IADL tasks did not influence DM self-care performance, 
but as mentioned previously, the self-care activities that were evaluated may not be highly 
dependent on decision making and problem-solving.  A performance based measure of problem 
solving related specifically to DM self-care would be beneficial.  Further study is needed to 
examine the self-care processes of sign and symptom recognition and treatment implementation, 
which do require decision making and problem solving.  That research would be beneficial in 
designing DM education programs that assists persons with DM to develop cognitive skills that 
promote problem detection, decision making, and problem-solving  
These findings provide a foundation for further studies that can impact clinical practice. 
As the prevalence of DM rises and affects younger people, there is an urgent need to further 
understand how DM impacts learning, memory, self-care, job performance and quality of life.  
  
 
 
